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CHAPTER 1 
INTRODUCTION 
1.1 Background and Significance 
Proteins are biological macromolecules that play a central role in 
numerous biological and physiological processes in living organisms, carrying out 
most biochemical functions of the cell and being widely employed in structural 
roles.1 The biological function of a particular protein derives from its unique 
folded structure, which in turn is defined by the amino acid sequence of its 
polypeptide chain.2 The diverse and important roles that proteins play in the 
biological world, and the correlation between their structure and function have 
long intrigued scientists.3 In this context, that of understand the underlying 
mechanism of these processes at molecular level, the ability to modify structural 
and functional properties of bioactive proteins is crucial in biological and medical 
research.4 The first requirement for the study of proteins is accessibility in terms 
of purity and quantity. There are three main approaches to consider: (i) native 
protein isolation, (ii) recombinant techniques for the expression of proteins in 
microorganisms, and (iii) chemical synthesis. 
For the past thirty years, techniques of recombinant DNA-based molecular 
biology have been used for systematic variation of the amino acid sequence of a 
polypeptide chain and the resulting changes in behavior of these 
macromolecules have been correlated to their amino acid sequence. This 
approach, which is recognized as protein engineering, has provided useful 
insights into protein function.3 However, the protein engineering approach to 
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probing the molecular basis of protein function has some limitations, but mainly 
the fact that only twenty genetically encoded amino acids can be readily 
incorporated and that site-specific post-translational modifications of the protein 
molecule are technically difficult to control with precision.2 Intrepid efforts have 
been made to overcome these limitations, both in vitro and by the use of 
synthetic biology in engineered microorganisms but to date, only limited 
improvements have been made in elucidating the molecular basis of protein 
function.5,6 
Chemical synthesis of proteins overcomes these limitations and enables 
many modifications to the covalent structure of a protein molecule by the 
introduction of unnatural amino acids, site-specific isotopic labeling, labels for 
imaging, and the site-specific attachment of affinity tags without limitation as to 
the number and kind of labels and tags introduced.7  
1.2 Chemical Synthesis 
The quest to make enzymes and other protein molecules by chemical 
synthesis was one of the most ostentatious challenges for organic chemistry in 
the twentieth century. In the early years of the century, the great German chemist 
Emil Fischer and his scientific descendants pioneered the field of chemical 
peptide synthesis that eventually enabled the total chemical synthesis of the 
complex biologically active peptide hormone oxytocin (with its nine amino acid 
residues).8 The total chemical synthesis of proteins remained a major objective of 
the organic synthesis community in the decades following the Second World 
War. 
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The chemical synthesis of a protein involves the formation of an amide 
bond between a peptide acid and an amine segment. This process involves the 
activation of a peptidyl acid, which is then subjected to aminolysis with a peptidyl 
amine to form native amide bond (Scheme 1). 
Scheme 1. Amide bond formation 
Amide bond formation can often present difficulties such as low yields, 
epimerization of adjacent stereogenic centers,9 degradation, difficulties with 
purification, etc. Activation of the carboxylic group can lead to racemization of C-
terminal α-amino acid via the oxazolone intermediate (Scheme 2).9  
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Scheme 2. Mechanism of epimerization via oxazolone formation 
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However, additives, such as 1-hydroxybenzotriazole 22 suppress 
racemization by formation of a less-reactive HOBt ester. Over the years, 
numerous mild coupling reagents and methods have been developed that are not 
only high yielding, but also help to minimize the racemization of neighboring 
stereogenic centers, and permit difficult couplings with sterically hindered amino 
acids. A selection of the most widely used coupling reagents is shown in Figure 
1.10-12 
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Figure 1. Common coupling reagents and additives 
The development of the Merrifield solid-phase method13 along with the 
tremendous improvements made in the application of high performance liquid 
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chromatography for peptide and protein purification has provided the ability to 
synthesize peptides containing 40-50 amino acid residues with high purity. 
However, synthesizing long peptide chains beyond 100 amino acid residues 
remains a very difficult task.14 The major problems encountered with solid phase 
synthesis arise from incomplete couplings and deprotection reactions, which 
create impurities that accumulate in each step ultimately yielding the target 
peptide in an impure state. In order to circumvent this limitation of solid-phase 
methodology for the preparation of longer proteins, new approaches have been 
developed. The most useful and important among these approaches was 
chemical ligation introduced by Kent and coworkers in 1992, which allowed the 
coupling of unprotected peptide fragments in aqueous solution.15 For example, 
the HIV-1 protease analog containing 99 amino residues 29, was synthesized by 
chemical ligation of a 51-residue peptide bearing a C-terminal thioacid 27 and a 
48-residue peptide having an N-terminal alkyl bromide 28 (Scheme 3).1 
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Scheme 3. Chemical ligation of HIV-1 PR analogue 
A major disadvantage of this chemical ligation, however, is the formation 
of an unnatural structure at the ligation site. 
1.3 Native Chemical Ligation 
In 1994, Kent and coworkers described an important extension of the 
existing chemical ligation method referred to as the native chemical ligation,16 
which leads to the formation of a native amide bond at ligation site. The original 
version of this ligation used the chemistry first described by Wieland for coupling 
cysteine to other amino acids.17 Thus, the first step of this ligation involves a 
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chemoselective trans-thioesterification of the unprotected peptide-α-thioester with 
the sulfhydryl group of a second unprotected peptide segment containing an 
amino terminal cysteine residue. This gives rise to a thioester linked intermediate 
as the initial product, which spontaneously rearranges to give the native amide 
bond at the ligation site joining two unprotected peptide segments and 
regenerates the cysteine side chain thiol (Scheme 4). 
 
Scheme 4. Native chemical ligation 
Over the years, the native chemical ligation method introduced by the 
Kent group has found wide applications in chemical synthesis of hundreds of 
moderate sized proteins and glycoproteins. By combination with molecular 
biology methods, site specifically modified proteins of up to 52 kDa (the β-subunit 
of F1-ATPhase)18 can be synthesized by expressed protein ligation; a form of 
protein semi-synthesis that uses NCL to react a peptidyl thiosester generated by 
recombinant means with a Cys-peptide. In one example, Kent and coworkers 
have achieved the total synthesis of a covalently coupled HIV-1 protease dimer19 
with the impressive number of 203 amino acids, using modified native chemical 
ligation methodology. However, NCL strategy has some limitations. First and 
most important among these is the absence of a truly practical synthesis of 
peptidyl thioesters, and second is the fact that a cysteine residue is required at 
the ligation site. This latter is considered to be a serious limitation as naturally 
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occurring proteins do not always contain a cysteine residue in the right position of 
their sequences. Therefore, several modifications of the initial method have been 
introduced to overcome this drawback. 
1.4 Native Chemical Ligation without Cysteine 
1.4.1 Assistance from Nα-Linked Auxiliaries 
In principle, reversible attachment of the functional equivalent of a 
cysteine side chain onto the N-terminus of a peptide would provide universal 
ligation chemistry. This approach was first tried by Kent and co-workers using a 
cleavable aminooxy-linked ethanethiol side chain (Scheme 5).20 However, the 
slow rearrangement of the thioester via a six membered cyclic intermediate onto 
the aminooxy group (which is more hindered and less nucleophilic than α-amine 
used in native chemical ligation) limited the application of this concept. 
Scheme 5. Auxiliary mediated ligation 
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In another variation, several groups have applied the 2-
mercaptobenzylamine linker 3021-24 at the ligation site as a replacement of N-
terminal cysteine residue. In this system, the intramolecular acyl shift also 
proceeds through a six membered ring with the linker, which was subsequently 
removed by treatment with an acid, leading to the native peptides 33 (Scheme 
6).21 
Scheme 6. Ligation through a mercaptobenzylamine linker 
A third type of auxiliary for the thioester ligation of unprotected peptide 
fragments was introduced by Kawakami and Aimoto25 and shortly thereafter by 
Marinzi et al.26 Here, the auxiliary attached at the N-terminus of one peptide 
fragment is based on an O-nitrobenzyl scaffold, with which the thioester present 
in the second peptide fragment can undergo trans-thioesterification as shown in 
Scheme 7.25 
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Scheme 7. Ligation through a photo removable auxiliary 
In another pathway, devised by Danishefsky and coworkers, a phenolic 
ester of a C-terminal peptide is ligated with an N-terminal peptide through two 
consecutive O→S and S→N acyl transfer (Scheme 8).27 This method suffers 
from epimerization in the preparation of phenolic ester and is limited by slow 
rearrangement steps with sterically hindered amino acids.  
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Scheme 8. Ligation via O→S and S→N acyl transfer 
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Owing to the attachment of the auxiliary to the N-terminus, a secondary 
amine is involved in the S→N acyltransfer reaction. This increases the steric 
hindrance at the N-terminus and limits this approach of Nα-linked auxiliaries 
mainly to Gly ligation sites.7 
In a similar vein, Ito and co-workers introduced an approach, which 
employs a preformed Fmoc-amino acid 2-formyl-4-nitrophenyl thioester 34 to 
facilitate S→N acyl transfer by reaction of an amine (Scheme 9). 
Scheme 9. Ligation via S→N acyl transfer 
1.4.2 Side Chain Linked Auxiliaries 
Side chain-tethered auxiliaries have also been investigated to facilitate 
S→N acyl transfer to form a native amide bond (Scheme 10a).28-31 In this 
approach, although, the S→N acyl transfer proceeds through a large ring, the N-
terminal amine of the peptide is not modified by the auxiliary and is less 
hindered. This concept is based on the earlier work by Kemp et al. on the prior 
thiol capture strategy,32,33 which employs dibenzofuran-based auxiliaries 
(Scheme 10b) to bring about a high local concentration of each component. 
Recently, Wong et al. introduced the sugar-mediated ligation28,29 for 
glycopeptides in which thiol-modified carbohydrates were attached to the side 
chain of serine and threonine (Scheme 10c, d). Here, the sugar auxiliary can be 
converted to a natural glycoform through desulfurization28 or hydrazinolysis31 and 
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can be removed enzymatically.29 In an analogous approach, a thiol-modified 
cyclohexane has been attached as an auxiliary to the carboxylate group of 
aspartic acid or glutamic acid through an ester bond (Scheme 10e).34 After 
ligation, this auxiliary can be removed by saponification at pH 10. Still, 
modulating the efficiency and chemoselectivity of long-range acyl transfer at 
neutral pH remains a significant challenge in the development of such 
approaches.7 
Scheme 10. Ligation through side chain linked auxiliaries 
1.4.3 NCL-Desulfurization Combination 
In addition to the use of auxiliaries discussed above, considerable efforts 
have been devoted to removing the restriction to cysteine-containing ligation 
sites. For example, the use of synthetic β-mercaptoamino acids and their 
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subsequent desulfurization can offer an alternative to the use of auxiliaries.7,35,36 
In this context, the combination of two chemoselective reactions, native chemical 
ligation, and desulfurization were applied for the synthesis of non-cysteine 
containing proteins. Dawson applied this approach to chemically modify the 
cysteine residue, which was converted into an alanine residue after ligation 
(Scheme 11).37 Since alanine is one of the most abundant amino acid residues in 
proteins, the methodology was a significant extension of NCL. The usefulness of 
the approach was demonstrated by the total chemical synthesis of various 
polypeptides such as the cyclic antibiotic microcin J25, the 56-amino acid 
streptococcal protein GB1 domain, and a variant of the 110-amino acid 
ribonuclease, Barnase.37 Over a period of time, significant progress has been 
achieved in the development of new thiolated building blocks that serve as 
precursors to other amino acids. Crich et al.  and Botti et al. extended this 
strategy to ligation at phenylalanine,38,39 which was accomplished by means of a 
synthetic β-mercaptophenylalanine building block and subsequent 
desulfurization. The building blocks β-mercaptovaline (penicillamine)40 introduced 
by Seitz and co-workers and γ-mercaptovaline41 promoted by Danishefsky and 
co-workers provide access to hydrophobic ligation sites (Xaa-Val). Danishefsky 
and co-workers augmented this approach to γ-thiol threonine surrogate to 
establish ligation at threonine sites.42 Recently, lysine has been equipped with a 
δ- and γ-mercapto groups,43,44 which enables ligations at both the α- and the є-
amino groups. 
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Scheme 11. NCL followed by desulfurization 
1.4.4 Met Ligation: Alkylation of Hcy 
Another important ligation strategy has been developed which involves the 
alkylation of a homocysteine (Hcy) containing polypeptide with no Cys 
residues.45,46 Hcy-containing polypeptides can be obtained, in analogy to NCL, 
with a homocysteine at the N terminus, where the reaction proceeds via a six-
membered transition state (Scheme 12). The final alkylation can be performed 
under basic, neutral and acidic conditions to yield Met-containing peptides.47,48 
Scheme 12. NCL at methionine 
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1.4.5 Ser Ligation 
Kajihara and Okamoto made a significant contribution with the introduction 
of NCL at serine sites.36,49,50 This strategy depends on the conversion of cysteine 
to serine after conventional NCL. The conversion reaction consists of three 
steps; the S-methylation of cysteine, reaction with cyanogen bromide to afford an 
O-ester linked peptide, and an O→N acyl shift to provide the native peptide 
linkage with a serine residue (Scheme 13). 
 
Scheme 13. NCL at serine 
1.5 Other Ligation Methods 
1.5.1 His Ligation 
In another modification designed to overcome the drawback of native 
chemical ligation, homocysteine,45,47 selenocysteine,51-53 homoselenocysteine54 
and histidine55 were used at the N-terminal position as replacements for cysteine. 
In the case of histidine located at the N-terminus of a peptide, the imidazole side 
chain nitrogen acts as a nucleophile in the ligation reaction (Scheme 14).1,55 
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Scheme 14. Histidine-mediated ligation of peptidiyl thioacids 
1.5.2 The Staudinger Ligation 
An elegant way to overcome the various limitations of the original native 
chemical ligation was developed independently by two research groups: those of 
Raines56-60 and Bertozzi61,62 and is based on the Staudinger reaction.1,63 The 
Staudinger reaction, first reported in 1919, is the reaction of a phosphine 37 with 
an azide to produce an iminophosphorane 38. This iminophosphorane 
intermediate 38 can then be trapped by different electrophiles. In the initial 
Staudinger Ligation approach, the iminophosphorane intermediate 38 was 
intramolecularly trapped by an ester leading to an amidophosphonium salt 39. 
The amidophosphonium salt 39 was then hydrolyzed to produce an amide bond 
attached to a phosphine oxide moiety 40 (Scheme 15).62 
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Scheme 15. Staudinger ligation 
A modification of the Staudinger ligation, in which an amide bond is 
formed between the two coupling partners to give a product without a 
triarylphosphane oxide moiety, appears even more attractive. Shortly after their 
first report, Bertozzi et al.64 and Raines et al.56,57,65 reported such traceless 
Staudinger ligation, in which the phosphine oxide moiety is cleaved during the 
hydrolysis step. This reaction can be applied to coupling of two peptide 
fragments, one bearing a C-terminal phosphinothioester group 41 and another N-
terminal azido group 42. In the first step of this Staudinger ligation, the 
phosphinothioester 41 reacts with an azide 42 to give an iminophosphorane 43, 
which then undergoes an intramolecular S→N acyl shift leading to an 
amidophosphonium salt 44. The amidophosphonium salt 44 is then hydrolyzed to 
produce the amide product 45 and a phosphine oxide (Scheme 16). However, 
the high reactivity of the aza-ylide does not permit the presence of unprotected 
side-chain functionalities and therefore the Staudinger ligation is limited to the 
coupling of fully protected peptide fragments. Owing to the obligatory use of the 
azide, this ligation is restricted to the formation of secondary amides, furthermore 
its success depends critically on the choice of the appropriate phosphinothiol.66 
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Scheme 16. Traceless Staudinger ligation 
1.5.3 Chemoselective Decarboxylative Amide Ligation 
A very promising methodology developed by Bode et al. for the formation 
of amide bond employs a chemoselective decarboxylative condensation of N-
alkylhydroxylamines with α-ketoacids.67,68 This reaction does not involve an 
addition–elimination reaction of an activated carboxylic acid derivative unlike 
most other amide bond forming strategies. The reaction proceeds at 40 oC in 
polar solvents in good yields without epimerization of the α-ketoacids. Most 
importantly, peptides containing unprotected Lys and Asp as well as Trp, Tyr, 
and Arg residues can be ligated as demonstrated in the synthesis of a 
hexapeptide (Scheme 17).67 The major limitation of this method, however, is the 
need to synthesize both peptidyl α-ketoacids and N-hydroxypeptides. 
 
Scheme 17. Decarboxylative amide condensation 
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1.5.4 Non-conventional Peptide Synthesis 
Most recently, Johnston et al. have discovered a non-conventional route 
for the synthesis of native amide bond via iodonium-promoted nitroalkane-amine 
coupling (Scheme 18).69 This method is an uncommon type of reaction wherein 
the inherent polarity of the acyl donor and amine are reversed (umpolung) from 
the conventional one. This strategy establishes a novel alternative in peptide 
synthesis to the long-standing reliance on the activated electrophilic carboxylic 
acid feedstock. 
 
Scheme 18. Umpolung reactivity in peptide synthesis 
1.6 Thioacid Chemistry 
Thioacids present a similar degree of nucleophilicity and selectivity to 
thiols, but have the additional advantage of incorporating an electrophilic 
carbonyl group capable of undergoing a number of valuable transformations.70,71  
1.6.1 Cysteine Acyl Hydrosulfide Strategy 
In an alternative approach to peptide ligation at a cysteine junction, the 
capture of an acyl hydrosulfide derivative was performed at lower pH (Scheme 
19). The first step of this sequence involves nucleophilic attack of the 
thiocarboxylic acid 47 on a disulfide 46 to form a Cys-based acyl hydrosulfide 48, 
which then undergoes S→N acyl transfer to give the side chain hydrosulfide 49 
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that can be reduced to the thiol 50 to generate the cysteine at ligation 
junction.72,73 This methodology takes the advantage of the strong nucleophilicity 
of the thiocarboxylic acid and can be performed at a pH <2. 
Scheme 19. Thioacid ligation at cysteine junction 
1.6.2 Thioacid/Azide Amidation 
The reaction of thioacids with azides has recently been developed by the 
Williams and Liskamp groups as an efficient ligation strategy.74-77  In contrast to 
the conventional methods for the chemical synthesis of amides, this method does 
not need active esters and amines as precursors. Moreover, the application of 
this methodology for the preparation of several classes of complex amides in 
nonpolar and polar solvents including water has also been reported (Scheme 
20).77 
However, these excellent azide-based coupling methods are not without 
limitations, among which the need to prepare azides and the consequent 
obligatory restriction to the formation of secondary amides are the most 
important. 
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Scheme 20. Coupling of thioacid with azide 
1.6.3 Coupling of Thioacids with Isocyanates and Isothiocyanates  
Crich and Sasaki revealed a new methodology based on the reaction of 
thioacids with more widely available isocyanates and isothiocyanates, which 
results in the formation of amide bonds (Scheme 21).78 However, like the azide 
chemistry described above, this method only permits the formation of secondary 
amides and requires the synthesis of the electrophilic partner. 
 
Scheme 21. Reaction of thioacids with isocyanates ans isothiocyanates 
1.6.4 Thioacid/Aziridine Ligation 
Recently, Yudin and co-workers have developed a ligation in which 
peptidyl thioacids react chemoslectively with NH aziridine terminated amino acids 
and peptides to incorporate a peptidomimetic linkage at the ligation site (Scheme 
22).79 
 
Scheme 22. Peptidomimetic ligation 
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The reaction between thioacids and aziridines was first observed by Tam 
et al. when they performed a chemo-selective reaction between a C-terminal 
thioacid and an electrophilic β-bromoalanine residue located at the N-terminus of 
a peptide.80 At pH 5 or lower, this reaction resulted in the formation of a Cys-
thioester which underwent S→N acyl shift to form a native amide bond. However, 
at pH 6 or higher, the β-bromoalanine residue suffered 1,3-elimination of HBr, 
which resulted in the formation of an aziridine. Subsequent ring opening of the 
aziridine by the thioacid led to the formation of an undesired side product 
(Scheme 23). 
Scheme 23. Thioacid ligation resulting in native peptide bonds 
Although, the above chemical ligations have proven to be very useful for 
peptide coupling, they are restricted to some extent because of the requirement 
of a cysteine or cysteine type auxiliaries at the ligation site in NCL, and the need 
to prepare an N-terminal azide or related group in others. Therefore, there is still 
a need for a general method to perform fast epimerization free ligation with any 
amino acid at the ligation site.81-84 
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1.7 Convergent Strategies for Multiple Fragment Ligations 
All of the strategies presented above require a stepwise congregation of 
the individual fragments from the C to the N terminus. However, the convergent 
assembly of multiple fragments in parallel represents a more efficient way for 
generating whole synthetic proteins.85,86 Such a convergent synthetic approach 
making repeated use of the native chemical ligation strategy, would require 
double protection of a central fragment at the N-terminal Cys as well as at the C-
terminal thioester. With this in mind, Kent and co-workers developed a one-pot 
strategy wherein the N-terminal cysteine of the thioester peptide for the first 
ligation step was protected as in the form of a thiazolidine group.87 Once the first 
reaction reached completion, the N-terminal thiazolidine was converted to a 
cysteine residue with 0.2 M methoxylamine (pH 4). Subsequently, the pH was 
readjusted to pH 7 and the next peptidyl thioester was introduced for the second 
ligation. This methodology was successfully applied in the one-pot synthesis of a 
46 amino acid model protein, crambin (Scheme 24).87,88  
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Scheme 24. One pot synthesis of crambin 
Kent and co-workers also introduced an alternative strategy, called the 
kinetically controlled ligation86,89 in which they exploited the different reactivities 
of aryl and alkyl thioesters (Scheme 25). Alkyl thioesters are less reactive than 
and do not compete with aryl thioesters in ligation reactions.90 They can even 
tolerate unprotected N-terminal Cys residues without suffering significant 
amounts of self-ligation. The feasibility of this approach has been demonstrated 
for in a convergent synthesis of crambin87 and of lysozyme91 using judicious 
Cys(Acm) protection to avoid thiolactone formation. 
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Scheme 25. Kinetically controlled ligation 
1.8 Synthesis of C-Terminal Peptidyl Thioesters 
Unprotected peptides bearing a C-terminal thioester group are key 
intermediates in the synthesis and modification of proteins by chemical ligation 
and its variants.2,24,85,86 However, synthetic access to unprotected peptidyl 
thioesters is still a significant bottleneck in this ligation chemistry. Several 
approaches have therefore been investigateded for their preparation using Boc 
as well as Fmoc-SPPS strategies.86 
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1.8.1 Synthesis of C-Terminal Peptidyl Thioesters on Solid Support using 
Boc Chemistry 
The lability of the carbonyl-sulfur bond in thioesters to the repeated exposure of 
the nucleophilic base piperidine in standard Fmoc-SPPS protocols led to an initial 
reliance on Boc-SPPS chemistry for the synthesis of peptidyl thioesters. The first 
report for the synthesis of unprotected peptidyl thioacid was communicated by 
Blake et al., who employed a preformed benzhydryl thioester linker 4-[α-(Boc–
Gly–S)benzyl]phenylacetic acid.92,93 Subsequently, several approaches have 
flourished based on the use of a modified linker, 2-[4-
(mercapto(phenyl)methyl)phenoxy]acetic acid 51,94-96 which was derivatized by 
the first amino acid before hooking it to an aminomethyl polystyrene resin. 
Standard Boc-SPPS97 was then applied to the preparation of the desired peptide 
sequence 54. Lastly, cleavage of the peptide from the resin with HF led to the 
formation of the peptidyl thioacid,95 which was then converted into the thioester 
55 in solution phase by the nucleophilic reaction of the thioacid with an alkyl 
halide such as benzyl bromide or a symmetrical disulfide such as 5, 5’-
dithiobis(2-nitrobenzoic acid) as shown in Scheme 26.16,73,98 
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Scheme 26. Dawson’s protocol for the synthesis of peptidyl thioesters 
Partially protected peptidyl S-alkyl thioesters were first prepared by Aimoto 
et al. using the 3-sulfanylpropanoic acid linker99 or its tert-butylsulfanyl 
derivative,100 which were coupled to a p-methylbenzhydrylamine resin followed 
by the elongation of peptide chain by Boc-SPPS. In a similar vein, a third protocol 
for SPPS containing a C-terminal thioester using the Boc strategy was revealed 
by Tam and co-workers.80,101,102 This method was based on the usage of a 
MBHA resin, which was first loaded with S-trityl mercaptopropionic acid. After the 
removal of the trityl-protecting group, the desired polypeptide chain was 
assembled using standard Boc strategy. Finally, HF cleavage afforded the 
unprotected peptidyl thioester without the need for subsequent transformations, 
as are required in the Dawson method (Scheme 27).101 
29 
 
 
 
 
Scheme 27. Tam’s protocol for the preparation of C-terminal thioesters 
Recently, Yangmei et al. described an efficient synthesis of a fully 
deprotected peptide S-benzyl thioester using a volatilizable 
mercaptomethylphenyl-functionalized silica support.103 The first amino acid was 
coupled with the linker followed by the elongation of peptide chain by standard 
Boc chemistry. Subsequently, cleavage of the peptide from the resin with HF led 
to the formation of the peptidyl thioester (Scheme 28).103   
 
Scheme 28. Synthesis of peptidyl S-benzyl thioester on silica support. 
Despite the considerable ingenuity showcased in the development of the 
above methods, none combine the directness that obviously results from the use 
of a simple C-terminal thioester-based linker with a method for release from the 
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resin that avoids the use of hazardous HF.104,105 With this in mind, Crich and 
Sana introduced the 9-fluorenylmethyl thioester linker 56,106 which was fully 
compatible with the general conditions of Boc-SPPS peptide assembly.  
Treatment with piperidine, which released the Boc-protected peptide into 
solution, resulted in the formation of a C-terminal thioacid 60. This latter could be 
readily transformed into a thioester 61 by simple alkylation (Scheme 29). This 
method employs conditions no more forcing than those encountered in standard 
Boc-SPPS protocols and circumvents the terminal HF treatment that limits most 
Boc chemistry SPPS methods.  
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Scheme 29. Thioester synthesis using 9-fluorenylmethyl thioester linker 
1.8.2 Synthesis of C-Terminal Peptidyl Thioesters on a Solid Support using 
Fmoc Chemistry 
Despite being a high yielding method, the Boc chemistry SPPS described above 
requires repeated exposure of the peptide to TFA and typically 
cleavage/deprotection with HF. These conditions are incompatible with 
glycoconjugates as they could damage glycosidic linkages. For this reason 
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glycopeptides and phosphopeptides are constructed primarily using Fmoc based 
chemistry, which utilizes a mild base (usually piperidine) during synthesis. Since 
thioesters are sensitive to piperidine, which is required to remove the widely used 
Fmoc protecting group in Fmoc-SPPS methodology, other non-nucleophilic 
cleavage cocktails have been explored for the removal of the N-α-Fmoc group. 
These include the replacement of piperidine by 1-
methylpyrrolidine/hexamethylenimine/HOBT or DBU/HOBT mixtures. It has been 
found, however, that these methods tend to epimerize the stereogenic center 
present at the thioester position.107,108 
In 1999, Barany et al. revealed the synthesis of peptidyl thioesters 
following Fmoc-SPPS with BAL strategy, in which the growing peptide was 
anchored through backbone nitrogen instead of a terminal Cα-carboxyl group.109-
111
 In the BAL strategy, an acid labile 4-[formyl-3,5-dimethoxyphenoxy]butyric 
acid-based handle 62 was linked with an amino-functionalized PEG-resin. This 
was followed by on-resin reductive amination with an allyl ester of amino acid 
hydrochloride salt and the target peptide was assembled by standard Fmoc 
chemistry. Selective removal of the C-terminal allyl ester followed by coupling of 
an amino acid thioester led to the backbone amide anchored C-terminal peptidyl  
thioester 65, which was cleaved using TFA to obtain the peptidyl thioester 66 
(Scheme 30).109 
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Scheme 30. Preparation of peptidyl thioesters using the BAL approach 
Although, this approach was successful in many cases, its scope is limited 
because of the special precautions required in the coupling of second amino acid 
to prevent diketopiperazine formation. Another major drawback of this method is 
the need for careful control in the activation of backbone peptide carboxylic acid 
to avoid epimerization during introduction of thioester to the C-terminal end of the 
peptide chain.112,113 To circumvent these problems, numerous other approaches 
have been developed using Fmoc chemistry. Most of these were based on the 
activation of the C-terminal amino acid followed by thiolysis to generate the 
peptidyl thioester. 
In this regard, Ingenito et al.114 developed the use of an acylsulfonamide 
‘safety-catch linker’ 67 for SPPS containing a C-terminal thioester by the Fmoc 
strategy. This linker, which is stable to both strongly basic and acidic conditions, 
was first introduced by Kenner et al.115 and later modified by Backes and 
Ellman.116 The peptide was assembled using the standard Fmoc protocol to 
afford solid-phase bound peptides. After the final peptide coupling, the resin was 
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activated by treatment with diazomethane or iodoacetonitrile to yield the 
secondary sulfonamide 69. The peptide was then released from the activated 
resin by nucleophilic displacement involving a thiol group to yield the peptidyl 
thioester 70 (Scheme 31).116  
 
Scheme 31. Synthesis of a peptidyl thioester on Safety-Catch linker 
The major drawbacks of this method are low yields of isolated peptidyl 
thioesters and an undesirable alkylation of unprotected hydroxyl groups on an 
attached carbohydrate as well as of cysteine and methionine residues. 
 Another strategy117,118 introduced by Sewing and Hilvert employed a PAM 
or HMBA resin for the elongation of the peptide chain by Fmoc-SPPS. The 
cleavage was performed by activation of the ester linkage with AlMe2Cl in the 
presence of a large excess of a nucleophilic thiol to yield peptidyl thioester 
(Scheme 32).118 
 
Scheme 32. Lewis acid activation strategy 
In this method, Sewing and Hilvert observed that treatment with a large 
excess of oxophilic reagent favored the formation of trithioortho esters and 
ketone dithioacetals, which on acidic workup yielded peptidyl thioesters, but had 
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the propensity to racemize at the C-terminal amino acid. However, the need to 
expose the whole assembled peptide to harsh reagents caused side-reactions to 
varying degrees, including conversion of side-chain ester groups to their 
thioesters and the formation of aspartimide units. In this regard, Albericio et al. 
reported a modification of the BAL approach to the synthesis of peptidyl 
thioesters, wherein they linked a masked thioester, i.e., a trithioortho ester, with a 
4-[formyl-3,5-dimethoxyphenoxy]butyric acid handle and assembled the peptide 
using Fmoc chemistry (Scheme 33).119 Although the concept of the masked 
thioester in this strategy can solve the problem of formation of diketopiperazines, 
its practical utility at present is restricted mainly to the preparation of glycine 
thioester peptides. 
  
Scheme 33. Synthesis of peptidiyl thioesters by masking of thioesters 
Another common approach for the synthesis of thioesters employs a 
highly acid-sensitive trityl120 or 2-chlorotrityl resin,121 which allow cleavage under 
mild acidic conditions to yield protected peptides.86 The thioester is introduced by 
C-terminal activation of the protected peptide in solution after cleavage from the 
resin and subsequent coupling with a thiol. Global deprotection finally affords an 
unprotected peptidyl thioester. However, the high risk of racemizing the C-
terminal residue by the activation limits this approach to C-terminal Gly residues 
(Scheme 34).86 
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Scheme 34. Coupling of C-terminal acid with thiol 
Another protocol for the synthesis of thioesters by Fmoc-SPPS and 
activation of linker was revealed by Camarero et al.122 who used an aryl 
hydrazine support 71, which was completely stable to the conditions of Fmoc- 
and Boc-SPPS. At the end of the synthesis, the fully protected peptide resin was 
activated by oxidation with N-bromosuccinimide to yield a peptide diazene 72. 
The reactive acyl diazene was then cleaved with an α-amino acid S-alkyl 
thioester followed by treatment with TFA to give the peptidyl thioesters 74 
(Scheme 35).122 
 
Scheme 35. Fmoc-SPPS using an aryl hydrazine support 
Another elegant way to synthesize petidyl thioesters based on activation 
of the linker by the formation of active C-terminal aromatic N-acylurea 
functionality was introduced by Dawson and co-workers.123 The C-terminal 
carboxylic group was attached to the linker 3,4-diamino benzoic acid, which was 
first coupled with PEG amine, and then the peptide chain was elongated using 
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Fmoc chemistry. The resulting peptide was efficiently transformed into an 
aromatic N-acylurea moiety 77, followed by deprotection and thiolysis to yield 
peptidyl thioester 78 (Scheme 36).123  
 
Scheme 36. Synthesis of peptidiyl thioesters through an N-acylurea moiety 
Recently, Tofteng et al. communicated a new concept entitled “backbone 
amide activation” and demonstrated its use for efficient synthesis of peptidyl 
thioesters.124 The method relies on a simple glutamic acid linker system, 
activation of which renders the C─N bond susceptible to thiolysis and provides 
the formation of peptide thioesters (Scheme 37). 
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Scheme 37. Thioester synthesis using a pyroglutamyl imide moiety 
Although, methods based on the activation of a linker followed by thiolysis 
leading to the synthesis of peptidyl thioesters have had noticeable success, they 
also have disadvantages, most pertinently the risk of epimerization on 
introduction of the thioester to the active C-terminal end of the peptide chain, and 
the need for additional steps after completion of peptide assembly on the linker.  
1.8.2.1 O→S Acyl Transfer 
Botti et al.,125 and Danishefsky et al.126 individually developed a novel 
methodology based on the in situ O→S acyl shift, which led to the formation of a 
thioester (Scheme 38).125 Recently, this O→S acyl shift protocol127 was 
successfully applied by Muir et al. to the synthesis a number of naturally 
occurring cyclic peptidyl thioesters i.e., peptidyl thiolactones.  
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Scheme 38. In situ formation of thioesters through O→S acyl shift 
1.8.2.2 N→S Acyl Shift 
A second protocol for the synthesis of peptidyl thioesters by Fmoc-SPPS 
is based on the in situ N→S acyl shift reaction.128-134 To this end, Melnyk and co-
workers discovered a solid-phase N→S acyl transfer for thioester synthesis in 
combination with the sulfonamide safety-catch linker, which has been a widely 
used platform for thioester synthesis.129 The acylsulfonamide group of the linker 
underwent an additional Mitsunobu alkylation with a mercaptoethanol derivative, 
which allowed the introduction of the prerequisite β-amino thiol component that 
facilitated the subsequent intramolecular N→S acyl shift (Scheme 39). This 
approach to thioester synthesis is highly dependent on the degree of alkylation. 
 
Scheme 39. N→S acyl shift using the sulfonamide-linker 
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In another variation, Aimoto et al. developed a modified 4,5-dimethoxy-2-
mercaptobenzyl protecting group to mediate peptidyl thioester formation via an 
N→S acyl shift as shown in Scheme 40.128 
 
Scheme 40. Thioester synthesis using a solid supported DMMB auxiliary 
Hojo and co-workers described a post-peptide chain assembly 
thioesterification method131 in which a peptide bearing a C-terminal 
mercaptomethylated proline derivative was converted into a thioester upon 
treatment with aqueous 3-mercaptopropionic acid (Scheme 41). A stated 
drawback of this method was the lengthy preparation of the initial 5-
mercaptomethyl proline to be incorporated at the C-terminus of the peptide.  
 
Scheme 41. Thioester through a mercapto-prolyl-prolyl ester motif 
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Having accredited the N→S acyl shift to the presence of the amino acid 
proline, Hojo and co-workers diverted their attention to the use of other amino 
acid residues that might promote thioesterification. For this purpose, N-alkylation 
of a C-terminal cysteine residue was devised as an alternative to facilitate the 
intramolecular N→S acyl migration under acidic conditions,135 followed by the 
intermolecular trans-thioesterification with MPA to afford the peptide thioester 
(Scheme 42). 
Scheme 42. N-Alkyl cysteine-assisted thioesterification 
Otaka and co-workers have shown that a modified C-terminal Cys residue, 
incorporated in the framework of an acyl oxazolidinone, can undergo N→S acyl 
transfer to yield peptidyl thioesters (Scheme 43).130 
 
Scheme 43. Thioesterification through N-acyloxazolidinones 
In another modification, Otaka et al. developed a different device to 
facilitate intramolecular acyl shift for peptidyl thioester synthesis using an N-
substituted aniline linker (Scheme 44).136 
 
Scheme 44. N-Substituted aniline linker mediated thioesterification 
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Recently, Kawakami and Aimoto proposed that a peptide containing 
cysteinyl prolyl ester moiety at the C-terminus could spontaneously transform into 
a diketopiperazine thioester via an intramolecular N to S acyl shift reaction.133 
Moreover, the CPE peptide could be ligated with a Cys-peptide in a one-pot 
procedure and could also be transformed into a peptide thioesters by 
intermolecular thiol–thioester exchange with external thiols (Scheme 45).133 
 
Scheme 45. CPE mediated thioesterification/ligation 
Despite these notable advances, the synthesis of peptidyl thioesters by 
Fmoc- SPPS remains significantly more challenging than the synthesis of the 
corresponding peptidyl acid or amide. Therefore, there is still a need for a direct 
Fmoc synthesis of peptidyl thioesters. 
1.9 Goals of This Thesis 
The work described in this thesis was undertaken with two different goals in 
mind. First, the development of new and alternative methods for peptide 
synthesis and second, the synthesis of peptidyl thioesters on the solid phase by 
Fmoc chemistry are presented. Chapter 2 describes the investigations conducted 
towards the development of a new chemistry for epimerization-free block 
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synthesis of peptides from thioacids and amines with reagents such as Sanger’s 
and Mukaiyama’s reagents. In Chapter 3, studies carried out to probe the 
reactivity of N-terminal sulfonamide towards peptidyl thioacids are described.  
The goal of these studies was to explore convergent strategies for multiple 
peptide fragment ligation by tuning the reactivity of peptidyl thioacids and 
sulfonamides. Continuing this theme studies were undertaken with a goal of 
developing direct method for the efficient synthesis of peptidyl thioesters by the 
widely used Fmoc-SPPS chemistry and the results of this work are presented in 
chapter 4. 
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CHAPTER 2 
BLOCK SYNTHESIS OF PEPTIDES FROM THIOACIDS AND AMINES WITH 
THE SANGER AND MUKAIYAMA REAGENTS 
2.1 Introduction 
As discussed in chapter 1, a number of elegant approaches have been 
investigated to meet the challenges present in the synthesis of peptides and 
proteins; however, these are not without limitations. In this context, the 
conception and development of a new method for peptide bond formation is 
outlined in this chapter. 
2.2 Amide Bond Formation by the Sanger’s Reagent  
In 1998, Tomkinson and co-workers described the reaction of 2,4-
dinitrobenzenesulfonamides with thioacids leading to the formation of amides at 
ambient temperature.137,138 The Crich group extended this reaction, combining 
amino thioacids and their C-terminal peptide congeners with N-terminal 
sulfonamides, leading to the synthesis of peptides and their glycoconjugates.139 
The Crich group further employed this mild and efficient process to capture 
thioacids generated in situ from nucleophilic ring-opening of a variety of monothio 
cyclic anhydrides resulting in a useful three-component coupling process.140 In 
the peptide-bond forming adaptation of this chemistry, the incompatibility of an 
unprotected lysine side chain amine, which underwent competing amide bond 
formation,139 revealed the mechanism to involve nucleophilic aromatic 
substitution of the thiocarboxylate on the electron-deficient sulfonamide with 
release of a highly reactive S-(2,4-dinitrophenyl) thioester. This is in contrast to 
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the alternative mechanism of intramolecular amide bond formation at the level of 
the intermediate Meisenheimer complex, which would be expected to exclude 
crossover with external amines. The mechanism of the reaction is outlined in 
Scheme 46. 
Scheme 46. Coupling of a thioacid with a N-terminal sulfonamide 
The use of nucleophilic aromatic substitution processes to generate active 
esters for amide and peptide bond formation has been described previously. 
Notably, Kamiński, Papini, and their coworkers reported the reaction of N-triazinyl 
ammonium salts with protected amino acids in acetonitrile in the presence of N-
methyl morpholine, leading to the formation of a “superactive ester” followed by 
coupling with the amine component.141 Ito and coworkers employed a S-(2-
formyl-4-nitrophenyl) thioester in peptide coupling reactions assisted by prior 
condensation of the amine with the formyl group, but generated the thioester in 
the classical manner by reaction of the 2-formyl-4-nitrothiophenol with a 
previously activated amino acid.142 Prior to Crich’s application of the Tomkinson 
sulfonamide reaction,139 thioacids had been employed directly in peptide coupling 
reactions as nucleophilic components in carbodiimide mediated protocols,143 in 
the form of their silver salts as electrophiles for direct condensation with 
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amines,144 and as the carboxyl component in peptide synthesis catalyzed by 
papain.145 Peptide-based thioacids also serve, by alkylation to thioesters, as a 
point of entry into native chemical ligation methods for chemical protein 
synthesis.146 
Sanger’s reagent, 2,4-dinitrofluorobenzene, through its reaction with N-
terminal amines, was traditionally used for the degradation of peptides and 
proteins, and identification of N-terminal amino acids.147-149 However, Sanger 
noticed that thiols and other nucleophiles, including the side-chains of histidine 
and tyrosine, were competing nucleophiles to amines for capture by 2,4-
dinitrofluorobenzene.147 This observation prompted the hypothesis that a 
thiocarboxylate salt would react significantly more rapidly than an amine with this 
reagent enabling the formation of the thioester and ultimately peptide synthesis 
thereby effectively turning a peptide degradation reagent into one for their 
synthesis. 
2.3 Synthesis of Peptidyl Thioesters  
A series of thioesters was prepared by coupling suitably-protected amino acids 
with either 9-fluorenylmethanethiol,139 2,4,6-trimethoxybenzylthiol,150 or 
triphenylmethanethiol151 in excellent yield as set out in Table 1.  
 
 
 
 
 
46 
 
 
 
Table 1. Preparation of Thioesters from Protected Amino Acids and Thiols 
 
Ent
ry 
Substrate Thiol/Reagent Product % Yield 
1 Boc-L-Val-OH (79) FmSH/DCC Boc-L-Val-SFm (87) 99 
2 Boc-Aib-OH (80) FmSH/DCC Boc-Aib-SFm (88) 82 
3 Boc-L-Asp-(α-OBn)-γ-
OH (81) 
FmSH/DCC Boc-L-Asp-(α-OBn)-γ-
SFm (89) 
97 
4 Fmoc-L-Ala-OH (82) TmobSH/DIC Fmoc-L-Ala-STmob (90) 98 
5 Boc-L-Phe-OH (83) TmobSH/DIC Boc-L-Phe-STmob (91) 96 
6 Z-L-Val-OH (84) TrtSH/DIC Z-L-Val-STrt (92) 95 
7 Z-L-Ala-L-Phe-OH (85) FmSH/PyBop Z-L-Ala-L-Phe-SFm (93) 72 
8 Boc-L-Lys(Boc)-L-
Arg(Pbf)-L-Asn(Trt)-L-
Arg(Pbf)-OH (86) 
FmSH/PyBop Boc-L-Lys(Boc)-L-
Arg(Pbf)-L-Asn(Trt)-L-
Arg(Pbf)-SFm (94) 
82 
 
With simple carbamate-protected amino acids, carbodiimide coupling 
reagents were employed for these condensations. However, for peptides (Table 
1, last two entries) the PyBOP reagent recommended by Kajihara and co-
workers152 was used to avoid the widely reputed problem of epimerization in the 
thioesterification of all but simple amino acids. The final entry in Table 1 is 
noteworthy both for the sterically hindered nature of the reaction site and for the 
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fact that no epimerization was observed under the PyBop coupling conditions 
(Figure 2). LCMS analysis showed only a single peak with retention time of 3.17 
min with a molecular weight corresponding to that of the thioester 94 (m/z = 
1712.7369, Figure 3). 
Inder-Boc-KRNRSFm--EDCI-pureD-Mw-1714-inmethanol
Time
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50
%
-24
76
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50
AU
0.0
2.0e-3
4.0e-3
6.0e-3
8.0e-3
1.0e-2
2008-09-01-490 Sm (SG, 2x3); Sb (4,40.00 ) 3: Diode Array 
Range: 1.223e-23.17
0.23
5.35
2008-09-01-490 Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
1.70e5
3.14
0.21
0.48
 
LCMS: [70-90% B (acetonitrile containing 0.1% formic acid) in A (10% 
CH3CN/H2O containing 0.1% formic acid) with a flow rate of 0.7 mL/min over 5 
min and 254 nm UV detection, retention time = 3.17 min] 
Figure 2. LCMS trace of Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-
SFm (94) obtained with the PyBOP reagent 
 
 
a) UV Trace: 3.17 min
b) MS: 3.14 min,
m/z = 1714.7357
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Figure 3. ESI-HRMS spectrum of the peak eluting at 3.14 min [Boc-L-
Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-SFm (94)] 
When the same thioester 94 preparation was conducted using the 
carbodiimide/hydroxybenzotriazole conditions reported153-155 for epimerization-
free thioester synthesis, the product was obtained in excellent yield (77%) but as 
a 3:1 mixture of epimers (Figure 4).  
[M+H]+
[M+2H]2+
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Inder-Boc-KRNRSFm--EDCI-Mw-1714-inmethanol
Time
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%
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Range: 2.018e-3
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2008-09-01-489 Sm (SG, 2x3); Sb (4,40.00 ) 1: TOF MS ES+ 
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3.14
2.97
3.60
3.30
Racemized Thioester with EDCI+HOBT coupling
 
LCMS: [70-90% B (acetonitrile containing 0.1% formic acid) in A (10% 
CH3CN/H2O containing 0.1% formic acid) with a flow rate of 0.7 mL/min over 5 
min and 254 nm UV detection, retention time = 3.00 and 3.17 min] 
Figure 4. LCMS trace of Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-
SFm (94) obtained by the EDCI/HOBT coupling 
The thioacids needed for the coupling reactions were released cleanly from 
the thioesters with piperidine139 in the case of the fluorenylmethyl thioesters, or 
with trifluoroacetic acid for the trimethoxybenzyl thioesters151 and triphenylmethyl 
thioesters,151 and were used immediately in the peptide bond forming reactions 
(Scheme 47). 
a) UV Trace: 3.00 and 3.17 min
b) MS: 2.97 and 3.14 min,
m/z = 1712.7357
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Scheme 47. Preparation of Thioacids 
2.4 Peptide Synthesis using the Sanger and Mukaiyama Reagents 
The coupling of thioacids with amines in the presence of Sanger’s reagent was 
first investigated with commercially available thioacetic acid, L-tryptophan and its 
methyl ester (Table 2, entries 1 and 2), and an excellent yield of the acetamide 
was obtained on mixing of the three components at room temperature in the 
presence of cesium carbonate.  Thus encouraged, a series of dipeptides was 
accessed by coupling amino thioacids with other amino esters and peptide esters 
with the yields reported in Table 2. All reactions in Table 2 were conducted at 
room temperature and involved stirring  0.1 M amine hydrochloride in DMF with 
thioacid (1.2 equiv) and Cs2CO3 (1.5 equiv) as base, followed by the addition of 
the Sanger’s reagent. 
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Table 2. Coupling of Thioacids with Amines with Sanger’s Reagent 
R1 SR
O
F
NO2O2N
R1 NHR2
O
R2NH2, Cs2CO3, DMFR
1 SH
OPiperidine
or TFA
 
Entry Thioester Release 
reagent 
Thioacid Amine Product % 
Yield 
1 - - AcSH L-Trp Ac-L-Trp (95) 76 
2 - - AcSH L-Trp-
OMe.HCl 
Ac-L-Trp-
OMe (96) 
99 
3 Boc-L-Val-
SFm (87) 
Piperidine Boc-L-
Val-SH 
L-Phe-
OMe.HCl 
Boc-L-Val-L-
Phe-OMe 
(97) 
84 
4 Boc-L-Val-
SFm (87) 
Piperidine Boc-L-
Val-SH 
D-Phe-
OMe.HCl 
Boc-L-Val-D-
Phe-OMe 
(98) 
82 
5 Boc-L-Val-
SFm (87) 
Piperidine Boc-L-
Val-SH 
L-Trp-
OMe.HCl 
Boc-L-Val-L-
Trp-OMe 
(99) 
76 
6 Boc-Aib-
SFm (88) 
Piperidine Boc-Aib-
SH 
L-Trp-
OMe.HCl 
Boc-Aib-L-
Trp-OMe 
(100) 
95 
7 Boc-Aib-
SFm (88) 
Piperidine Boc-Aib-
SH 
Gly-
OEt.HCl 
Boc-Aib-Gly-
OEt (101) 
96 
8 Boc-L-Asp-
(α-OBn)-γ-
Piperidine Boc-L-
Asp-(α-
L-Phe-
OMe.HCl 
Boc-L-Asp-
(α-OBn)-γ-L-
93 
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SFm (89) OBn)-γ-
SH 
Phe-OMe 
(102) 
9 Fmoc-L-
Ala-STmob 
(90) 
TFA Fmoc-L-
Ala-SH 
Gly-
OEt.HCl 
Fmoc-L-Ala-
Gly-OEt 
(103) 
60 
10 Fmoc-L-
Ala-STmob 
(90) 
TFA Fmoc-L-
Ala-SH 
L-Phe-
OMe.HCl 
Fmoc-L-Ala-
L-Phe-OMe 
(104) 
59 
11 Fmoc-L-
Ala-STmob 
(90) 
TFA Fmoc-L-
Ala-SH 
L-Tyr-
OMe.HCl 
Fmoc-L-Ala-
L-Tyr-OMe 
(105) 
64 
12 Z-L-Ala-L-
Phe-SFm 
(93) 
Piperidine Z-L-Ala-
L-Phe-
SH 
Gly-Gly-
OMe.HCl 
Z-L-Ala-L-
Phe-Gly-Gly-
OMe (106) 
66 
 
From Table 2, it is clear that deprotonated thioacids are more nucleophilic 
toward Sanger’s reagent than amines and make, 2,4-dinitrofluorobenzene an 
effective reagent for the formation of amide bonds between thioacids and 
amines. In particular, attention is drawn to entries 3 and 4 of Table 1 in which 
diastereomeric products 97 and 98 were obtained. To verify the possibility of 
epimerization in the course of thioester deprotection or in the coupling process, a 
qualitative comparison of the 500 MHz 1H NMR spectra of both diastereomers 97 
and 98 was performed as shown in Figure 5. A careful review of the proton NMR 
spectra of both isomers indicates that each spectrum corresponds to a single 
diastereomer. The characteristic chemical shifts of α and β protons of the 
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phenylalanine unit in the diastereomeric dipeptides identify the two 
diastereomers (Table 3). 
 
 
Figure 5. 1H-NMR  spectra of dipeptides in CDCl3 
Table 3. Selected 1H Chemical Shifts (δ in ppm) and Coupling Constants (J) 
of Dipeptides Boc-L-Val-L-Phe-OMe (97) and Boc-L-Val-D-Phe-OMe (98) 
Dipeptide δ of α-proton 
(multiplicity, J, proton counts) 
δ of β- proton 
(multiplicity, J, proton counts) 
Boc-L-Val-L-
Phe-OMe (97) 
4.87-4.86 (m, 1H) 3.12-3.06 (m, 2H) 
Boc-L-Val-D-
Phe-OMe (98) 
4.91-4.87 (m, 1H) 3.14-3.10 (dd, J = 5.5, 13.7 Hz, 1H) 
3.08-3.04 (dd, J = 5.5, 13.7 Hz, 1H) 
5.0 4.5 4.0 3.5 3.0 PPM
BocHN
O
H
N
O
OMe
Ph
α
β
97 β 
 α 
5.0 4.5 4.0 3.5 3.0 PPM 
BocHN
O
H
N
O
OMe
Ph
α
β
98 β 
α 
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The ability to form relatively hindered peptide bonds is evident from entries 
5 and 6 (Table 2), where a valine thioacid and an aminoisobutyric thioacid are 
coupled with the tryptophan amine. The good functional group compatibility of the 
process is clear from inspection of Table 2 in general. In spite of these promising 
results the yields with the Fmoc protected thioacids (Table 2, entries 9-12) are 
generally lower than those obtained with Boc protected thioacids. This was 
eventually traced to the competing cleavage of the Fmoc group by the fluoride 
anion released in the course of the nucleophilic aromatic substitution step.156-158 
To circumvent the relative incompatibility of Fmoc groups with fluoride anion, 2,4-
dinitroiodobenzene and 2-chloro-1-methylpyridinium iodide (Mukaiyama’s 
reagent)159 as the condensing agent were investigated. This ruse was successful 
as shown by the results presented in Table 4. All reactions in Table 4 were 
conducted at room temperature by stirring of 0.1 M amine hydrochloride in DMF 
with thioacid (1.2 equiv) and Cs2CO3 (1.5 equiv) as base followed by the addition 
of the coupling reagent. 
Table 4. Comparison of Sanger’s Reagent with 2,4-Dinitroiodobenzene and 
with Mukaiyama’s Reagent  
Cs2CO3, DMF
TFA/Et3SiH
CH2Cl2
RNH2
Fmoc-L-Ala-STmob Fmoc-L-Ala-SH Fmoc-L-Ala-NHR
 
  Coupling Reagent and % Yield 
Amine Product Sanger’s 
Reagent 
2,4-dinitro-
iodobenzene 
Mukaiyama’s 
Reagent 
Gly-OEt.HCl Fmoc-L-Ala-Gly- 60 83 80 
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OEt (103) 
L-Phe-
OMe.HCl 
Fmoc-L-Ala-L-Phe-
OMe (104) 
59 79 86 
L-Tyr-
OMe.HCl 
Fmoc-L-Ala-L-Tyr-
OMe (105) 
64 86 85 
L-Ala-
OMe.HCl 
Fmoc-L-Ala-L-Ala-
OMe (107) 
- 78 82 
L-Cys(Trt)-
OEt.HCl 
Fmoc-L-Ala-L-
Cys(Trt)-OEt (108) 
- 82 88 
 
The results presented in Tables 2 and especially 4 are noteworthy 
because of the high yields obtained in comparison with previous uses of 
Mukaiyama’s reagent to effect peptide coupling reactions between amines and 
simple carboxylic acids160,161 where the yields were modest except for secondary 
and sterically hindered amines.28,29 As is also implicit in the work of Sanger with 
peptides, simple peptide based primary amines are more nucleophilic toward 
electron-deficient arenes than the carboxylic acids. The clear difference between 
the results reported here and those reported previously in the literature is the use 
of the more nucleophilic thioacids rather than simple carboxylic acids. To 
underscore this difference a head to head comparison was undertaken. To this 
end, the dipeptide thioacid Z-Gly-L-Phe-SH (110) was first prepared as described 
in Scheme 48. This synthesis is noteworthy because it establishes the possibility 
of removing a Boc group in the presence of the Tmob thioester under acid 
conditions. In effect, as is clear from the second step of the protocol, removal of 
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the latter group requires the combination of trifluoroacetic acid and the 
nucleophilic agent triethylsilane. 
Scheme 48. Preparation of a dipeptide thioacid 
Parallel reactions between Z-Gly-L-Phe-SH (110) and Z-Gly-L-Phe-OH 
(112) for coupling to Val-OtBu were conducted with Mukaiyama’s reagent. The 
tripeptide 111 (Z-Gly-L-Phe-L-Val-OtBu) was achieved in 76% yield from the 
reaction of the thioacid, while the corresponding carboxylic acid gave only 23% 
yield under identical conditions (Scheme 49). 
Scheme 49. Thioacid vs carboxylic acid 
Examination of the reaction mixture from the coupling of the simple dipeptide 
with Mukaiyama’s reagent and L-Val-OtBu revealed a far more complex reaction 
mixture than that arising from the use of the corresponding dipeptidyl thioacid. In 
particular, a major byproduct was identified in this manner as the result of attack 
of the amine on the coupling reagent. LCMS analysis of the tripeptide 111 
produced from the dipeptidyl thioacid with the Mukaiyama’s reagent also enabled 
investigation of the extent of epimerization. A single peak with a retention time of 
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3.65 min was observed with a molecular weight corresponding to the tripeptide 
111 (Figure 6), consistent with an epimerization free reaction. 
Inder-Cbz-Gly--Phe-ValOtBuMw 511 Acid+Amine+Mukaiyama-rt in ACN/H2O
20-Nov-2008 1::6::5 
Time
1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40 4.60 4.80
AU
0.0
5.0e-4
1.0e-3
1.5e-3
2.0e-3
2.5e-3
3.0e-3
3.5e-3
4.0e-3
1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40 4.60 4.80
%
66
11_19_08_283 1: TOF MS ES+ 
TIC
4.64e4
3.64
3.13
2.842.632.401.57 1.73 2.172.051.83 2.31
2.44 2.75
2.89
3.423.37
4.69
4.614.434.254.173.78 3.99 4.34
11_19_08_282 Sb (4,40.00 ) 3: Diode Array 
Range: 4.6e-33.65
1.70
1.98 2.30
2.10
2.852.58 2.70 3.483.18 3.35
4.554.17
4.02 4.43 4.67
 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min. 
Figure 6. LCMS analysis of Z-Gly-L-Phe-L-Val-OtBu (111) from the thioacid 
To verify that the LC conditions were capable of resolving the epimeric 
peptides, a further sample of Z-Gly-Phe-L-Val-OtBu (111) was synthesized by 
EDCI coupling at room temperature (Scheme 49), i.e., under conditions likely to 
produce epimerization. The LCMS of this crude reaction mixture showed 
essentially full epimerization (ratio, L/D = 48/52) with two well resolved peaks 
having retention times 3.65 min and 3.78 min (Figure 7). 
 
Scheme 49. Coupling with EDCI 
a) MS: 3.64 min,
m/z = 511.2682
b) UV Trace: 3.65 min
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Inder-Cbz-Gly--Phe-ValOtBuMw 511EDCImethod in ACN/H2O
19-Nov-2008 4::7::0 
Time
1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40 4.60 4.80 5.00 5.20
%
-5
95
1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40 4.60 4.80 5.00 5.20
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0.0
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8.0e-2
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198633.6518246
2.93
2594
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2.55e5
3.78
3.64
2.051.38 2.24
3.46
 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min, 3.78 min 
Figure 7. LCMS analysis of Z-Gly-Phe-L-Val-OtBu (111) produced by EDCI 
coupling 
The lack of epimerization in the coupling of the thioacid using Mukaiyama’s 
reagent was further confirmed by synthesis of an authentic sample of Z-Gly-D-
Phe-L-Val-OtBu (116) which was shown to have a different retention time 
(Scheme 50, Figure 8). 
Scheme 50. Synthesis of authentic Z-Gly-D-Phe-L-Val-OtBu (116) 
 
Epimerized product with EDCI
b) MS: 3.64, 3.78 min,
m/z = 511.2682
a) UV Trace: 3.65, 3.78 min
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Inder-Cbz-Gly-D-Phe-ValOtBuMw511- LCMS ACN:H2O
01-Mar-2009 13:07:51
Time
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50
%
-8
92
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50
AU
-2.0e-3
0.0
2.0e-3
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6.0e-3
8.0e-3
1.0e-2
01_16_2009_44 Sm (Mn, 1x1); Sb (4,40.00 ) 3: Diode Array 
Range: 1.297e-23.77
0.00
1.350.55 5.17
01_16_2009_44 Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
4.79e5
3.74
0.74
 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.78 min. 
Figure 8: LCMS analysis of an authentic sample of Z-Gly-D-Phe-L-Val-OtBu 
(116) 
To further probe the superiority of thioacids as nucleophiles over carboxylic 
acids, a deuterium labeled thioacid 118 was synthesized as outlined in Scheme 
51. Here again, the ability to cleave a Boc group under acidic conditions in the 
presence of the electron-rich S-Tmob ester was a critical component of the 
synthesis. 
Scheme 51. Synthesis of deuterium labelled thioacid 118 
 
a) UV Trace: 3.77 min
b) MS: 3.74 min,
m/z = 511.2682
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This deuterium labeled dipeptidyl thioacid 118 was subjected to a direct 
competition with an equimolar amount of the corresponding dipeptidyl acid 112, 
lacking the label, for coupling by Mukaiyama’s reagent to L-valine (Scheme 52). 
Z-Gly-2,2-d2-L-Phe-SH (118) L-Val-OtBu.HCl
Mukaiyama's reagent,
Cs2CO3, DMF, 72%
Z-Gly-2,2-d2-L-Phe-L-Val-OtBu (119)
Z-Gly-L-Phe-OH (112) M+Na - 536
 
Scheme 52. Carboxylate/thiocarboxylate competition reaction 
The tripeptide product 119 isolated from this reaction mixture was shown by 
mass spectrometry to be fully deuterium labelled in the glycine residue, thereby 
unambiguously indicating the superiority of the thioacid in this chemistry (Figure 
9). Investigation of the tripeptide by 1H-NMR spectroscopy further confirmed the 
absence of the isotopomer. 
Inder-Cbz-Gly-d2Phe-ValOtBuMw 513Mukaiyama  inmethanol
LCT Premier 18-Nov-2008 7::7::1 
m/z
100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050
%
0
100
11_17_08_232 14 (0.284) Cm (12:20-(25:39+2:9)x300.000) 1: TOF MS ES+ 
1.11e3536.2709
532.3270
376.0747325.2862309.0045224.0512158.0145 453.3439
552.2590
733.2255613.3999 758.3717 803.0422 899.8801 989.7980 1028.7050
 
Figure 9. ESI-HRMS spectrum of Z-Gly-2,2-d2-L-Phe-L-Val-OtBu (119) 
 
M+Na
No Z-Gly-L-Phe-Val-OtBu
M+Na -- 534
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In a further reaction the coupling of a valine-derived thioacid 120 with L-valine 
was conducted in the presence of Z-L-Arg resulting in a high yield of a single 
dipeptide 121. This reaction reinforces the superior reactivity of the thioacid over 
the simple carboxylic acid, while also demonstrating compatibility with the 
guanidine and carboxylic acids moieties of the arginine derivative (Scheme 53). 
Z-L-Arg-OH.HCl, L-Val-OtBu.HCl
Mukaiyama's reagent, Cs2CO3, DMF
Z-L-Val-SH Z-L-Val-L-Val-OtBu
82%120 121
 
Scheme 53. Functional Group Compatibility 
That the coupling reaction with Mukaiyama’s reagent could be conducted 
under aqueous conditions was demonstrated by the example of Scheme 54. A 
good yield of a dipeptide 121 was achieved in this coupling reaction of a valine-
derived thioacid 120 affected with Mukaiyama’s reagent in aqueous buffer.162 
 
Scheme 54. Coupling under Aqueous Conditions 
Finally, the application of this new peptide bond forming reaction to the 4+4 
block synthesis of an octapeptide L-Lys-L-Arg-L-Asn-L-Arg-L-Asn-L-Asn-L-Ile-L-
Ala (122) was demonstrated. This octapeptide 122 is the C-terminal sequence of 
oxyntomodulin from Porcine jejunoileum and is responsible for the gastric acid 
secretion inhibitory properties of an extended version of glucagon.163 This 
octapeptide was selected as a target because of the widespread current interest 
in oxyntomodulin derivatives as appetite suppressants and as potential 
therapeutics for obesity,164 and because of its concatenation of multiple 
functionalized side chains that provides a true test of the methodology. 
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Two tetrapeptides 123 and 124 were synthesized by standard manual 
solution phase techniques (Scheme 55 and 56). 
Asn Asn Ile Ala
H OEtBoc OH
Boc
HFmoc OH
Fmoc
HFmoc OH
Fmoc
H
OEt
OEt
OEt
OEt
OEt
OEt
Trt
Trt
Trt
Trt
Trt
Trt
Trt
Trt
i
ii
i
iii
i
iii
 
i) DIC/HOBt or EDCI/HOBt; ii) TFA/CH2Cl2; iii) DBU/EtSH/THF 
Scheme 55. Solution phase synthesis of amine segment NH2-L-Asn(Trt)-L-
Asn(Trt)-L-Ile-L-Ala-OEt (123) 
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i) SOCl2/allyl alcohol; ii) DBU/EtSH/THF; iii) DIC/HOBt or EDCI/HOBt; 
iv) Pd(PPh3)4/PhSiH3 
Scheme 56. Solution Phase Synthesis of the Peptide Acid Segment Boc-L-
Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-OH (124) 
At the completion of the second tetrapeptide synthesis an allyl ester protecting 
group was removed from the C-terminal arginine residue to release the 
corresponding acid, which was purified by reverse phase HPLC and then 
subjected to LCMS analysis to check the extent of epimerization at the C-
terminus (Figure 10). A single peak in the LCMS trace having a retention time of 
3.45 min and a molecular weight of 1518.7357 argues against the possibility of 
epimerization during synthesis (Figure 11). 
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Inder-Boc-KRAsn-L-Arg-OHMw1518 LCMS ACN:H2O
16-Jan-2009 18:43:01
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LCMS: 50-90% B with a flow rate of 0.7 mL/min over 5 min and 254 nm UV 
detection, retention time = 3.45 min. 
Figure 10. LCMS analysis of Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-
Arg(Pbf)-OH (124) 
 
 
 
a) UV Trace: 3.45 min
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LCT Premier 03-Sep-2008 20:22:20
Inder-Boc-K-R-N-R-OH-Mw-1519-LCMS
m/z
200 400 600 800 1000 1200 1400 1600 1800 2000 2200 2400 2600 2800
%
0
100
2008-09-01-454 102 (2.225) Cm (102-11:51x20.000) 1: TOF MS ES+ 
2.26e3760.3691
713.6380574.3978
208.0518
760.8710
761.3729
761.8734
1519.7335
762.3727 923.9857
1039.5012 1159.99741316.1034
1520.7463
1523.7485
1846.9316 1956.0228 2427.07252320.1191 2534.3989 2820.8789 2911.5576
 
Figure 11. ESI-HRMS spectrum of peak eluting at 3.64 min [Boc-L-Lys(Boc)-
L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-OH (124)] 
The resulting acid 124 was then converted to the 9-fluorenylmethyl thioester 
94 as set out in the final entry of Table 1. Finally, the stage for the 4+4 fragment 
coupling was set by liberation of the thioacid functionality 125 with piperidine as 
set out in Scheme 57.  
Scheme 57. Synthesis of C-terminal thioacid 124 
The LCMS trace and ESI-TOF mass spectrum of the resulting crude 
peptidyl thioacid 125 are presented in Figures 12 and 13 which includes a single 
peak with a retention time of 3.02 min with a molecular weight corresponding to 
that of the thioacids 125.  
 
[M+H]+
[M+2H]2+
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LCMS: 60-95% B with a flow rate of 0.5 mL/min over 5 min and 254 nm UV 
detection, retention time = 3.02 min. 
Figure 12. LCMS analysis of Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-
Arg(Pbf)-SH (125) 
 
a) UV Trace: 3.02 min
b) MS: 3.02 min,
m/z = 1534.5687
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Figure 13. ESI-HRMS spectrum of peak eluting at 3.02 min [Boc-L-Lys(Boc)-
L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-SH (125)] 
The 4+4 fragment coupling was achieved by coupling of C-terminal thioacid 
125 with the N-terminal tetrapeptide 123 in the presence of Mukaiyama’s reagent 
in DMF with cesium carbonate as base. The protected target octapeptide 126 
was isolated in 66% yield as single epimer (Scheme 58, Figure 14). 
This block synthesis provided an opportunity for the comparison of the thioacid 
methodology with more common methods. To this end, coupling of the 
tetrapeptide carboxylic acid was affected with PyBop, HATU, EDCI/HOBT and 
EDCI10,11 in DMF under standard conditions of temperature and concentration, 
and employed epimerization-free, all L-tetrapeptides (Scheme 58). The PyBop 
EDCI/HOBT and HATU methods gave comparable yields to the thioacid method 
but required significantly longer reaction times to do so, and were not exempted 
[M+H]+
[M+2H]2+
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from epimerization (Figure 16). The carbodiimide method was not complete even 
after 14 h and resulted in significantly more epimerization. 
 
X Coupling Reagent T (h) % Yield Epimer ratio 
SH Mukaiyama‘s 1 66 >99:1 
OH PyBop 8 69 93.7:6.3 
OH HATU 6 70 93.1:6.9 
OH EDCI 14 54 85.8:14.2 
OH EDCI-HOBt 8 63 94.2:5.8 
 
Scheme 58. Comparative block syntheses of an octapeptide 126 
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LCMS of the crude reaction mixture: 80-92% B over 0.5 min then 92-98% B over 
3 min with a flow rate of 0.5 mL/min and 254 nm UV detection, retention time = 
2.33 min. 
Figure 14. LCMS of octapeptide Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-
Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (126) obtained by coupling of 
the thioacid with the Mukaiyama’s reagent 
b) MS: 2.33 min,
m/z = 2443.1994
a) UV Trace: 2.33 min
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Figure 15. ESI-HRMS spectrum of peak eluting at 2.33 min [Boc-L-Lys(Boc)-
L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (126)] 
 
 
[M+2H]2+
[M+H]+[2M+H]3+
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Inder-Boc-LysArgAsn-L-Arg-NNIA-OEt-Mw2443-EDCIHOBT-LCMS ACN:H2O
16-Jan-2009 15:52:44
Time
0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00
%
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0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00
AU
0.0
5.0e-3
1.0e-2
1.5e-2
2.0e-2
2.5e-2
3.0e-2
01_16_2009_04 Sm (Mn, 1x2) 3: Diode Array 
Range: 3.396e-2
Area
2.35
3752
2.57
218
01_16_2009_05 Sm (Mn, 2x1); Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
1.01e5
2.33
1.11
0.30 1.38 2.54
Epimerized Sample with EDCI+HOBT coupling
 
LCMS of the crude reaction mixture showed epimerization: 80-92% B over 0.5 
min then 92-98% B over 3 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 2.35 min and 2.57 min. 
Figure 16. LCMS analysis of octapeptide 126 produced by the EDCI/HOBT 
method 
Epimerization ratios were determined with the help of an authentic sample 
of Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-D-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-
Ala-OEt 130 (Figure 17). To obtain this isomeric octapeptide 130, the C-terminal 
tetrapeptide first was synthesized by Fmoc solid phase peptide synthesis on the 
2-chloro trityl resin 127 (Scheme 59) and then the coupling of the acid fragment 
129 with N-terminal tetrapeptide 123 was affected with HATU to afford the 
octapeptide, which was purified by reverse phase HPLC to provide the pure 
authentic D-isomer 130. As expected the retention time of this isomeric 
a) UV Trace: 2.35 and 2.57 min
b) MS: 2.33 and 2.54 min,
m/z = 2443.1994
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octapeptide corresponded with that of the minor in the couplings set out in 
Scheme 58. 
 
Scheme 59. Synthesis of an authentic D-isomer 
Inder-Boc-LysArgAsn-D-Arg-NNIA-OEt-Mw2443LCMS ACN:H2O
16-Jan-2009 15:19:25
Time
0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00
%
-3
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0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00
AU
0.0
5.0e-3
1.0e-2
1.5e-2
2.0e-2
2.5e-2
01_16_2009_01 3: Diode Array 
Range: 2.858e-20.35
2.57
01_16_2009_01 Sm (Mn, 2x1); Sm (Mn, 1x1); Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
1.95e5
2.54
1.690.32
1.00
 
LCMS: 80-92% B over 0.5 min then 92-98% B over 3 min with a flow rate of 0.5 
mL/min and 254 nm UV detection, retention time = 2.57 min. 
Figure 17. LCMS analysis of authentic D-isomer Boc-L-Lys(Boc)-L-Arg(Pbf)-
L-Asn(Trt)-D-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (130) 
 
a) UV Trace: 2.57 min
b) MS: 2.54 min,
m/z = 2443.1994
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Finally, treatment of this octapeptide 126 with trifluoroacetic acid in 
dichloromethane removed the complete suite of acid-labile protecting groups, 
and afforded the octapeptide 122 as a single epimer in 66% yield after 
purification by reverse phase HPLC (Scheme 60, Figure 18 and 19). 
 
Scheme 60. Deprotection of side chains 
Inder--KRNRNNIA-OEt--Mw-1012-LCMS
Time
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2008-09-01-485 Sm (SG, 2x3); Sb (4,40.00 ) 3: Diode Array 
Range: 5.672e-22.87
0.95
0.73
2.35 3.32
2008-09-01-485 Sb (4,40.00 ); Sm (SG, 2x3); Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
8.97e4
2.86
1.800.90
2.33
KRNRNNIA-OEt
 
LCMS: 0-55% A over 3.5 min with a flow rate of 0.5 mL/min and 190 nm UV 
detection, retention time = 2.87 min. 
Figure 18. LCMS analysis of NH2-L-Lys-L-Arg-L-Asn-L-Arg-L-Asn-L-Asn-L-Ile-
L-Ala-OEt (122) 
 
b) MS: 2.86 min,
m/z = 1012.5968
a) UV Trace: 2.87 min
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Figure 19. ESI-HRMS spectrum of the peak eluting at 286 min [NH2-L-Lys-L-
Arg-L-Asn-L-Arg-L-Asn-L-Asn-L-Ile-L-Ala-OEt (122)] 
2.5. Summary 
The high nucleophilicity of thiocarboxylates enables their preferential 
reaction with electron-deficient aromatic halides by a nucleophilic substitution 
process in the presence of amines. This method generates highly reactive 
thioesters in situ, which then react directly with the amine to afford peptide 
bonds. The method tolerates the presence of all proteinogenic amino acid side 
chains except for cysteine and lysine,139 which must be protected. This new 
coupling method does not require the presence of any particular amino acid for 
coupling, in contrast to native chemical ligation and its variants,27,146 and is 
capable of peptide bond forming reactions at hindered residues which makes this 
methodology ideal for the block synthesis of sterically hindered peptides. 
 
[M+H]+
[M+3H]3+ [M+2H]2+
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CHAPTER 3 
CONVERGENT SYNTHESIS OF PEPTIDES AND PEPTIDE THIOESTERS 
WITH REACTIVITY-DIFFERINTIATED SULFONAMIDES AND PEPTIDYL 
THIOACIDS 
3.1 Introduction 
As discussed in Chapter 1, convergent approaches to peptide synthesis 
based on NCL have been developed by Kent and co-workers for multiple 
fragment ligations.19,87-89,91 These convergent approaches make repeated use of 
the NCL strategy and require double protection of a central fragment at the N-
terminal Cys as well as at the C-terminal thioester.91 The development of two 
approaches for the convergent synthesis for peptides and peptide thioesters is 
delineated in this chapter.  
3.2 Convergent Synthesis of Peptides 
As reported in chapter 2, the activation of thioacids by nucleophilic 
aromatic substitution in the presence of amines is a viable method for the 
formation of peptide bonds. The application of this method to a convergent 
approach involving multiple segment couplings and minimal protecting group 
manipulation would require a set of at least two sulfonamides with differential 
reactivity toward thiocarboxylates (Scheme 61).  
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Scheme 61. One pot triblock peptide synthesis 
In this proposed sequence a first peptide (peptide 1) representing the C-
terminal segment of the eventual target is activated as the highly reactive 
dinitrobenzenesulfonamide. This segment is expected to react in a first step with 
peptide 2 which carries a C-terminal thioacid and an N-terminal sulfonamide that 
is less reactive than the dinitrobenzenesulfonamide. Finally, a second thioacid 
(peptide 3) is introduced and is caused to react with the remaining sulfonamide. 
The main challenge in this approach is the reactivity of the sulfonamide on 
peptide 2, which must be less than that of the dinitrobenzenesulfonamide, but yet 
sufficient to enable the second coupling to take place. A second challenge is 
represented by the need to synthesize the second peptide unit without self-
condensation.  
3.3 Preparation of Sulfonyl Chlorides 
As a very first step towards the convergent approach, a series of benzene 
sulfonyl chlorides having different electron withdrawing groups around the 
aromatic ring was prepared. All the sulfonyl chlorides in the series were 
commercially available except two (ENS-Cl and CNS-Cl), which were 
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synthesized from the commercially available starting materials 131 and 134 as 
described in Scheme 62.  
Scheme 62. Synthesis of sulfonyl chlorides 
An interesting point to note in this synthesis is the use of nucleophilic 
aromatic substitution approach described in Chapter 2 for the synthesis of the 
thiol, which was then subjected to oxidation with NCS151 to provide the 
corresponding sulfonyl chloride.  
3.4. Screening of N-Arenesulfonylphenylalanine Derivatives for Reaction 
with Thioacetic Acid 
With the sulfonyl chlorides in hand, a series of N-
arenesulfonylphenylalanine derivatives was prepared and then screened for 
reactivity toward thioacetic acid (Table 5). All the reactions were run under a 
standard set of conditions and employed 0.15 M sulfonamide in DMF with 
thioacetic acid (1.5 equiv), and Cs2CO3 (1.5 equiv) as base. 
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Table 5. Reactivity of thioacetic acid toward N-arenesulfonylphenylalanines 
 
Entry R1 R2 R3 R4 Ar-SO2-NH-
L-Phe-OMe 
(Yield, %) 
T 
(h) 
Ac-Phe-
OMe 145 
(Yield, %) 
1 H H Ac H 136 (88) 12 - 
2 H H CN H 137 (92) 12 - 
3 CF3 H H H 138 (91) 12 - 
4 NO2 H H H 139 (90) 12 - 
5 H CF3 H CF3 140 (93) 12 - 
6 COO
Me 
H NO2 H 141 (92) 6 85 
7 CN H NO2 H 142 (91) 6 87 
8 NO2 H CF3 H 143 (90) 4 88 
9 NO2 H NO2 H 144 (71) 0.07 94 
 
It is clear from Table 5 that a single electron-withdrawing group is 
insufficient to induce the desired reaction, as was the presence of two 
trifluoromethyl groups in the 3- and 5-positions. However, 2,4-disubstituted 
systems in which a single nitro group was complemented by a second, but less 
potent electron-withdrawing group functioned nicely (entry 6, 7 and 8). The ENS 
and the CNS systems were found to be less reactive than the FNS system 
(Figure 19). All three such systems (ENS, CNS and FNS) investigated proved 
significantly less reactive than the 2,4-dinitrobenzenesulfonamide (entry 9) and 
therefore met the reactivity criteria for the block synthesis approach. 
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Figure 19. The ENS, CNS, FNS and DNS systems 
3.5 Synthesis of Thioacids 
For a more elaborate study of the reactivity pattern, side chain peptidyl 
thioacids of glutamic acid and aspartic acid along with α-amino derived thioacids 
such as glycine thioacids were prepared as described in Scheme 63. The side 
chain amino thioacids were obtained in the form of the trityl esters, while glycine 
derived thioacids were equipped with Tmob groups. The thioacids were released 
from the corresponding thioesters after treatment with TFA and triethylsilane.  
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Scheme 63. Synthesis of thioacids 
The synthesis of the glutamic and aspartic thioacids is noteworthy in so far 
as it establishes the possibility of removing a Trt group in the presence of the Boc 
group under acidic conditions. 
3.6 Synthesis of the ENS and the CNS Protected Peptidyl Thioesters 
Following the literature, the ENS protected α-amino acids were prepared 
from the reaction of α-amino acids and the ENS chloride in presence of 
triethylamine (Scheme 67). These ENS protected α-amino acids were coupled 
either with the 2,4,6-trimethoxybenzyl thiol to provide the ENS protected α-amino 
thioester 167 or with an α-amino thioester 165 (Prepared by selective removing 
of a Boc group in the presence of Tmob thioester under acidic conditions) to 
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provide the ENS protected di-peptidyl thioesters 169 and 170. The CNS 
protected α-amino thioester was directly synthesized by the reaction of the CNS 
chloride and α-amino thioester in the presence of diisopropylethylamine in 
methylene chloride in good yield (Scheme 64). 
Scheme 64. Synthesis of the sulfonamide protected peptidyl thioesters 
3.7 Synthesis of the DNS Peptides 
Following the literature,165 several N-[(2,4-dinitrobenzene)sulfonyl]-α-
amino acid alkyl esters were prepared from the reaction of the hydrochloride 
salts of α-amino acid esters and 2,4-dinitrobenzenesulfonyl chloride in presence 
of pyridine (Scheme 65). However, these conditions were found to be unsuitable 
for the synthesis of the higher DNS-peptides as the reactions of peptidyl amines 
and 2,4-dinitrobenzenesulfonyl chloride did not proceed smoothly. To circumvent 
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this incompatibility, a different route was investigated, which involved the 
synthesis a N-[(2,4-dinitrobenzene)sulfonyl]-α-amino acid tert butyl ester by the 
reaction of the corresponding hydrochloride salts of α-amino acid tert butyl esters 
and 2,4-dinitrobenzenesulfonyl chloride in presence of pyridine (Scheme 68) 
followed by the cleavage of the tert butyl group under acidic conditions. This 
route gave access to N-[(2,4-dinitrobenzene)sulfonyl]-α-amino acids, that were 
then coupled with the peptidyl amines by the HATU method. Several DNS 
peptides were accessed in this way in excellent yield as described in Scheme 65.  
Scheme 65. Synthesis of the DNS peptides 
The last entry in Scheme 65 is noteworthy as a Boc group was removed 
from a peptide SFm thioester under acidic conditions to generate a 
trifluoroacetate salt of peptide thioester lacking protection at the N-terminus. As 
thioesters are vulnerable to cyclization with the free N-terminal amine, the salt 
was first mixed with the N-[(2,4-dinitrobenzene)sulfonyl]-α-valine and HATU in 
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methylene chloride and then was neutralized with DIPEA to provide a DNS 
protected peptide thioester 178. The LCMS traces and ESI-TOF mass spectra of 
all the DNS peptides so-prepared are presented in Figures 20-25. 
Inder-DNS-V-M-V-P-A-OEtMw773- LCMS ACN:H2O
09-Feb-2009 11:21:49
Time
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2.5e-3
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1.25e-2
1.5e-2
1.75e-2
2.0e-2
2.25e-2
01_16_2009_25 Sm (Mn, 2x1); Sb (4,40.00 ) 3: Diode Array 
Range: 2.308e-24.25
0.25
1.05
0.53 3.13 3.40
01_16_2009_24 Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
4.68e4
4.22
1.27
3.37 4.61
 
LCMS: 5-20% B over 1 min then 20-55% B over 4 min with a flow rate of 0.7 
mL/min and 254 nm UV detection, retention time = 4.25 min. 
Figure 20. LCMS analysis of DNS-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (174) 
 
a) UV Trace: 4.25 min
b) MS: 4.22 min,
m/z = 773.2562
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Inder-DNS-V-M-V-P-A-OEtMw773- LCMS ACN:H2O
LCT Premier 09-Feb-2009 11:14:46
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
01_16_2009_24 193 (4.218) Cm (192:193-(163:189+206:216)x20.000) 1: TOF MS ES+ 
1.92e4774.3470
427.1696
406.6571 456.1741
791.3789
796.3350
797.3409
798.3416 1569.6794
 
Figure 21. ESI-HRMS spectrum of the peak eluting at 4.22 min [DNS-L-Val-L-
Met-L-Val-L-Pro-L-Ala-OEt (174)] 
 
 
 
 
 
 
 
[M+NH4]+
[M+H]+
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Inder-DNS-FNNIA-OEt Mw1319 -LCMS ACN:H2O
15-Apr-2009 06:29:20
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Range: 2.486e-34.77
0.33
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0.65 4.453.08 5.28
01_16_2009_62 Sm (SG, 1x1); Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
1.73e5
4.76
0.31
4.421.24 3.81
5.26
 
LCMS: 5-98% B over 5 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 4.77 min. 
Figure 22. LCMS analysis of the DNS-L-Phe-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-
OEt (175) 
 
 
a) UV Trace: 4.77 min
b) MS: 4.76 min,
m/z = 1319.4895
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Inder-DNS-FNNIA-OEt Mw1319 -LCMS ACN:H2O
LCT Premier 15-Apr-2009 06:13:55
m/z
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0
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01_16_2009_64 219 (4.756) Cm (219:221-(238:241+201:213)x2.000) 1: TOF MS ES+ 
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464.3972 709.2873 1078.49781012.6308
1339.6522
2657.28831998.4644
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2641.25761999.9645
2000.4572 2640.2605
2001.4521
2009.9087
2659.2659
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2661.2832
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2665.2556
2989.0645
 
Figure 23. ESI-HRMS spectrum of the peak eluting at 4.76 min [DNS-L-Phe-
L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (175)] 
 
 
 
 
 
 
[M+NH4]+
[3M+2NH4]2+
[2M+NH4]+
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Inder-DNS-V-A-T-V-SFm Mw812 -LCMS ACN:H2O
12-Apr-2009 22:22:13
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LCMS: 5-98 % B over 5 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 4.28 min. 
Figure 24. LCMS analysis of the DNS-L-Val-L-Ala-L-Thr-L-Val-SFm (178) 
 
 
a) UV Trace: 4.28 min
b) MS: 4.27 min,
m/z = 812.2407
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Inder-DNS-V-A-T-V-SFm Mw812 -LCMS ACN:H2O
LCT Premier 12-Apr-2009 22:22:13
m/z
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%
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01_16_2009_61 193 (4.255) Cm (193-195:200x2.000) 1: TOF MS ES+ 
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830.3214
840.7766
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Figure 25. ESI-HRMS spectrum of the peak eluting at 4.27 min [DNS-L-Val-L-
Ala-L-Thr-L-Val-SFm (178)] 
3.8 Triply Convergent Synthesis 
A further series of experiments was conducted with the side chain peptidyl 
thioacids to probe the reactivates of both the CNS and the ENS sulfonamides. To 
this end the ENS sulfonamides were first used in a three component coupling 
sequence, which involved the ring opening of thiosuccinic anhydride with a 
sugar-based amine 179 to release a primary thioacid 180 followed by trapping 
with the ENS sulfonamide to provide a glycoconjugate 181 (Scheme 66). Next, 
the reactivity of the ENS sulfonamides was further checked with the glutamic acid 
and aspartic side chain thioacids. It was found that the ENS sulphonamides were 
amenable to reaction with the glutamic side chain thioacids 155 but reacted only 
slowly with the corresponding aspartic thioacid 151 (Scheme 66).  Moreover, the 
[M+H]+
[M+NH4]+
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ENS sulfonamides either failed to react or reacted only very slowly with peptide-
based thioacids such as Z-Gly-SH (158) or Alloc-Gly-Gly-SH (161). 
Scheme 66. Reactivity of the ENS group 
The CNS sulfonamides were also tested in the same three component 
coupling sequence, and were screened for reactivity toward side chain thioacids 
and peptide-based thioacids such as Z-gly-SH 158 (Scheme 67). The CNS 
sulfonamides were found to be more reactive than the corresponding ENS 
sulfonamides as demonstrated by the synthesis of the tripeptide Z-Gly-L-Phe-L-
Phe-OMe 184 (Schemes 67). Nevertheless, the CNS sulfonamides either failed 
to react or reacted only very slowly with peptide-based thioacids such as Alloc-
Gly-Gly-SH (161). 
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Scheme 67. Reactivity of the CNS group 
While not ideal, the overall reactivity pattern of the ENS and the CNS 
sulfonamides was sufficient to enable a first series of triply convergent reactions 
employing an amino acid or peptide protected at the N-terminus by an ENS or 
CNS group and carrying a 2,4,6-trimethoxybenzy thioester at the C-terminus. 
These sulfonamide protected Tmob thioesters were first treated with triethylsilane 
and trifluoroacetic acid to release the C-terminal thioacids and were then 
exposed to a DNS protected peptide followed by addition of a mild base (Table 
6). This critical series of experiments established the feasibility of generation of a 
thioacid in the presence of a moderately electron-deficient sulfonamide though 
the use of the acid labile Tmob thioesters, and the ability of that thioacid to 
undergo subsequent and selective condensation with the more reactive DNS-
class of sulfonamides on addition of a mild base. This first coupling resulted in 
the formation of new  peptides bearing the ENS or CNS group at the N-terminus 
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ready for subsequent coupling with a further thioacid, albeit necessarily a primary 
one (Table 6). 
Table 6: Triply Convergent Synthesis 
 
Entry Peptide 
2-STmob 
DNS-
Peptide 1 
Peptide 2-
Peptide 1 
(Yield, %) 
Peptide 3-
SH 
Peptide 3-Peptide 
2-Peptide 1 
(Yield, %) 
1 ENS-Trp-
STmob 
(167) 
DNS-Phe-
OMe 
(144) 
ENS-Trp-Phe-
OMe 185 
Ac-SH Ac-Trp-Phe-OMe 
190 (60) 
2 CNS-
Phe-
STmob 
(171) 
DNS-Phe-
OMe 
(144) 
CNS-Phe-Phe-
OMe 186 (84) 
Boc-
Glu(SH)-
OtBu (148) 
Boc-Glu(Phe-
Phe-OMe)-OtBu 
191 (81) 
3 CNS-
Phe-
STmob 
(171) 
DNS-Phe-
OMe 
(144) 
CNS-Phe-Phe-
OMe 186 (84) 
Boc-
Asp(SH) –
Obn (151) 
Boc-Asp(Phe-
Phe-OMe)-OBn 
192 (78) 
4 ENS-Ala-
Phe-
STmob 
(169) 
DNS-Phe-
OMe 
(144) 
ENS-Ala-Phe-
Phe-OMe 187 
(81) 
Boc-
Glu(SH)-
OtBu (148) 
Boc-Glu(Ala-Phe-
Phe-OMe)-OtBu 
193 (83) 
5 ENS-Ala-
Phe-
STmob 
DNS-Val-
Met-Val-
Pro-Ala-
ENS-Ala-Phe-
Val-Met-Val-
Pro-Ala-OEt 
Boc-
Glu(SH)-
OtBu (148) 
Boc-Glu(Ala-Phe-
Val-Met-Val-Pro-
Ala-OEt)-OtBu 
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(169) OEt (174) 188 (81) 194 (71) 
6 ENS-Ala-
Val-
STmob 
(170) 
DNS-Val-
Met-Val-
Pro-Ala-
OEt (174) 
ENS-Ala-Val-
Val-Met-Val-
Pro-Ala-OEt 
189 (78) 
Boc-
Glu(SH)-
OtBu (148) 
Boc-Glu(Ala-Val-
Val-Met-Val-Pro-
Ala-OEt)-OtBu 
195 (65) 
7 ENS-Ala-
Phe-
STmob 
(169) 
DNS-Phe-
OMe 
(144) 
ENS-Ala-Phe-
Phe-OMe 187 
(74) 
Boc-
Glu(SH)-
OtBu (148) 
Boc-Glu(Ala-Phe-
Phe-OMe)-OtBu 
193 (80) 
 
The feasibility of a one pot triply convergent synthesis by this methodology 
was demonstrated by the successful synthesis of the dipeptide Ac-Trp-Phe-OMe 
190 in moderate yield (Table 6, entry 1). The reaction sequence was also applied 
successfully to synthesis of simple tri- and tetrapeptides (Table 6, entries 2, 3 
and 4) and to the synthesis of model octapeptides (Table 6, entries 5 and 6). The 
ability to form relatively hindered peptide bonds such as Val-Val is evident from 
entry 6 (Table 6). The diastereomeric purity of all peptides produced in this way 
was controlled by LCMS, with examples of the chromatograms given in in 
Figures 26-29.  
Finally, the sequence was shown to be amenable to the use of aqueous 
buffered media, rather than DMF as solvent, with little loss of yield as is clear 
from a comparison of entries 4 and 7 of Table 6. 
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Inder-NSE-A-F-V-M-V-P-A-OEtMw1004- LCMS ACN:H2O
23-Feb-2009 22:47:49
Time
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50
%
-20
80
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50
AU
0.0
1.0e-2
2.0e-2
3.0e-2
4.0e-2
5.0e-2
6.0e-2
7.0e-2
8.0e-2
9.0e-2
01_16_2009_26 Sm (Mn, 2x1); Sm (Mn, 2x1); Sb (4,40.00 ) 3: Diode Array 
Range: 9.793e-23.18
1.30
01_16_2009_23 Sm (Mn, 2x1); Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
1.73e5
3.14
0.67
5.23
 
LCMS: 5-30% B over 1 min then 30-60% B over 4 min with a flow rate of 0.7 
mL/min and 254 nm UV detection, retention time = 3.18 min. 
Figure 26. LCMS analysis of the ENS-L-Ala-L-Phe-L-Val-L-Met-L-Val-L-Pro-L-
Ala-OEt (188) 
 
 
a) UV Trace: 3.18 min
b) MS: 3.14 min,
m/z = 1004.3837
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Inder-NSE-A-F-V-M-V-P-A-OEtMw1004- LCMS ACN:H2O
LCT Premier 23-Feb-2009 22:47:49
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
01_16_2009_23 144 (3.144) Cm (144-(122:137+159:171)x20.000) 1: TOF MS ES+ 
2.65e41023.4996
522.2258
522.7256
791.3503523.2252
1024.5184
1027.4896
1028.4896
1029.4923
1527.7316
1107.4470 1254.4260 1592.2139
 
Figure 27. ESI-HRMS spectrum of the peak eluting at 3.14 min[ ENS-L-Ala-L-
Phe-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (188)] 
 
 
 
 
 
[M+H]+
[M+NH4]+
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Inder-Boc-Glu-tBu-A-F-V-M-V-P-A-OEtMw1046- LCMS ACN:H2O
23-Feb-2009 23:04:12
Time
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75 5.00 5.25 5.50
%
-23
77
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75 5.00 5.25 5.50
AU
0.0
2.0e-2
4.0e-2
6.0e-2
8.0e-2
1.0e-1
01_16_2009_27 Sm (Mn, 2x1); Sb (4,40.00 ) 3: Diode Array 
Range: 1.083e-10.27
3.60
2.771.12
5.37
01_16_2009_28 Sm (Mn, 2x1); Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
7.66e4
3.58
0.69
2.882.17 4.45 4.71 5.19
 
LCMS: 5-30% B over 1 min then 30-60% B over 4 min with a flow rate of 0.7 
mL/min and 195 nm UV detection, retention time = 3.60 min. 
Figure 28. LCMS analysis of Boc-L-Glu(L-Ala-L-Phe-L-Val-L-Met-L-Val-L-Pro-
L-Ala-OEt)-OtBu (194) 
 
 
2a) UV Trace: 3.60 min
b) MS: 3.58 min,
m/z = 1046.5726
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Inder-Boc-Glu-tBu-A-F-V-M-V-P-A-OEtMw1046- LCMS ACN:H2O
LCT Premier 23-Feb-2009 23:04:12
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
01_16_2009_27 167 (3.649) Cm (167-140:153x20.000) 1: TOF MS ES+ 
1.28e41064.7131
1047.6841
553.2926483.9445 973.7407
604.4314
833.5345
1065.7136
1066.7211
1069.6678
1070.6721
1071.6722
1072.66821244.7244
 
Figure 29. ESI-HRMS spectrum of the peak aluting at 3.58 min (Boc-L-Glu(L-
Ala-L-Phe-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt)-OtBu) 
3.9 Verification of the Extent of Epimerization in the DNS Coupling 
To investigate the extent of epimerization during the thioacid-sulfonamide 
coupling, a tripeptide Z-Gly-L-Phe-L-Val-OtBu 111 was synthesized by the 
coupling of a dipeptide thioacid Z-Gly-L-Phe-SH 110 with the DNS-L-Val-OtBu 
172 in DMF (Scheme 68). 
 
Scheme 68. Synthesis of Z-Gly-L-Phe-L-Val-OtBu (111) by the DNS coupling 
method 
LCMS analysis of the tripeptide 111 produced by this sequence shows a 
single peak with a retention time of 3.65 min with a molecular weight 
[M+H]+
[M+NH4]+
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corresponding to the tripeptide 111 (Figure 30), consistent with an epimerization 
free reaction. 
Inder-Cbz-Gly-L-Phe-ValOtBuMw511-DNSmethod- LCMS ACN:H2O
01-Mar-2009 14:04:39
Time
1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75 5.00 5.25
%
-4
96
1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75 5.00 5.25
AU
-5.0e-3
0.0
5.0e-3
1.0e-2
1.5e-2
2.0e-2
2.5e-2
3.0e-2
3.5e-2
4.0e-2
01_16_2009_42 Sm (Mn, 1x1); Sb (4,40.00 ) 3: Diode Array 
Range: 4.889e-23.62
1.38
4.15
01_16_2009_43 Sb (4,40.00 ) 1: TOF MS ES+ 
TIC
9.69e4
3.64
0.90
4.57 4.96
 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min. 
Figure 30. LCMS analysis of Z-Gly-L-Phe-L-Val-OtBu (111) from the DNS 
coupling 
To verify that the LC conditions were capable of resolving the epimeric 
peptides, a further sample of Z-Gly-L-Phe-Val-OtBu (111) was synthesized by 
EDCI coupling under conditions likely to produce epimerization akin to the ones 
described in Chapter 2. LCMS of this crude reaction mixture showed essentially 
full epimerization (ratio, L/D = 48/52) with two well resolved peaks having 
retention times 3.65 min and 3.78 min (Chapter 2, Figure 7). 
The lack of epimerization in the coupling of the thioacid using the DNS coupling 
method was further confirmed by synthesis of an authentic sample of Z-Gly-D-
a) UV Trace: 3.62 min
b) MS: 3.64 min,
m/z = 511.2682
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Phe-Val-OtBu (116) as described in Chapter 2, which was shown to have a 
different retention time (Chapter 2, Figure 8). 
3.10 Synthesis of the FNS Protected Peptidyl Thioesters 
Synthesis of the N-FNS protected di-peptide thioester FNS-L-Val-L-Val-
STmob (197) involved the preparation of a FNS α-valine tert butyl ester (196) by 
the reaction of the corresponding hydrochloride salts of α-valine tert butyl ester 
and the FNS chloride in presence of diisopropylethyl amine (Scheme 69) 
followed by the cleavage of the tert butyl group under acidic conditions. This 
route gave access to a FNS protected α-valine acid, that was then coupled with 
the valine thioester amine 165 (NH2-L-Val-STmob) by the EDCI/HOBT method to 
access the FNS protected Val-Val thioester in good yield (Scheme 69). 
 Scheme 69. Synthesis of the FNS thioesters 
A left to right strategy was applied to the synthesis of the N-FNS protected 
tri-peptide thioester, which involved the preparation of a FNS protected di-peptide 
tert butyl ester by the reaction of the corresponding hydrochloride salts of α-
amino acid tert butyl ester 199 and the FNS protected α-amino acid 198 with 
EDCI/HOBT coupling method (Scheme 69) followed by the cleavage of the tert 
butyl group under acidic conditions. This route gave access to a FNS protected 
di-peptide acid that was then coupled with the valine thioester amine 165 (NH2-L-
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Val-STmob) by the HATU method to access the FNS protected tri-peptide 
thioester 200 in excellent yield. 
3.11 The Left to Right Strategy using the FNS group 
Further investigation revealed the FNS group to be somewhat more 
reactive than the CNS and the ENS groups toward the thiocarboxylates as 
illustrated by the examples in Scheme 70. These reactions proceeded in good 
yield with α-amino-derived thioacids unlike the case of the CNS and the ENS 
derivatives, but still took significantly more time than the side chain amino 
thioacids.  
Scheme 70. Reactivity of the FNS group toward thiocarboxylates 
A critical point in the use of the FNS group was the switch from cesium 
carbonate to cesium bicarbonate for the coupling reaction. With cesium 
carbonate as base the N-FNS protected di- and higher peptides were observed 
by mass spectrometry to undergo cyclization, with retention of the FNS group, 
rather than condensation when exposed to a DNS peptide and cesium 
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carbonate. This was attributed to the acidity of the FNS sulfonamide NH group 
and so was circumvented by the use of the milder base. The use of pyridine as 
base also afforded a similar result to cesium carbonate (Scheme 71). 
FNS-L-Val-L-Val-STmob
TFA/Et3SiH
FNS-L-Val-L-Val-SH
i) DNS-Peptide
ii) Py or Cs2CO3
DMF
CH2Cl2
NH2-Peptide
M+Na: 508
M-H : 484
M+Na: 474
M-H : 450
FNS-L-Ala-L-Phe-L-Val-STmob FNS-L-Ala-L-Phe-L-Val-SH
M+Na: 627
M-H : 603
M+Na: 593
M-H : 569
NH2-Peptide
Identified by MS but not isolated
F3C S N NH
O
O
O2N
O
O
Identified by MS but not isolated
TFA/Et3SiH
CH2Cl2
i) DNS-Peptide
ii) Py or Cs2CO3
DMF
Identified by MS but not isolated
F3C
S N
O
O
O2N
Identified by MS but not isolated
N
H
H
N
O
O
O
Ph
206
207
208
209
197
200
 
Scheme 71. Rationalization of problems encountered with the use of 
Cs2CO3 and pyridine in the activation of N-FNS peptide thioacids 
This block synthesis strategy based on the thiocarboxylate-sulfonamide 
coupling is complementary to the methods developed by Kent based on native 
chemical ligation. However, for maximum flexibility in approaching future targets, 
compatibility of the thioester functionality with the thiocarboxylate-sulfonamide 
coupling approach was required. Thus, building on the promising results 
presented in Scheme 70, the FNS protected Tmob thioester 200 was first treated 
under acidic conditions to release the corresponding thioacids 208, which was 
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then exposed to a DNS protected peptide 178 carrying a Fm thioester at the C-
terminal position followed by the treatment with cesium hydrogen carbonate to 
provide the FNS protected peptide Fm thioester 210 (Figures 31 and 32) in good 
yield (Scheme 72). The FNS protected peptide Fm thioester 210 was then 
trapped with Alloc-Gly-Gly-SH to afford the nonapeptide Fm thioester 211. This 
triblock synthesis in which a fluorenylmethyl thioester is carried through two 
coupling steps nicely illustrates the compatibility of simple thioester moieties with 
the thiocarboxylate-sulfonamide approach and opens the door for further chain 
extension by the well-established native chemical ligation method. 
Scheme 72. Compatibility of the Fm Thioesters with the Thioacid-
Sulfonamide Block Synthesis 
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HPLC: 40 -100% acetonitrile in water over 25 min with a flow rate of 1.0 mL/min 
and 254 nm UV detection, retention time = 10.264 min  
Figure 31. HPLC trace of FNS-L-Ala-L-Phe-L-Val-L-Val-L-Ala-L-Thr-L-Val-SFm 
(210) 
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Inder-FNS-AFV-VATV-SFm-Mw1152 inmethanol
LCT Premier 10-May-2009 07:59:15
m/z
200 400 600 800 1000 1200 1400 1600 1800 2000 2200 2400 2600 2800
%
0
100
01_16_2009_69 178 (3.901) Cm (178:179-166:177x2.000) 1: TOF MS ES+ 
3.63e41153.4304
816.2698
672.2471604.6954
941.3856
1154.4476
1170.4747
1171.4863
1172.4846
1175.4432
1252.5634
1254.5714 2322.93331902.6610
 
Figure 32. ESI-HRMS spectrum of the peak eluting at 10.264 min [FNS-L-Ala-
L-Phe-L-Val-L-Val-L-Ala-L-Thr-L-Val-SFm (210)] 
3.12 The Left to Right Strategy 
While successful, the right to left strategy for block peptide synthesis 
described above suffered from a major limitation, namely its necessary reliance 
on the use of a series of sulfonamides of decreasing reactivity. This design 
requirement essentially means that a first fast reaction is followed up by a second 
inherently slower one, and ultimately limits the application of the method.  In view 
of this limitation an alternative left to right strategy was envisaged that employs 
the more reactive DNS sulphonamide in all coupling steps (Scheme 73).  
[M+H]+
[M+NH4]+
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Scheme 73. Convergent synthesis by the left to right strategy 
As is apparent from Scheme 73, this new sequence necessitates the 
compatibility of the Tmob thioester functionality with the sulfonamide coupling 
reaction. While this was a reasonable expectation on the basis of the tolerance of 
the thioacid-sulfonamide coupling for the Fm thioesters as presented above, 
corroboration was required. To this end, the Fmoc protected di-peptide Tmob 
thioester 212 was treated under acidic conditions to release the corresponding 
thioacid, which was then exposed to a DNS protected di-peptide Tmob thioester 
followed by the treatment with cesium carbonate to provide the Fmoc protected 
tetra-peptide Tmob thioester 213 in good yield (Scheme 74). The Tmob group in 
this tetrapeptide was then cleaved off to release the thioacids 214, which was 
then reacted with the DNS protected tetra-peptide Fm thioester 178 to afford an 
Fmoc protected octapeptide Fm thioester 215, whose diastereomeric purity was 
established in the usual manner (Figure 33). This last sequence of reactions 
confirms the stability of both the Fm and Tmob thioesters, thereby again setting 
the stage for the application of this chemistry in the preparation of thioesters for 
native chemical ligation sequences. The octapeptide Fm thioesters are also 
important building blocks for cyclic peptide synthesis as has been demonstrated 
very recently.154 
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In another variation on the general theme of left to right block synthesis, 
the Fmoc protected tetra-peptide thioacid 214 was treated with a DNS protected 
penta-peptide 175 to afford a nona-peptide 216 (Scheme 74).  
 
Scheme 74. Left to right strategy showing compatibility with thioesters 
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HPLC: 40 -100% acetonitrile in water over 25 min with a flow rate of 0.7 mL/min 
and 254 nm UV detection, retention time = 11.66 min  
Figure 33. HPLC trace of Fmoc-L-Phe-L-Ala-L-Val-L-Ala-L-Val-L-Ala-L-Thr-L-
Val-SFm (215) 
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Inder-Fmoc-F-A-V-A-V-A-T-V-SFm Mw1192 -LCMS ACN:H2O
LCT Premier 12-Apr-2009 22:29:24
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400
%
0
100
01_16_2009_58 232 (5.100) Cm (232-233:245x2.000) 1: TOF MS ES+ 
4.57e31210.6897
1193.6621
597.3305
426.3733364.3489302.2047104.2934
574.4052
616.8039
625.2929 841.4377722.4927 1140.6403946.3966 992.5199
1215.6466
1216.6478
1217.6537
1218.6517
1232.6261
1294.7793
1353.6360
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Figure 34. ESI-MS spectrum of the peak eluting at 11.66 min [Fmoc-L-Phe-L-
Ala-L-Val-L-Ala-L-Val-L-Ala-L-Thr-L-Val-SFm (215)] 
3.13. Attempted Redesign of the System to Intramolecular Amine Transfer 
to the Active Thioester 
While successful, the strategies delineated above for block peptide 
synthesis involve the intermolecular coupling for the formation of an amide bond 
and suffer from the usual limitations of intermolecular reactions, namely slower 
reactions for the coupling of larger segments. In native chemical ligation Kent 
overcame this problem by using the more nucleophilic thiol in the intermolecular 
step, and thereby rendering the amide bond forming step intramolecular.  Taking 
a leaf from Kent’s book, a coupling sequence was envisaged in which the N-
terminal amine of one peptide segment would be captured in the form of a 
Schiff’s base with the 2-fluoro-5-nitrobenzaldehyde.  Subsequent intermolecular 
nucleophilic substitution by a C-terminal thioacid on this moiety would then give a 
[M+NH4]+
[M+H]+
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thioester, suitably place to accept the nitrogen nucleophile in an intramolecular 
manner (Scheme 75).  This reaction scheme intercepts the previous work of Ito 
and coworkers who accessed essentially the same key intermediate for S-N acyl 
transfer by reaction of an amine with a preformed 2-formyl-4-nitrophenyl 
thioester.142 
 
Scheme 75. Potential S-N acyl transfer 
3.14 Synthesis of the Schiff Bases 
Following the literature,153 several Schiff bases 217-220 were prepared in 
excellent yields from the reaction of the corresponding primary amine and 2-
fluoro-5-nitrobenzaldehyde in presence of anhydrous sodium sulfate in 
methylene chloride (Scheme 76). 
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Scheme 76. Synthesis of the Schiff bases 
3.15 Synthesis of Thioesters 
The synthesis of the α-amino thioesters was performed as described in 
Chapter 2. However, for the synthesis of higher peptidyl thioesters, an α-amino 
thioester was coupled with the corresponding peptidyl acid by the EDCI coupling 
method as outlined in Scheme 77. 
 
Scheme 77. Synthesis of peptidyl thioesters employing EDCI as reagent 
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3.16 Peptide Synthesis using the Thioacids and the Schiff Bases 
The coupling of thioacids with the Schiff bases was first investigated with 
commercially available thioacetic acid, and the Schiff bases of phenylethylamine 
and L-tryptophan methyl ester (Table 7, entries 1 and 2), and a good yield of the 
acetamide was obtained on mixing of the both components in DMF at room 
temperature in the presence of cesium carbonate. Thus encouraged, a series of 
oligopeptides was accessed by coupling amino thioacids with other Schiff bases 
with the yields reported in Table 7. All reactions in Table 7 were conducted at 
room temperature and involved 0.1 M Schiff base in DMF with thioacid (1.2 
equiv) and Cs2CO3 (1.5 equiv) as base. 
Table 7. Coupling of Thioacids with Schiff Bases 
R1 SR
O
R1 NHR2
O
R1 SH
OTFA F
O2N
N R2
CsHCO3, DMF,
T (h)
 
Entry Thioester Thioacid Schiff 
Base 
T 
(h) 
Product % 
Yield 
1 - AcSH 217 4 AcNHCH2CH2Ph 
(227) 
75 
2 - AcSH 218 4 Ac-L-Trp-OMe (96)  78 
3 Z-L-Val-STrt (92) Z-L-Val-
SH 
218 8 Z-L-Val-L-Trp-OMe     
(228) 
57 
4 Alloc-Gly-Gly-
STmob (160) 
Alloc-Gly-
Gly-SH 
218 6 Alloc-Gly-Gly-L-Trp-
OMe (229) 
83 
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5 Z-L-Val-L-Ala-
STmob (224) 
Z-L-Val-L-
Ala-SH 
218 6 Z-L-Val-L-Ala-L-Trp-
OMe (230) 
81 
6 Z-L-Val-STrt (92) Z-L-Val-
SH 
219 14 Z-L-Val-L-Phe-L-Phe-
OMe (231) 
54 
7 Z-L-Val-L-Ala-
STmob (224) 
Z-L-Val-L-
Ala-SH 
219 10 Z-L-Val-L-Ala-L-Phe-
L-Phe-OMe (232)  
71 
8 Alloc-Gly-Gly-
STmob (160) 
Alloc-Gly-
Gly-SH 
219 10 Alloc-Gly-Gly-L- Phe-
L-Phe-OMe (233) 
74 
9 Z-L-Val-L-Ala-
STmob (224) 
Z-L-Val-L-
Ala-SH 
220 12 Z-L-Val-L-Ala-L-Ala-
L-Phe-L-Phe-OMe 
(234) 
55 
10 Z-L-Ala-L-Phe-
Gly-L-Ala-
STmob (226) 
Z-L-Ala-L-
Phe-Gly-
L-Ala-SH 
220 14 Z-L-Ala-L-Phe-Gly-L-
Ala-L-Ala-L-Phe-L-
Phe-OMe (235) 
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The ability to form relatively hindered peptide bonds is evident from entries 
3 and 6 (Table 7), where a valine thioacid is coupled with the Schiff bases of 
tryptophan and phenylalanine. The good functional group compatibility of the 
process is clear from inspection of Table 7 in general. In spite of these promising 
results the yields for the formation of the sterically and electronically more 
demanding junctions (Table 7, entries 3 and 6) are lower than those obtained in 
less demanding cases (Table 7, entries 4, 5, 7 and 8). S→N Acyl transfer is also 
substrate dependent in this protocol and becomes slow with the increase chain 
length of the peptide fragments as evident from the entries 9 and 10.  
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Monitoring of this reaction sequence by mass spectrometry revealed that 
the intermolecular nucleophilic aromatic substitution step to be rapid and to 
provide the thioester intermediate within an hour for all the examples presented 
in Table 7.  The second step in the sequence, the S→N acyl transfer with release 
of the peptide, however, was found by mass spectrometric monitoring to be 
highly substrate dependent. Thus, for small segments the desired amide 
functionality was formed in good yield in a few hours. On the other hand , larger 
fragments were found to afford the peptide only very slowly with the initial adduct 
continuing to be observed as a major product after several hours.  Because of 
this slower transfer, hydrolysis competes and the overall yields are 
correspondingly lowered (Scheme 78). In view of this dependence on the size of 
the units to be coupled it is interesting to note that the Ito group only reported the 
synthesis of di and tripeptides in their closely related approach.142  
Scheme 78. Hydrolysis of the thioester intermediate 
It is conceivable that the problem of slow transfer might be circumvented by the 
introduction of a group X at the 3-position of the aromatic linker such that would 
bias the conformation about the Ar-imine bond by steric buttressing166-168 in such a 
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way as to predispose it toward cyclization onto the thioester (Scheme 82).  This 
possibility remains to be tested.  
 
Scheme 79. Potential application of steric buttressing to accelerate S→N 
acyl transfer 
3.17. Conclusion 
Overall, a combination of powerful new methods for the block synthesis of 
peptides based on the reaction of thioacids with electron-deficient sulfonamides 
is presented in this chapter.  The assembly of the various blocks was conducted 
in a right to left or left to right manner and arranged in such a way as to provide a 
peptide thioester ready for incorporation in to a native chemical ligation 
sequence. 
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CHAPTER 4 
 Direct Fmoc-SPPS of Peptidyl Thioesters 
4.1 Background and Significance 
As discussed in Chapter 1, over the years several useful, elegant and 
indirect methods have been developed for the synthesis of C-terminal peptidyl 
thioesters by Fmoc-SPPS. Despite these notable advances, the synthesis of 
peptidyl thioesters remains significantly more challenging than the synthesis of 
the corresponding peptidyl acids or amides. In this regard, the development of a 
general and direct approach for solid-phase peptidyl α-thioesters synthesis was 
undertaken, the results of which are described in this chapter. 
4.2 Fmoc-SPPS of Peptidyl Thioesters from Thioamides 
 Thioamides are analogs of amides and are versatile building blocks in 
organic chemistry.169-171 They have also been incorporated into peptides as 
isosteres for the amide bond in the design of peptidase and/or protease 
inhibitors.172-174 The small difference in electronegativity between carbon and 
sulfur and the larger size of sulfur allow greater charge transfer from nitrogen to 
sulfur in thioamides, which makes them more nucleophilic than amides and 
enables their selective alkylation in the presence of amides (Figure 35).175  
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Figure 35. Amide vs thioamide resonance 
Thioamides can be converted to thioesters as described previously by 
several groups.155,160,161,176-179 For example, thioamides have been converted to 
thioesters by simply warming in an aqueous solution containing an alkylating 
agent, which implies thioimide formation followed by hydrolysis (Scheme 80). 
 
Scheme 80. Thioamide to thioester 
Peptidyl thioesters have also been generated from the corresponding 
thioamides by sequential S-alkylation with isolation of the thioimidates followed 
by subsequent acidic hydrolysis.176,178 The thioamide moiety was also found to 
be completely stable under the cleavage conditions180-184 used to remove the N-
Fmoc group in peptide chemistry.185,186 
Based on these observations, Fmoc-SSPS of the peptidyl thioesters was 
envisaged by a process in which an Fmoc protected thioamide derivative would 
be attached to the resin by HBTU/HOBT coupling followed by the elongation of 
the peptide chain by Fmoc-SPPS. Subsequent S-benzylation of this resin bound 
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peptide 245 would then give a thioimidate 246 that could be easily hydrolyzed to 
provide the peptidyl thioester (Scheme 81). 
Scheme 81. Projected Fmoc solid-phase synthesis of peptidyl thioesters 
4.3 Synthesis of the Thioamides Linkers 
Following the literature,10,11 several Fmoc-protected dipeptides were 
prepared from the corresponding Fmoc-protected α-amino acids and the 
hydrochloride salt of glycine tert butyl ester by coupling with EDCI/HOBT in 
excellent yields (Scheme 82). These dipeptides were converted to the 
corresponding thioamides by the well documented reaction of Lawesson’s 
reagent187,188 in refluxing toluene followed by the removal of tert butyl group 
under acidic conditions to afford the corresponding Fmoc protected thioamide 
acids in good yields. In these thionation reactions, the Lawesson reagent was 
completely selective for the transformation of the amide bond in the presence of 
the carbamate and ester bonds. This is clear from the IR and 13C NMR spectra. 
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Thus, in the IR spectra of the products which only the amide carbonyl at 
1660 cm-1 was lost, with the carbamate and ester absorptions at 1705 and 1740 
cm-1 being retained; the new thioamide thiocarbonyl absorption was typically 
seen at 1248 cm-1. In the 13C-NMR spectrum the amide carbonyl at δ 172 was 
converted to the thiocarbonyl resonance at δ 203, while the carbamate and ester 
carbonyl resonances remained unchanged. 
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Scheme 82. Synthesis of the thioamide linkers 
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4.4 Amino Acid Side-Chain Protection Strategies in Fmoc-SPPS 
More than half of the amino acids commonly encountered in proteins have 
side chains that contain reactive functional groups. One of the more demanding 
parts of solid phase peptide synthesis is the necessity to mask these reactive 
functional groups to prevent their interference in peptide bond formation. Self-
evidently any side chain protecting groups employed must be stable to the 
conditions employed for removal of the N-terminal protecting group and for 
peptide chain extension. 
The Fmoc-SPPS approach developed in this chapter involves an 
orthogonal protecting group strategy, known as the Fmoc/t-Butyl strategy, which 
involves the use of base-labile Nα-Fmoc group and acid-labile side chain 
protecting groups. All the side chain protecting groups were selected based on 
their orthogonality to Fmoc-SPPS and were removed during the final cleavage of 
peptidyl thioesters from the linker. Thus, side-chain alcohols and acids were 
protected as tBu ethers and esters, whereas amines and guanidines were 
protected as tBu carbamates and Pbf sulfonamides, respectively. In addition, 
thioether function of methionine was further protected as sulfoxides to avoid any 
undesired alkylation.36,49,50 All the amino acids used in this Fmoc-SPPS approach 
were commercially available. 
4.5. Synthesis of the both L- and D-Diastereomers of L-Val-L-Ala-Phe-SBn 
With all the building blocks in hand attention was turned to solid-phase 
synthesis of peptidyl thioesters on the aminomethyl polystyrene resin, using 
manual techniques (Scheme 83). Accordingly, the first Nα-Fmoc protected 
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thioamide acid was activated with HBTU and HOBt in DMF and the pre-activated 
amino acid was then allowed to react with the aminomethyl polystyrene resin to 
yield the resin bound thioamide derivative. Subsequently, the desired peptide 
chain was elongated using standard Fmoc techniques, which consisted of the 
following steps in each cycle: (i) removal of the Nα-Fmoc protecting group of the 
last coupled amino acid by treatment with piperidine; (ii) washing of the resin with 
isopropyl alcohol, hexane, methylene chloride and, (iii) coupling of the next pre-
activated appropriate side-chain protected Nα-Fmoc amino acid. Between each of 
these steps a thorough flow wash with DMF was carried out to remove excess 
reagents. The final amino acid was introduced with Boc protection rather than the 
standard Fmoc group. Finally after completion of the on-resin procedure, the 
resin-bound peptide was treated with a solution of DBU (10 equiv) and benzyl 
bromide (9 equiv) in DMF to provide the resin bound thioimidate, that was 
subjected to hydrolysis with TFA/water to afford the desired peptidyl thioesters as 
shown in Scheme 83. 
Scheme 83. Synthesis of the diastereomers 
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An unprotected tri-peptide thioester L-Val-L-Ala-L-Phe-SBn was obtained 
in this manner in good yield as set out in Scheme 84. 500 MHz 1H NMR analysis 
of the tripeptide thioester in CDCl3 produced from this method also enabled 
investigation of the extent of epimerization. To verify that the 1H NMR was 
capable of resolving the epimeric peptide thioesters, the diastereomeric tripeptide 
L-Val-L-Ala-D-Phe-SBn was also synthesized in the same manner. Both the 
isomers were subjected to 500 MHz 1H NMR analysis in CDCl3. A qualitative 
comparison of the 500 MHz 1H NMR spectra of both diastereomers was 
performed as shown in Figure 36. A careful review of the proton NMR spectra of 
both isomers indicates that each spectrum corresponds to a mixture of 
diastereomers. The characteristic chemical shifts of benzyl protons of the 
thioester unit and the methyl protons of alanine and valine in the diastereomeric 
tripeptides identify the two diastereomers as shown in Table 8. It is evident from 
the 1H NMR integration analyses that the tripeptide thioester sequence proceeds 
with ~ 22% epimerization under standard conditions. 
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Figure 36. 1H-NMR  spectra of tripeptide thioesters in CDCl3. 
Table 8. Selected 1H Chemical Shifts (δ in ppm) and Coupling Constants (J) 
of Tripeptide Thioesters L-Val-L-Ala-L-Phe-SBn (254) and L-Val-L-Ala-D-Phe-
SBn (255) 
Tripeptide 
Thioesters 
δ of benzyl proton 
(multiplicity, J, 
proton counts) 
δ of methyl proton of Ala and Val 
(multiplicity, J, proton counts) 
Epimer 
Ratio % 
(L:D) 
L-Val-L-Ala-
L-Phe-SBn 
(254) 
4.11 (s, 1H) 1.33 (d, J = 7.0 Hz, 3H), 0.97 (d, 
J = 7.0 Hz, 3H), 0.79 (d, J = 7.0 
Hz, 3H) 
77.5:22.5 
L-Val-L-Ala-
D-Phe-SBn 
(255) 
4.07 (s, 1H) 1.25 (d, J = 7.0 Hz, 3H), 0.94 (d, 
J = 7.0 Hz, 3H), 0.78 (d, J = 7.0 
Hz, 3H) 
21.9:78.1 
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4.6. Fmoc-SPPS of Peptidyl Thioesters on the 2-Chlorotrityl Resin  
Thus encouraged, a series of unprotected C-terminal oligo-peptide 
thioesters was accessed using Fmoc-SPPS on 2-chlorotrityl resin,121 which could 
be cleaved under exceptionally mild acidic conditions leaving all the acid 
sensitive protecting groups intact.  After each coupling step, the formation of the 
desired sequence was verified by cleavage of a small amount (~ 5 mg) of 2-
chlorotrityl resin using a solution of 2% TFA in methylene chloride, followed by 
examination by ESI-TOF mass spectrometry.  
To avoid the risk of racemization, a Gly residue was introduced at the C-
terminal position in all peptide sequences. To probe the scope of the method, a 
number of peptides were synthesized employing various amino acid residues 
(Ala, Thr, Val, Ser, Tyr, Arg, Asn, Trp, Ile, Phe) at different positions of the 
sequences, thereby providing a true test of this Fmoc-SPPS approach. 
The synthetic work commenced with the commercially available 4-
(aminomethyl)benzoic acid 256, of which Fmoc protection of the amine was 
achieved in quantitative yield. The acid 257 was then attached to the 2-
chlorotrityl resin by the reaction with resin bound 2-chlorotrityl chloride and 
diisopropylethylamine in methylene chloride as illustrated in Scheme 84. The 
Fmoc group was then removed and the resulting amine 258 was coupled with the 
glycine thioamide linker 253 using the HBTU/HOBT method to provide the resin 
bound thioamide derivative. Subsequently, the peptide chain was elongated on 
the 2-chlorotrityl resin using standard Fmoc techniques as described previously 
in this chapter. The sequence was capped by introduction of a Boc-protected 
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amino acid at the N-terminus. Finally after completion of the on-resin procedure, 
the resin-bound peptide was treated with a solution of DBU (10 equiv) and benzyl 
bromide (9 equiv) in DMF to provide the resin bound thioimidate 261 that was 
subjected to hydrolysis with TFA/water with concomitant side chain deprotection 
to provide the protecting group free peptidyl thioesters in the form of their 
trifluoroacetate salts, as shown in Scheme 84. All the crude peptide thioesters 
were purified by reverse phase HPLC with 0.1% TFA in water/ acetonitrile as 
eluent and obtained in the yields presented in Scheme 84. 
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Scheme 84. Functional group compatibility 
The good functional group compatibility of the process is clear from 
inspection of Scheme 84 in general. In particular, the last entry in Scheme 84 
places special emphasis on the robustness of the method, as it illustrates the 
synthesis of a functionally diverse nonapeptide thioester containing several types 
of side chain functionality such as the guanidine of arginine, the primary amide of 
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asparagine, the indole of tryptophan, the phenol of tyrosine, and the hydroxyl 
group of serine and threonine, which had suitable protection throughout the 
synthesis. The analytical RP-HPLC traces and ESI-TOF mass spectra of the 
peptidyl thioesters prepared in this manner are presented in Figures 37-42. 
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HPLC: 10 -90% acetonitrile in water over 30 min with a flow rate of 1 mL/min and 
215 nm UV detection, retention time = 15.52 min 
Figure 37. HPLC trace of L-Thr-L-Ala-L-Ser-L-Phe-L-Ser-L-Leu-Gly-SBn (262) 
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Inder-NH2--SBn--Mw913-LCMS-ACN:H2O
LCT Premier 12-Aug-2010 07:06:23
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400
%
0
100
03_19_2010_103 120 (2.630) Cm (120-115:118x2.000) 1: TOF MS ES+ 
2.66e4788.3381
529.2700463.2588343.1900 788.1351
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862.4047 976.4261 1146.55071031.4508 1208.5059 1297.1229 1490.7139
 
Figure 38. ESI-HRMS spectrum of the peak eluting at 15.52 min [L-Thr-L-Ala-
L-Ser-L-Phe-L-Ser-L-Leu-Gly-SBn (262)] 
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HPLC: 10 -90% acetonitrile in water over 30 min with a flow rate of 1 mL/min and 
215 nm UV detection, retention time = 17.90 min  
Figure 39. HPLC trace of L-Thr-L-Phe-L-Tyr-L-Ser-L-Ala-L-Tyr-Gly-SBn (263) 
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Inder-NH2--SBn--Mw913-LCMS-ACN:H2O
LCT Premier 12-Aug-2010 06:27:00
m/z
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%
0
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Figure 40. ESI-HRMS spectrum of the peak eluting at 17.90 [L-Thr-L-Phe-L-
Tyr-L-Ser-L-Ala-L-Tyr-Gly-SBn (263)] 
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HPLC: 10 -90% acetonitrile in water over 30 min with a flow rate of 1 mL/min and 
215 nm UV detection, retention time = 23.18 min  
Figure 41. HPLC trace of L-Asp-L-Trp-L-Arg-L-Tyr-L-Ile-L-Ser-L-Thr-L-Phe-
Gly-SBn (264) 
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Inder-NH2--SBn--Mw1248-LCMS-ACN:H2O
LCT Premier 12-Aug-2010 06:12:43
m/z
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%
0
100
03_19_2010_100 97 (2.135) Cm (97:98-(90:95+100:110)x2.000) 1: TOF MS ES+ 
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Figure 42. ESI-HRMS spectrum of the peak eluting at 23.18 min of [L-Asp-L-
Trp-L-Arg-L-Tyr-L-Ile-L-Ser-L-Thr-L-Phe-Gly-SBn (264)] 
4.7 Synthesis of the Thioester Containing Methionine Residue 
The compatibility of the method with cysteine and methionine residues 
was next tested. To this end, solid-phase synthesis of tetra-peptides containing 
cysteine and methionine residues was performed on the aminomethyl 
polystyrene resin (Scheme 85). The first Nα-Fmoc protected thioamide acid was 
activated with HBTU and HOBt in DMF and the pre-activated amino acid 253 
was then allowed to react with the aminomethyl polystyrene resin to yield the 
resin bound thioamide derivative 265. As discussed above the methionine was 
introduced in the form of sulfoxide to obviate the possibility of their alkylation on 
introduction of benzyl bromide in the cleavage step. Subsequently, the desired 
peptide chain was elongated using standard Fmoc techniques. The peptide chain 
was terminated with a Boc-protected amino acid (Boc-L-Glu(OtBu)-OH). Finally 
[M+H]+
[M+2H]2+
[2M+H]3+
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after completion of the on-resin procedure, the resin-bound peptide was treated 
with a solution of DBU (10 equiv) and benzyl bromide (9 equiv) in DMF to provide 
the resin bound thioimidate 246, that was subjected to hydrolysis with TFA/water. 
The final step of the sequence was the in situ reduction of the sulfoxide groups 
with NH4I/Me2S49 followed by reverse phase HPLC purification to access the 
unprotected peptidyl thioester 266 as shown in Scheme 85.  
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Scheme 85. Peptides containing methionine residue 
The reduction of the sulfoxide was followed by mass spectrometry 
presented in Figures 43 and 44 for the case of the methionine-containing 
tetrapeptide. Thus, in the mass spectrum of the product, peaks with mass 614 
(M+H) and 636 (M+Na) corresponding to the the sulfoxide were converted to the 
mass 598 (M+H) and 620 (M+Na) respectively, which clearly indicate the 
complete conversion of methionine sulfoxide to methionine. 
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Inder-NH2--Glu-Arg-Met-Gly-SBn-Mw597inmethanol
LCT Premier 27-Oct-2010 22:30:39
m/z
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Figure 43. ESI-HRMS spectrum of L-Glu-L-Met(O)-L-Arg-Gly-SBn 
Inder-NH2--Glu-Arg-Met-Gly-SBn-Mw597inmethanol
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Figure 44. ESI-HRMS spectrum of L-Glu-L-Met-L-Arg-Gly-SBn (266) 
The results presented in Scheme 85 support the earlier work from several 
groups on the use of sulfoxides as protecting groups in advanced peptide 
[M+H]+
[M+Na]+
[M+Na]+
[M+H]+
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synthesis.189-192 In particular it is demonstrated that the sulfoxide group is 
compatible with the thioamide to thioester transformation and thereby enables 
the methionine residue in peptidyl thioesters to be prepared for native chemical 
ligation by the methodology of this chapter.  
4.8 Conclusion 
The work presented in this chapter has resulted in the development of a novel, 
direct approach to the solid phase synthesis of peptidyl glycyl thioesters based on 
the use of a thioamide linker in conjunction with standard Fmoc chemistry, followed 
by an alkylative procedure and simple acidic hydrolysis. This methodology is fully 
compatible with the Fmoc-SPPS approach and does not require any special 
linkers, resins or complicated protocols. This chemistry provides a very convenient 
and mild means to access unprotected peptidyl benzyl thioesters that could be use 
directly in native chemical ligation and its variants. While issue of the racemization 
at the C-terminal remains to be solved, the new strategy is viewed as a promising 
platform for the future initiatives in peptide chemistry. 
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CHAPTER 5 
 CONCLUSIONS 
The applicability of novel methodologies to the block synthesis of peptides 
and peptidyl thioesters was demonstrated and a direct approach for the synthesis 
of peptidyl thioesters with standard Fmoc chemistry was developed. 
A new chemistry for the epimerization-free block peptide synthesis has 
been developed. This chemistry involves the in situ formation of highly active 
thioesters by nucleophilic aromatic substitution of C-terminal thioacids on 
electron-deficient halogenoarenes followed by trapping with an N-terminal amine. 
This epimerization-free methodology is superior to available methods and does 
not require the presence of any particular amino acid for coupling, in contrast to 
native chemical ligation and its variants.  The method is capable of peptide bond 
forming reactions at hindered residues. 
The reactivity pattern of N-terminal sulfonamides towards peptidyl 
thioacids was optimized. Convergent strategies for multiple peptide fragment 
ligation, based on the reactivity differences of various sulfonamides, were 
developed and employed in triply convergent synthesis. Simple peptidyl 
thioesters are compatible with these reaction sequences, which enables the 
block synthesis of peptidyl thioesters ready for incorporation into a native 
chemical ligation sequence.  
A novel and direct approach to the solid phase synthesis of peptidyl thioesters 
was established based on the use of a thioamide linker in conjunction with 
standard Fmoc chemistry. This methodology is fully compatible with the Fmoc-
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SPPS approach and has been applied to access unprotected peptidyl benzyl 
thioesters that could be use directly in native chemical ligation and its variants.  
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CHAPTER 6 
EXPERIMENTAL SECTION 
General: 
All solvents were dried and distilled by standard protocols. All reactions 
were conducted under an inert atmosphere of argon or nitrogen unless otherwise 
stated. All organic extracts were dried over sodium sulfate, and concentrated 
under aspirator vacuum. Chromatographic purifications were carried out over 
silica gel. All peptide syntheses were carried out employing 1% DVB cross linked 
aminomethyl polystyrene resin or 2-chlorotrityl resin in a 10 mL manual 
synthesizer glass reaction vessel with a Teflon-lined screw cap. Unless otherwise 
stated optical rotations were recorded on an Autopol® III automatic polarimeter in 
CHCl3 solution and 1H and 13C spectra were recorded in CDCl3 solution. Melting 
points were measured on a Barnstead electrothermal (9100) instrument and are 
uncorrected. Chromatographic purifications were carried out over silica gel. 
Reverse phase HPLC (RP-HPLC) was performed with 215 and 254 nm UV 
detection, using a C-18 analytical and preparative columns (250 × 4.6) and (250 
× 21.4), respectively. All runs used linear gradients of A in B (A: CH3CN 
containing 0.1% TFA and B: 5% CH3CN/H2O containing 0.1% TFA). LCMS 
chromatographic analyses were performed using a Waters Acquity UPLC with a 
Waters TUV detector equipped with an Acquity UPLC BEH C18 analytical 
column (2.1 x 50 mm) at a flow rate of 0.5–0.7 mL/min using linear gradients 
buffer B in A (B: CH3CN containing 0.1% formic acid, A: 10% CH3CN/H2O 
containing 0.1% formic acid). Electrospray mass spectroscopic and LCMS 
analyses were conducted on a Waters Micromass LCT premier XE mass 
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spectrometer in conjunction with the Waters Acquity UPLC. Data is only provided 
here for new compounds. Epimerization ratios given are those of the integrated 
HPLC peaks. All yields refer to isolated, chromatographically homogeneous 
materials. 
Fmoc-L-Ala-STmob (90) 
To a solution of Fmoc-L-Ala-OH (2.33 mmol), 2,4,6-trimethoxybenzylthiol 
(2.8 mmol) and DMAP (0.23 mmol) in methylene chloride (20 mL) was added 
DIC (2.8 mmol) at 0 ºC. The suspension was stirred for 1 h at 0 ºC and overnight 
at room temperature. The suspension was filtered to remove the resulting white 
solid, which was washed with methylene chloride (10 mL) repeatedly. The filtrate 
was concentrated, after which chromatographic purification afforded a white solid 
(1.2 g, 98%). Mp 152-153 ºC; [α]22D  –8.4 (c = 1, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ  7.76 (d, J = 7.5 Hz, 2H), 7.61 (dd, J = 6.0, 7.0 Hz, 2H), 7.40–7.27 (m, 
4H), 6.10 (s, 2H), 5.36 (d, J = 8.0 Hz, 1H), 4.52 (t, J = 7.5 Hz, 1H), 4.45 (m, 1H), 
4.34 (m, 1H), 4.24 (s, 2H), 4.22 (d, J = 7.5 Hz, 1H), 3.80 (s, 3H), 3.78 (s, 6H), 
1.45 (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 201.9, 161.2, 159.5, 
155.8, 144.2, 144.0, 141.5, 127.9, 127.3, 125.4, 125.3, 120.2, 104.6, 90.7, 67.3, 
56.8, 56.0, 55.6, 47.4, 22.5, 19.6; ESI-HRMS calcd for C28H29NO6SNa [M + Na]+, 
530.1624; found, 530.1613.  
Boc-L-Phe-STmob (91) 
To a solution of Boc-L-Phe-OH (1.5 mmol), 2,4,6-trimethoxybenzylthiol (1.5 
mmol) and DMAP (0.15 mmol) in methylene chloride (12 mL) was added DIC 
(1.8 mmol) at 0 ºC. The suspension was stirred for 1 h at 0 ºC and overnight at 
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room temperature. The suspension was concentrated after which 
chromatographic purification afforded a white solid (0.67 g, 96%). [α]23D  –36.1 (c 
= 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.29–7.17 (m, 5H), 6.11 (s, 2H), 4.95 
(d, J = 9 Hz, 1H), 4.67 (d, J = 7 Hz, 1H), 4.23 (s, 2H), 3.81 (s, 9H), 3.19 (dd, J = 
5.5, 5.0 Hz, 1H), 3.05 (dd, J = 7.0, 7.0 Hz, 2H), 1.39 (s, 9H); 13C NMR (125.6 
MHz, CDCl3) δ 201.48, 161.1, 159.5, 155.2, 136.3, 129.7, 128.7, 127.1, 104.8, 
90.7, 80.2, 61.2, 56.0, 55.6, 39.0, 28.5, 28.3, 22.6; ESI-HRMS calcd for 
C24H31NO6SNa [M + Na]+, 484.1770; found, 484.1770. 
 Z-L-Val-STrt (92) 
To a solution of Z-L-Val-OH (1.99 mmol), triphenylmethanethiol (2.19 
mmol) and DMAP (0.4 mmol) in methylene chloride (15 mL) was added DIC 
(2.59 mmol) at 0 ºC. The suspension was stirred for 1 h at 0 ºC and overnight at 
room temperature. The suspension was concentrated, after which 
chromatographic purification afforded a white solid (0.96 g, 95%). [α]23D  –45.5 (c 
= 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.40–7.35 (m, 5H), 7.33–7.27 (m, 
15H), 5.24–5.16 (m, 2H), 5.15 (d, J = 12.5 Hz, 2H), 4.41–4.38 (m, 1H), 2.20 (q, J 
= 6.5 Hz, 1H), 0.93 (d, J = 6.5 Hz, 3H), 0.74 (d, J = 7.0 Hz, 3H); 13C NMR (125.6 
MHz, CDCl3) δ 197.6, 156.4, 143.7, 136.6, 130.4, 130.1, 128.9, 128.8, 128.5, 
128.3, 128.2, 128.2, 128.0, 127.4, 71.0, 67.4, 65.9, 31.7, 19.7, 17.1; ESI-HRMS 
calcd for C32H31NO3SNa [M + Na]+, 530.1922; found, 530.1920.  
General procedure 1. Synthesis of peptides with Sanger’s Reagent 
To a stirred solution of thioacid (0.33 mmol) in DMF (2 mL) was added 
Cs2CO3 (0.47 mmol). After the solution was stirred for 5 min at room 
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temperature, a solution of Sanger’s reagent (0.31 mmol) in DMF (1 mL) was 
added to the above solution followed by the addition of amine hydrochloride salt 
(0.28 mmol) such that the overall concentration of the reaction mixture became 
~0.1 M in amine.  The reaction mixture was stirred for 3 h at room temperature 
then was concentrated and the concentrate was diluted with ethyl acetate. The 
organic layer was washed with water and brine, dried, concentrated. 
Chromatographic purification afforded the desired peptides. 
General procedure 2. Synthesis of peptides with Mukaiyama’s Reagent or 
2,4-dinitroiodobenzene 
To a solution of thioacid (0.36 mmol) in DMF (3 mL) was added Cs2CO3 
(0.44 mmol). After the solution was stirred for 5 min at room temperature, 
Mukaiyama’s reagent (0.33 mmol) was added to the above solution followed by 
the addition of amine hydrochloride salt (0.3 mmol). The reaction mixture was 
stirred for 3 h at room temperature then was concentrated and the concentrate 
was diluted with ethyl acetate. The organic layer was washed with water and 
brine, dried, concentrated. Chromatographic purification afforded the desired 
peptides. 
Fmoc-L-Ala-L-Tyr-OMe (105) 
Prepared by the general procedure 2 with a yield of 222 mg 
(86%).Colorless solid, Mp 161-162 ºC; [α]22D  +27.6 (c = 0.8, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.76 (d, J = 7.5 Hz, 2H), 7.58(d, J = 5.0 Hz, 2H), 7.39 (t, J = 
7.5 Hz, 2H), 7.30 (t, J = 7.5 Hz, 2H), 6.90 (d, J = 7.5 Hz, 2H), 6.64 (d, J = 7.0 Hz, 
2H), 6.55 (d, J = 7.0 Hz, 1H), 5.97 (s, 1H), 5.40 (d, J = 6.5 Hz, 1H), 4.82 (dd, J = 
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6.0, 6.5 Hz, 1H), 4.40 (m, 1H), 4.33 (m, 1H), 4.19 (m, 1H), 3.71 (s, 3H), 3.07(dd, 
J = 5.0, 5.0 Hz, 1H), 2.97(dd, J = 6.0, 5.5 Hz, 1H), 1.34 (d, J = 6.0 Hz, 3H); 13C 
NMR (125.6 MHz, CDCl3) δ 172.6, 172.1, 156.4, 155.7, 144.0, 143.9, 141.5, 
141.5, 130.6, 128.0, 127.4, 127.1, 125.4, 120.2, 115.8, 67.5, 53.7, 52.7, 50.6, 
47.3, 47.2, 37.2, 18.8; ESI-HRMS calcd for C28H28N2O6Na [M + Na]+, 511.1845; 
found, 511.1864.  
Fmoc-L-Ala-L-Cys(Trt)-OEt (108) 
Prepared by the general procedure 2 with a yield of 57 mg (88%). White 
solid, Mp 69-70 ºC; [α]23D  +7.3 (c = 1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.76 
(d, J = 7.2 Hz, 2H), 7.57(d, J = 7.2 Hz, 2H), 7.41–7.17 (m, 19H), 6.23 (d, J = 6.8 
Hz, 1H), 5.38 (bs, 1H), 4.52 (d, J = 5.6 Hz, 1H), 4.39 (d, J = 5.6 Hz, 2H), 4.23–
4.14 (m, 4H), 2.72 (dd, J = 5.6, 6.4 Hz, 1H), 2.60 (dd, J = 4.0, 4.0 Hz, 1H), 1.37 
(d, J = 6.8 Hz, 3H), 1.24 (t, J = 6.4 Hz, 3H); 13C NMR (100.6 MHz, CDCl3) δ 
172.0, 170.2, 156.0, 144.4, 144.1, 144.0, 141.6, 141.5, 129.7, 128.3, 128.0, 
127.3, 127.2, 125.3, 120.2, 67.3, 67.2, 62.1, 51.5, 50.5, 47.4, 33.8, 19.2, 14.3; 
ESI-HRMS calcd for C46H50N4O10S2Na [M + Na]+, 707.2556; found, 707.2552.  
Z-Gly-Phe-STmob (109) 
To a stirred solution of Z-Gly-OH (1.43 mmol), NH2-L-Phe-STmob (1.3 
mmol) and DMAP (0.39 mmol) in methylene chloride (10 mL) was added EDCI 
(1.69 mmol) at rt and the reaction mixture was stirred for 1h. Chromatographic 
purification (40% ethyl acetate: hexane) afforded the desired product (0.65 g, 
91%). [α]24D  –38.1 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.36–7.35 (m, 
5H), 7.25–7.22 (m, 3H), 7.12 (d, J = 6.5 Hz, 2H), 6.67 (d, J = 8.0 Hz, 1H), 6.11 (s, 
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2H), 5.29 (s, 1H), 5.11 (s, 2H), 5.02–4.97 (m, 1H), 4.24 (dd, J = 12.0, 12.5 Hz, 
2H), 3.84–3.77 (m, 11H), 3.19 (dd. J = 5.5 Hz, 1H), 3.10 (dd. J = 7.0 Hz, 1H); 13C 
NMR (125.6 MHz, CDCl3) δ 200.1, 168.9, 161.2, 159.5, 156.7, 136.4, 135.9, 
129.7, 128.8, 128.8, 128.5, 128.3, 127.3, 104.4, 90.7, 67.4, 59.7, 56.0, 55.6, 
44.7, 38.7, 31.2, 22.6; ESI-HRMS calcd for C29H32N2O7SNa [M + Na]+, 
575.1828; found, 575.1799.  
LCMS: 5-50% B over 1 min then 50-70% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 2.08 min. 
Z-Gly-L-Phe-SH (110) 
Z-Gly-L-Phe-STmob (200 mg, 0.36 mmol) was dissolved in a mixture of 70% TFA 
in methylene chloride (4 mL) with triethylsilane (300 µL) and stirred at rt for 1 h. 
Toluene (8 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude thioacid Z-Gly-L-Phe-SH which was applied 
immediately to the next step 
Z-Gly-L-Phe-L-Val-OtBu (111) by the thioacid coupling with Mukaiyama’s 
reagent  
To a stirred solution of Z-Gly-Phe-SH (0.27 mmol), L-valine t-butyl ester 
hydrochloride (0.23 mmol) in DMF (3 mL) was added cesium carbonate (0.27 
mmol) at 0 ºC. After 5 min, Mukaiyama’s reagent (0.25 mmol) was added to the 
reaction mixture at 0 ºC. The reaction mixture was stirred at 0 ºC for 10 min and 
then warmed up to rt and stirred for 30 min. The organic layer was extracted with 
ethyl acetate followed by washing with water and brine, dried over sodium sulfate 
and concentrated under reduced pressure. Chromatographic purification (50% 
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ethyl acetate: hexane) afforded the desired product (89 mg, 76%). [α]23D  +2.8 (c 
= 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.35–7.31 (m, 5H), 7.25–7.15 (m, 5H), 
6.90 (d, J = 8.0 Hz, 1H), 6.63 (d, J = 8.0 Hz, 1H), 5.65 (s, 1H), 5.11 (s, 2H), 4.80 
(d, J = 7.0 Hz, 1H), 4.35–4.32 (m, 1H), 3.87 (d, J = 5.0 Hz, 2H), 3.07–3.04 (m, 
2H), 2.1–2.07 (m, 1H), 1.45 (s, 9H), 0.86 (d. J = 6.5 Hz, 3H), 0.84 (d. J = 7.0 Hz, 
3H); 13C NMR (125.6 MHz, CDCl3) δ 170.6, 169.1, 156.8, 136.4, 129.6, 128.8, 
128.7, 128.4, 128.3, 128.2, 127.3, 82.3, 67.4, 57.9, 54.7, 44.7, 38.6, 31.6, 28.3, 
19.0, 17.9; ESI-HRMS calcd for C28H37N3O6Na [M + Na]+, 534.2580; found, 
534.2552.  
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min. 
Z-Gly-L-Phe-L-Val-OtBu (111) by acid coupling with the Mukaiyama’s 
reagent 
To a stirred solution of Z-Gly-Phe-OH (0.27 mmol), L-valine t-butyl ester 
hydrochloride (0.23 mmol) in DMF (3 mL) was added cesium carbonate (0.27 
mmol) at 0 ºC. After 5 min, Mukaiyama’s reagent was added to the reaction 
mixture at 0 ºC. The reaction mixture was stirred at 0 ºC for 10 min and then 
warmed up to rt and stirred overnight. The organic layer was extracted with ethyl 
acetate followed by washing with water and brine, dried over sodium sulfate and 
concentrated under reduced pressure. Chromatographic purification (50% ethyl 
acetate: hexane) afforded the desired product (35 mg, 23%). 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min. 
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An epimerized sample of Z-Gly-L-Phe-L-Val-OtBu (111) by the EDCI 
coupling method 
To a stirred solution of Z-Gly-L-Phe-OH (0.14 mmol), L-valine t-butyl ester 
hydrochloride (0.14 mmol) in methylene chloride (3 mL) was added EDCI (0.17 
mmol) followed by the addition of DIPEA (0.17 mmol) at rt and the reaction 
mixture was stirred for 4 h. Chromatographic purification (50% ethyl acetate: 
hexane) afforded the desired product (56 mg, 78%). 
LCMS of the crude reaction mixture shows epimerization (ratio, L/D = 48/52): 5-
40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 mL/min and 
215 nm UV detection, retention time = 3.65 min, 3.78 min. 
Z-Gly-L-Phe-L-Val-OtBu (111) by the EDCI+HOBT method 
To a stirred solution of Z-Gly-L-Phe-OH (0.14 mmol), L-valine t-butyl ester 
hydrochloride (0.14 mmol) and HOBT (0.17 mmol) in methylene chloride (4 mL) 
was added EDCI (0.17 mmol) at 0 ºC. The reaction mixture was stirred at 0 ºC for 
10 min and then warmed up to rt and stirred for 5 h. Chromatographic purification 
(50% ethyl acetate in hexane) afforded the desired product (60 mg, 84%). 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min. 
Fmoc-D-Phe-L-Val-OtBu (114) 
To a stirred solution of Fmoc-D-Phe-OH (0.52 mmol) and L-valine t-butyl 
ester hydrochloride (0.52 mmol) in methylene chloride (4.5 mL) was added HATU 
(0.88 mmol) followed by the addition of DIPEA (0.88 mmol) at 0 ºC. The reaction 
mixture was stirred at 0 ºC for 30 min and then warmed up to rt and stirred for 6 
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h. Chromatographic purification (30% ethyl acetate in hexane) afforded the 
desired product (274 mg, 98%). [α]23D  +9.8 (c = 1, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 7.77 (d, J = 7.5 Hz, 2H), 7.55(t, J = 7.0 Hz, 2H), 7.41 (t, J = 7.5 Hz, 2H), 
7.33–7.23 (m, 7H), 6.30 (d, J = 7.0 Hz, 1H), 5.48 (d, J = 5.5 Hz, 1H), 4.53 (d, J = 
5.5 Hz, 1H), 4.43–4.33 (m, 3H), 4.21 (d, J = 7.0 Hz, 1H), 3.13 (br. s, 2H), 2.06–
2.03 (m, 1H), 1.45 (s, 9H), 0.79–0.76 (m, 6H); 13C NMR (125.6 MHz, CDCl3) δ 
170.8, 156.1, 144.0, 143.9, 141.5, 136.7, 129.5, 129.0, 128.0, 127.3, 125.3, 
120.2, 82.4, 67.4, 57.8, 56.6, 47.3, 39.1, 31.6, 28.3, 18.9, 17.9; ESI-HRMS calcd 
for C33H38N2O5Na [M + Na]+, 565.2678; found, 565.2628. 
NH2-D-Phe-L-Val-OtBu (115) 
To a stirred solution of Fmoc-D-Phe-L-Val-OtBu (0.28 mmol) in THF (5 
mL), was added ethanethiol (2.8 mmol) followed by DBU (0.08 mmol) at rt after 
which the reaction mixture was stirred for 1 h. The solvents were removed and 
the chromatographic purification afforded the free amine, which was immediately 
taken forward to the next step. 
Synthesis of an authentic sample of Z-Gly-D-Phe-L-Val-OtBu (116) 
To a stirred solution of Z-Gly-OH (0.42 mmol), NH2-D-Phe-L-Val-OtBu in 
methylene chloride (4 mL) was added EDCI (0.42 mmol) at rt .The reaction 
mixture was stirred at rt for 1h before it was subjected to chromatographic 
purification (50% ethyl acetate in hexane) which afforded the desired product 
(112 mg, 79%). [α]23D +15.1 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.35–
7.31 (m, 5H), 7.27–7.18 (m, 5H), 6.97 (d, J = 8.0 Hz, 1H), 6.63 (d, J = 8.5 Hz, 
1H), 5.73 (t, J = 5.5 Hz, 1H), 5.11 (d, J = 2.0 Hz, 2H), 4.87 (d, J = 7.0 Hz, 1H), 
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4.35–4.32 (m, 1H), 3.88 (d, J = 5.5 Hz, 2H), 3.09–3.06 (m, 2H), 2.0–1.97 (m, 1H), 
1.42 (s, 9H), 0.75 (t. J = 7.0 Hz, 6H); 13C NMR (125.6 MHz, CDCl3) δ 170.8, 
170.7, 169.2, 156.8, 136.6, 136.5, 129.6, 128.9, 128.8, 128.4, 128.3, 127.2, 82.3, 
67.4, 58.0, 54.7, 44.7, 39.1, 31.5, 28.3, 18.9, 17.9; ESI-HRMS calcd for 
C28H37N3O6Na [M + Na]+, 534.2580; found, 534.2542.  
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.78 min. 
Z-Gly-L-Phe-L-Val-OtBu (111) by the HATU method 
To a stirred solution of Z-Gly-L-Phe-OH (0.28 mmol) and L-valine t-butyl 
ester hydrochloride (0.28 mmol) in methylene chloride (4 mL) was added HATU 
(0.36 mmol) followed by the addition of DIPEA (0.36 mmol) at 0 ºC. The reaction 
mixture was stirred at 0 ºC for 30 min and then warmed up to rt and stirred for 2 
h. Chromatographic purification (50% ethyl acetate: hexane) afforded the desired 
product (117 mg, 82%). 
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.65 min. 
Z-Gly-2,2-d2-OH 
To a stirred solution of glycine-2,2-d2 (6.49 mmol) in 1N NaOH solution in 
water (6.5 mL, pH~10) was added benzyl chloroformate (7.79 mmol) at room 
temperature.  The resulting reaction mixture was stirred at rt for 4h before it was 
extracted with methyl t-butyl ether and the aqueous layer was acidified (pH~1) 
with 2M HCl solution. The product was extracted with ethyl acetate from aqueous 
layer, dried over sodium sulfate and concentrated under reduced pressure to 
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give a white solid (0.96 g, 72%). Mp 110-111 ºC, 1H NMR (500 MHz, CDCl3) δ 
7.27 (s, 5H), 5.04(s, 2H); ESI-HRMS calcd for C10H9D2NO4Na [M + Na]+, 
234.0711; found, 234.0691.  
NH2-L-Phe-STmob (162) 
Boc-L-Phe-STmob (0.65 mmol) was dissolved in a mixture of 40% TFA in 
CH2Cl2 (7 mL) and stirred at rt for 5 min. then solvents were removed and the the 
organic layer was extracted with ethyl acetate followed by washing with 20% 
aqueous sodium carbonate solution. The organic layer was dried over sodium 
sulfate and concentrated under reduced pressure to afford the free amine which 
was applied immediately to the next step. 
Z-Gly-2,2-d2-L-Phe-STmob (117) 
To a stirred solution of Z-Gly-2,2-d2-OH (0.72 mmol), NH2-L-Phe-STmob 
(0.65 mmol) and DMAP (0.2 mmol) in methylene chloride (8 mL) was added 
EDCI (0.85 mmol) at rt and the reaction mixture was stirred for 1h. 
Chromatographic purification (40% ethyl acetate: hexane) afforded the desired 
product (0.32 g, 89%). [α]23D  –28.9 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.35–7.32 (m, 5H), 7.25–7.20 (m, 3H), 7.12 (d, J = 7.0 Hz, 2H), 6.66 (d, J = 8.5 
Hz, 1H), 6.10 (s, 2H), 5.46 (s, 1H), 5.09 (s, 2H), 5.01–4.97 (m, 1H), 4.24 (dd, J = 
12.5 Hz, 2H), 3.80 (s, 3H), 3.79 (s, 6H), 3.19 (dd. J = 5.0 Hz, 1H), 3.05 (dd. J = 
7.5 Hz, 1H); ESI-HRMS calcd for C29H30D2N2O7SNa [M + Na]+, 577.1953; found, 
577.1928.  
LCMS: 5-50% B over 2 min then 50-70% B over 3 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 2.93 min. 
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Z-Gly-2,2-d2-L-Phe-L-Val-OtBu (119) 
To a stirred solution of Z-Gly-2,2-d2-Phe-SH (0.22 mmol), Z-Gly-L-Phe-OH 
(0.22 mmol), L-valine t-butyl ester hydrochloride (0.15 mmol) in DMF (3 mL) was 
added cesium carbonate (0.3 mmol) at 0 ºC. After 5 min, a solution of 
Mukaiyama’s reagent (0.15 mmol) in DMF (0.5 mL) was added to the reaction 
mixture dropwisely at 0 ºC over 10 min. The reaction mixture then was stirred at 
0 ºC for further 30 min before the organic layer was extracted with ethyl acetate.  
The extracts were washed with water and brine, dried over sodium sulfate and 
concentrated under reduced pressure. Chromatographic purification (50% ethyl 
acetate: hexane) afforded the desired product (55 mg, 72%). [α]23D  –1.1 (c = 1, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.35–7.31 (m, 5H), 7.25–7.15 (m, 5H), 6.89 
(d, J = 7.5 Hz, 1H), 6.61 (d, J = 8.0 Hz, 1H), 5.62 (s, 1H), 5.11 (s, 2H), 4.79 (d, J 
= 7.0 Hz, 1H), 4.35–4.32 (m, 1H), 3.07–3.05 (m, 2H), 2.1–2.07 (m, 1H), 1.45 (s, 
9H), 0.85 (d. J = 7.0 Hz, 3H), 0.84 (d. J = 7.0 Hz, 3H); ESI-HRMS calcd for 
C28H35D2N3O6Na [M + Na]+, 536.2706; found, 536.2695.  
LCMS: 5-40% B over 1 min then 40-50% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.60 min. 
Z-L-Val-L-Val-OtBu (121) 
To a stirred solution of Z-L-Val-SH (0.39 mmol), L-valine t-butyl ester 
hydrochloride (0.33 mmol), and Z-L-Arg-OH hydrochloride (0.33 mmol) in DMF (3 
mL) was added cesium bicarbonate (1.31 mmol) at rt.  After 5 min, Mukaiyama’s 
reagent (0.33 mmol) was added to the reaction mixture at rt and the reaction 
mixture was stirred for 1 h. The organic layer was extracted with ethyl acetate 
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followed by washing with water and brine, dried over sodium sulfate and 
concentrated under reduced pressure. Chromatographic purification afforded the 
desired product with a yield of 110 mg (82%). [α]23D  +1.7 (c = 1, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.34–7.27 (m, 5H), 6.53 (d, J = 9.0 Hz, 1H), 5.55 (d, J = 8.5 
Hz, 1H), 5.12 (d, J = 3.5 Hz, 2H), 4.44–4.42 (m, 1H), 4.11 (t, J = 7.5 Hz, 1H), 
2.16–2.11 (m, 2H ), 1.45 (s, 9H), 0.98–0.88 (m, 12H); 13C NMR (125.6 MHz, 
CDCl3) δ 171.5, 171.0, 156.7, 136.6, 128.7, 128.3, 128.2, 82.2, 67.2, 60.6, 57.8, 
31.5, 28.3, 19.5, 19.1, 18.1, 18.0; ESI-HRMS calcd for C22H34N2O5Na [M + Na]+, 
429.2365; found, 429.2330.  
Z-L-Val-L-Val-OtBu 121 (Reaction in aqueous buffer) 
To a stirred solution of Z-L-Val-SH (0.39 mmol), L-valine t-butyl ester 
hydrochloride (0.33 mmol) in ligation buffer (3 mL, [4:1 v/v N-methyl-2-
pyrrolidinone (NMP): 6 M guanidine hydrochloride, 1 M HEPES, pH = 8][a]) was 
added Mukaiyama’s reagent (0.33 mmol) at 0 ºC and then the reaction mixture 
was stirred at rt for 1 h. The organic layer was extracted with ethyl acetate 
followed by washing with water and brine, dried over sodium sulfate and 
concentrated under reduced pressure. Chromatographic purification afforded the 
desired product with a yield of 115 mg (86%). 
[a]
 An aqueous buffer containing 6 M Gn.HCl and 1 M HEPES was prepared and 
adjusted to pH 8 using 25% cesium carbonate solution in water. The resulting 
solution (1 mL) was diluted with NMP (4 mL) to produce the final buffer for use in 
peptide coupling reaction. 
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NH2-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (123) 
The N-terminal tetrapeptidyl amine was prepared by stepwise solution 
phase synthesis according to the scheme below, beginning with L-Ala-OEt.  
Fmoc protected amino acid building blocks were coupled using standard 
conditions EDCI/HOBT in either CH2Cl2 or DMF. Fmoc groups were removed 
using DBU/EtSH in dry THF. ESI-HRMS calcd for C57H63N6O7 [M + H]+, 
943.4758; found, 943.4761. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-OH (124)  
The C-terminal tetrapeptidyl acid was prepared by stepwise solution 
phase synthesis according to the Scheme below, beginning with L-Arg(Pbf)-OAll. 
Fmoc protected amino acid building blocks were coupled using standard 
conditions EDCI/HOBT in either CH2Cl2 or DMF. Fmoc groups were removed 
using DBU/EtSH in dry THF. Allyl deprotection was conducted with 
Pd(PPh3)4/PhSiH3 in CH2Cl2. ESI-HRMS calcd for C77H107N12O16S2 [M + H]+, 
1519.7369; found, 1519.7335. 
LCMS: 50-90% B with a flow rate of 0.7 mL/min over 5 min and 254 nm UV 
detection, retention time = 3.45 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-SFm (94) by EDCI+HOBT 
coupling  
To a stirred solution of the peptidyl acid 124 (0.01 mmol), 9-
fluorenylmethanethiol (0.25 mmol) and HOBT (0.05 mmol) in dry DMF (0.5 mL) 
was added EDCI (0.05 mmol) at rt and the reaction mixture was stirred at rt for 4 
h before it was diluted with ethyl acetate. The organic layer was washed with 
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water and brine, dried and concentrated and subjected to reversed-phase HPLC 
purification (50-100% A with a flow rate of 10 mL/min over 72 min and 254 nm 
UV detection, rt = 59 min) to provide the protected peptidyl thioester with a yield 
of 13 mg (77%). 
LCMS: 70-90% B with a flow rate of 0.7 mL/min over 5 min and 254 nm UV 
detection, retention time = 3.00, 3.17 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-SFm (94) by PyBOP 
method 
To a solution of the peptidyl acid 124 (~0.01 mmol) in DMF (0.5 mL) was 
added 4Å molecular sieves (~ 0.01 g) and 9-fluorenylmethanethiol (0.25 mmol) 
and the mixture was stirred at -20 oC. After 15 min., PyBOP (0.05 mmol) and 
DIPEA (0.05 mmol) were added and the reaction mixture was stirred at -20 oC for 
1.5 h, before it was filtered, quenched with a saturated solution of NH4Cl, and 
diluted with ethyl acetate. The organic layer was washed with water and brine, 
dried and concentrated. Reversed-phase HPLC purification (50-100% A with a 
flow rate of 10 mL/min over 72 min and 254 nm UV detection, rt = 60 min) 
provided the protected peptidyl thioester with a yield of 14 mg (82%) ESI-HRMS 
calcd for C91H117N12O15S3 [M + H]+, 1713.7924; found, 1713.7991. LCMS: 70-
90% B with a flow rate of 0.7 mL/min over 5 min and 254 nm UV detection, 
retention time = 3.17 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-SH (125) 
The peptidyl thioester 94 (0.008 mmol) was dissolved in a mixture of 50% 
piperidine: DMF (0.5 ml) and stirred at rt for 1.5 h. The reaction mixture was 
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diluted with ethyl acetate (40 ml) and acidified with 1M HCl. The organic layer 
was washed with water and brine, dried over sodium sulfate and concentrated 
under reduced pressure. LCMS: 60-95% B with a flow rate of 0.5 mL/min over 5 
min and 254 nm UV detection, retention time = 3.02 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-
L-Ala-OEt (126) by the thioacid coupling with Mukaiyama’s Reagent Method 
To a stirred solution of the peptidyl thioacid 125 (0.008 mmol, 1.1 equiv.) 
and the peptide amine 123 (0.007 mmol, 1 equiv.) in dry DMF (0.5 ml) was 
added Cs2CO3 (0.009 mmol, 1.2 equiv.) at 0 ºC. After the reaction mixture was 
stirred at 0 ºC for 5 min, Mukaiyama’s reagent (0.008 mmol, 1.1 equiv.) was 
added to the reaction mixture and stirred at rt for 1 h. The reaction mixture was 
diluted with ethyl acetate and the organic layer was washed with water and brine, 
dried, concentrated. Reversed-phase HPLC purification (80-100% A with a flow 
rate of 10 mL/min over 72 min and 254 nm UV detection, retention time = 31 min) 
provided the octapeptide with a yield of 12 mg (66%). ESI-HRMS calcd for 
C134H167N18O22S2 [M + H]+, 2444.1944; found, 2444.1365. LCMS of the crude 
reaction mixture: 80-92% B over 0.5 min then 92-98% B over 3 min with a flow 
rate of 0.5 mL/min and 254 nm UV detection, retention time = 2.33 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-
L-Ala-OEt (126) by the PyBOP Method 
To a stirred solution of the peptidyl acid 124 (0.011 mmol) and the peptidyl 
amine (0.011 mmol) in dry DMF (0.5 mL) was added PyBOP (0.013 mmol) 
followed by DIPEA (0.013 mmol) at 0 ºC and the reaction mixture was stirred at rt 
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for 8 h. The reaction mixture was diluted with ethyl acetate and the organic layer 
was washed with water and brine, dried, concentrated. Reversed-phase HPLC 
purification (80-100% A with a flow rate of 10 mL/min over 72 min and 254 nm 
UV detection, rt = 30 min) provided the octapeptide with a yield of 18 mg (69%). 
LCMS of the crude reaction mixture shows epimerization: 80-92% B over 0.5 min 
then 92-98% B over 3 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 2.35 min and 2.57 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-
L-Ala-OEt (126) by the EDCI+HOBT Method 
To a stirred solution of the peptidyl acid 124 (0.013 mmol), the peptidyl 
amine (0.013 mmol) and HOBT (0.017 mmol) in dry DMF (0.7 ml) was added 
EDCI (0.017 mmol) 0 ºC. After 5 min, the reaction mixture was warmed up to rt 
and stirred at rt for 8 h. The reaction mixture was diluted with ethyl acetate and 
the organic layer was washed with water and brine, dried, concentrated. 
Reversed-phase HPLC purification (80-100% A with a flow rate of 12 mL/min 
over 72 min and 254 nm UV detection, retention time = 29 min) provided the 
octapeptide with a yield of 20 mg (63%). LCMS of the crude reaction mixture 
showed epimerization: 80-92% B over 0.5 min then 92-98% B over 3 min with a 
flow rate of 0.5 mL/min and 254 nm UV detection, retention time = 2.35 min and 
2.57 min. 
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Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-
L-Ala-OEt (126) by the EDCI Method 
To a stirred solution of the peptidyl acid 124 (0.01 mmol) and the peptidyl 
amine (0.01 mmol) in dry DMF (0.5 ml) was added EDCI (0.013 mmol) followed 
by DIPEA (0.013 mmol) at 0 ºC and the reaction mixture was stirred at rt for 14 h. 
The reaction mixture was diluted with ethyl acetate and the organic layer was 
washed with water and brine, dried, concentrated. Reversed-phase HPLC 
purification (80-100% A with a flow rate of 10 mL/min over 72 min and 254 nm 
UV detection, retention time = 29 min) provided the octapeptide with a yield of 14 
mg (54%). LCMS of the crude reaction mixture showed epimerization: 80-92% B 
over 0.5 min then 92-98% B over 3 min with a flow rate of 0.5 mL/min and 254 
nm UV detection, retention time = 2.33 min and 2.54 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-L-Arg(Pbf)-L-Asn(Trt)-L-Asn(Trt)-L-Ile-
L-Ala-OEt (126) by the HATU Method 
To a stirred solution of the peptidyl acid 124 (0.012 mmol) and the peptidyl 
amine (0.012 mmol) in dry DMF (0.5 ml) was added HATU (0.013 mmol) followed 
by DIPEA (0.013 mmol) at 0 ºC and the reaction mixture was stirred at rt for 6 h. 
The reaction mixture was diluted with ethyl acetate and the organic layer was 
washed with water and brine, dried, and concentrated. Reversed-phase HPLC 
purification (80-100% A with a flow rate of 10 mL/min over 72 min and 254 nm 
UV detection, retention time = 30 min) provided the octapeptide with a yield of 20 
mg (70%). LCMS of the crude reaction mixture shows epimerization: 80-92% B 
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over 0.5 min then 92-98% B over 3 min with a flow rate of 0.5 mL/min and 254 
nm UV detection, retention time = 2.35 min and 2.57 min. 
Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-D-Arg(Pbf)-OH (129)  
The C-terminal tetrapeptidyl acid 129 was prepared by solid phase peptide 
synthesis in a manual solid phase peptide synthesis vessel beginning with Fmoc-
D-Arg(Pbf)-OH. 2-Chlorotrityl chloride resin (0.2 mmol) was suspended in 
methylene chloride (5 mL) shaken for 5 min and filtered. A solution of Fmoc-D-
Arg(Pbf)-OH (0.4 mmol) and DIPEA (1.0 mmol) in methylene chloride (4 mL) was 
added to the resin, shaken for 30 min at rt, and filtered. The resin was washed 
with DMF (2x 5 mL) and capped with 5.0 mL of a mixture of methylene 
chloride/MeOH/DIPEA (80:15:5). 
Iterative peptide assembly: The Fmoc group was removed with 25% 
piperidine in DMF. After Fmoc removal, the resin was washed with DMF (2x5 
mL), methylene chloride (2x5 mL), isopropanol (2x5 mL) and hexane (2x5 mL). 
All couplings were carried out by adding a preactivated solution of protected 
amino acid (0.8 mmol), HOBT (1.0 mmol), DIPEA (0.8 mmol), and DIC (1.0 
mmol) in dry DMF (4.0 mL) to the resin. After 3 h, the resin was washed with 
DMF (2x5 mL), methylene chloride (2x5 mL) and DMF (2x5 mL).  
Cleavage from the resin: The peptide-resin was suspended in a 6 mL 
mixture of trifluoroethanol/methylene chloride (2:8) and stirred magnetically for 45 
min at rt. The resin was filtered and washed twice with 10 mL of cleavage 
solution. The combined filtrates were concentrated and a mixture of methyl t-
butyl ether (15 mL) and hexane (15 mL) was added to the concentrate and the 
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resulting solid was isolated by centrifugation and washed with the methyl t-butyl 
ether and hexane (246 mg, 81%). ESI-HRMS calcd for C77H106N12O16S2Na [M + 
Na]+, 1541.7189; found, 1541.7253. 
LCMS: 50-90% B with a flow rate of 0.7 mL/min over 5 min and 254 nm UV 
detection, retention time = 3.38 min. 
An authentic sample of Boc-L-Lys(Boc)-L-Arg(Pbf)-L-Asn(Trt)-D-Arg(Pbf)-L-
Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (130) 
To a stirred solution of the peptidyl acid 129 (0.017 mmol) and the peptidyl 
amine 123 (0.017 mmol) in dry DMF (0.7 mL) was added HATU (0.033 mmol) 
followed by DIPEA (0.033 mmol) at 0 ºC. After 30 min, the reaction mixture was 
warmed up to rt and stirred for 4 h. The reaction mixture was diluted with ethyl 
acetate and the organic layer was washed with water and brine, dried, and 
concentrated. Reversed-phase HPLC purification (80-100% A with a flow rate of 
12 mL/min over 60 min and 254 nm UV detection, retention time = 31 min) 
provided the octapeptide with a yield of 29 mg (72%). ESI-HRMS calcd for 
C134H166N18O22S2Na [M + Na]+, 2466.1763; found, 2466.2322. 
LCMS: 80-92% B over 0.5 min then 92-98% B over 3 min with a flow rate of 0.5 
mL/min and 254 nm UV detection, retention time = 2.57 min. 
NH2-L-Lys-L-Arg-L-Asn-L-Arg-L-Asn-L-Asn-L-Ile-L-Ala-OEt (122) 
Octapeptide 126 (0.012 mmol) was dissolved in a solution of 50% TFA/ 
10%Et3SiH/ CH2Cl2 (1 ml) at room temperature. The reaction mixture was stirred 
at room temperature for 3 h and then solvents were removed and the crude was 
washed with diethyl ether 2-3 times and purified by reversed-phase HPLC (11 
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mg, 92%). ESI-HRMS calcd for C41H77N18O12 [M + H]+, 1013.5968; found, 
1013.5918.LCMS: 0-55% A over 3.5 min with a flow rate of 0.5 mL/min and 190 
nm UV detection, retention time = 2.87 min. 
 
Scheme 1: Preparation of Sulfonyl Chlorides 
General Procedure 3 for the Preparation of Sulfonyl Chlorides 
To a stirred solution of thioacetic acid (4.51 mmol) and glycineglycine (3.9 
mmol) in dry DMF (10 mL) was added cesium carbonate (9.03 mmol) at rt. After 
10 min, a solution of the corresponding 1-fluoro-4-nitro compound (3.01 mmol) in 
dry DMF (5 mL) was added slowly after which the reaction mixture and stirred for 
12h. The reaction mixture was diluted with ethyl acetate and washed with 1 M 
HCl, water and brine, dried over sodium sulfate and concentrated. 
Chromatographic purification gave the corresponding thiol. 
To a stirred solution of N-chlorosuccinimide (6.67 mmol) in 2M HCl (0.8 
mL) and acetonitrile (4 mL) was added the aboce prepared thiol (1.67 mmol) 
slowly at 10 ºC after which the reaction mixture was stirred for 30 min keeping 
the temperature below 20 ºC. The reaction mixture was diluted with ethyl acetate 
and washed with water and brine, dried over sodium sulfate and concentrated. 
Chromatographic purification gave the corresponding sulfonyl chlorides. 
Methyl 2-mercapto-5-nitrobenzoate (133): Prepared by the general 
procedure 3 with a yield of 3.40 g (87%). Pale yellow solid, Mp 104–105 ºC; 1H 
NMR (500 MHz, CDCl3) δ 8.90 (d, J = 3.0 Hz, 1H), 8.16(dd, J = 3.0, 9.0 Hz, 1H), 
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7.47 (d, J = 8.5 Hz, 1H), 5.40 (s, 1H), 4.00 (s, 3H); 13C NMR (125.6 MHz, CDCl3) 
δ 165.9, 148.5, 145.0, 131.6, 127.1, 126.6, 126.0, 53.2; ESI-HRMS calcd for 
C8H6NO4S [M-H]-, 212.0018; found, 212.0007. 
2-Methoxycarbonyl-4-nitrobenzenesulfonyl chloride (ENS-Cl): 
Prepared by the general procedure 3 with a yield of 3.0 g (80%). White solid, Mp 
108–112 ºC; 1H NMR (500 MHz, CDCl3) δ 8.58 (d, J = 2.5 Hz, 1H), 8.54(dd, J = 
2.5, 9.0 Hz, 1H), 8.41 (d, J = 8.5 Hz, 1H), 4.06 (s, 3H); 13C NMR (125.6 MHz, 
CDCl3) δ 164.4, 151.0, 146.0, 134.4, 131.1, 126.3, 125.6, 54.3; ESI-HRMS calcd 
for C8H6NO6SClNa [M + Na]+, 301.9510; found, 301.9502. 
2-Mercapto-5-nitrobenzonitrile (135): Prepared by the general 
procedure 3 with a yield of 423 mg (78%). 1H NMR (400 MHz, CDCl3) δ 8.46 (d, J 
= 2.4 Hz, 1H), 8.27(dd, J = 2.4, 8.8 Hz, 1H), 7.57 (d, J = 8.0 Hz, 1H), 4.49 (s, 
1H); 13C NMR (100.9 MHz, CDCl3) δ 147.5, 129.5, 128.7, 127.5, 115.7, 111.9; 
ESI-HRMS calcd for C7H3N2O2S [M-H]-, 178.9871; found, 178.9915. 
2-Cyano-4-nitrobenzenesulfonyl chloride (CNS-Cl): Prepared by the 
general procedure 3 with a yield of 394mg (95%). Pale yellow solid, Mp 108-109 
ºC; 1H NMR (500 MHz, CDCl3) δ 8.82 (d, J = 2.5 Hz, 1H), 8.70 (dd, J = 2.0, 8.5 
Hz, 1H), 8.48 (d, J = 8.5 Hz, 1H); 13C NMR (125.6 MHz, CDCl3) δ 150.9, 149.0, 
131.2, 128.6, 113.0, 112.6; EI-HRMS calcd for C8H6NO6SCl [M]+, 245.9508; 
found, 245.9502. 
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Scheme2: Preparation of Sulfonamides and their Reaction with Thioacetic 
Acid 
General Procedure 4 for the Preparation of Sulfonamides and their 
Reaction with Thioacetic Acid 
To a stirred solution of L-phenylalanine methyl ester hydrochloride (0.4 
mmol) and the corresponding sulfonyl chloride (0.48 mmol) in methylene chloride 
(4 mL) was added DIPEA (0.96 mmol) at rt. The reaction mixture was stirred for 
4h before chromatographic purification afforded the desired sulfonamides. 
To a stirred solution of thioacetic acid (0.24 mmol) and corresponding 
sulfonamide (0.15 mmol) in dry DMF (1 mL) was added cesium carbonate (0.24 
mmol) at rt. The reaction mixture was stirred for 4-12 h before the it was diluted 
with ethyl acetate. The organic layer was washed with water and brine, dried 
over sodium sulfate and concentrated under reduced pressure. Chromatographic 
purification afforded the desired products. 
N-[(4-Methylcarbonylphenyl)sulfonyl]–L-phenylalanine methyl ester 
(136): Prepared by the general procedure 4 with a yield of 600 mg (88%). [α]23D 
+1.9 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 8.0 Hz, 2H), 
7.81(d, J = 8.0 Hz, 2H), 7.22 (s, 3H), 7.06 (d, J = 3.5 Hz, 2H), 5.35 (d, J = 9.5 Hz, 
1H), 4.27–4.23 (m, 1H), 3.54 (s, 3H), 3.08 (dd, J = 5.5, 14 Hz, 1H), 3.01 (dd, J = 
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6.0, 13.5 Hz, 1H), 2.64 (s, 3H); 13C NMR (125.6 MHz, CDCl3) δ 197.0, 171.4, 
143.9, 140.2, 135.1, 129.6, 129.0, 128.9, 127.6, 57.1, 52.8, 39.5, 27.1; ESI-
HRMS calcd for C18H19NO5SNa [M + Na]+, 384.0914; found, 384.0882.  
N-[(4-Cyanophenyl)sulfonyl]–L-phenylalanine methyl ester (137): 
Prepared by the general procedure 4 with a yield of 130 mg (92%). [α]22D  –2.9 (c 
= 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 2.0, 7.0 Hz, 2H), 7.66 
(dd, J = 2.0, 6.5 Hz, 2H), 7.23–7.20 (m, 3H), 7.06–7.04 (m, 2H), 5.65 (d, J = 9.5 
Hz, 1H), 4.25–4.21 (m, 1H), 3.61 (s, 3H), 3.10 (dd, J = 5.5, 14 Hz, 1H), 2.96 (dd, 
J = 7.5, 14.0 Hz, 1H); 13C NMR (125.6 MHz, CDCl3) δ 171.5, 144.2, 135.2, 133.0, 
129.6, 129.0, 127.8, 127.6, 117.6, 116.4, 57.4, 53.0, 39.3; ESI-HRMS calcd for 
C17H16N2O4SNa [M + Na]+, 367.0712; found, 367.0728.  
N-[(2-Trifluoromethylphenyl)sulfonyl]–L-phenylalanine methyl ester 
(138): Prepared by the general procedure 4 with a yield of 121 mg (91%). [α]22D  
+10.8 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.07 (dd, J = 1.5, 8.25 Hz, 
1H), 7.82(dd, J = 1.0, 8.0 Hz, 1H), 7.68–7.62 (m, 2H), 7.24–7.21 (m, 3H),  7.07–
7.05 (m, 2H), 5.32 (d, J = 9.0 Hz, 1H), 4.33–4.29 (m, 1H), 3.49 (s, 3H), 3.10 (dd, 
J = 6.0, 14 Hz, 1H), 3.03 (dd, J = 6.5, 14.0 Hz, 1H); 13C NMR (125.6 MHz, 
CDCl3) δ 171.1, 138.6, 135.0, 133.0, 132.5, 131.2, 129.5, 128.9, 128.8, 128.7, 
128.3, 128.0, 127.7, 127.6, 127.5, 123.0 (q, J = 274.2), 57.5, 52.6, 39.4; ESI-
HRMS calcd for C17H16NO4SF3Na [M + Na]+, 410.0660; found, 410.0650.  
N-[(3,5-Trifluoromethylphenyl)sulfonyl]–L-phenylalanine methyl ester 
(140): Prepared by the general procedure 4 with a yield of 196 mg (93%); [α]23D  
–47.1 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.15 (s, 2H), 8.0 (s, 1H), 
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7.21–7.16 (m, 3H),   7.05–7.03 (m, 2H), 5.49 (d, J = 9.0 Hz, 1H), 4.35–4.31 (m, 
1H), 3.63 (s, 3H), 3.13 (dd, J = 5.5, 14 Hz, 1H), 3.0 (dd, J = 6.0, 14.0 Hz, 1H); 13C 
NMR (125.6 MHz, CDCl3) δ 171.3, 143.0, 134.8, 133.4, 133.1, 132.8, 132.5, 
129.4, 128.9, 127.8, 127.5, 126.4, 125.9, 123.7, 121.5, 119.3, 57.5, 53.0, 39.4; 
ESI-HRMS calcd for C18H15NO4SF6Na [M + Na]+, 478.0514; found, 478.0524.  
N-[(2-Methoxycarbonyl-4-nitrophenyl)sulfonyl]–L-phenylalanine 
methyl ester (141): Prepared by the general procedure 4 with a yield of 250 mg 
(92%), Mp 128–129 ºC; [α]23D  –3.3 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
8.62 (s, 1H), 8.35 (dd, J = 2.0, 8.5 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 7.21–7.18 
(m, 3H), 7.12–7.10 (m, 2H), 6.76 (d, J = 8.5 Hz, 1H), 4.49–4.45 (m, 1H), 4.01 (s, 
3H), 3.54 (s, 3H), 3.17 (dd, J = 5.5, 14 Hz, 1H), 3.06 (dd, J = 7.5, 14.0 Hz, 1H); 
13C NMR (125.6 MHz, CDCl3) δ 171.2, 165.6, 149.4, 145.7, 135.3, 131.6, 130.5, 
129.5, 128.9, 127.6, 126.5, 126.2, 58.1, 54.2, 52.7, 39.4; ESI-HRMS calcd for 
C18H18N2O8SNa [M + Na]+, 445.0656; found, 445.0682.  
N-[(2-Cyano-4-nitrophenyl)sulfonyl]–L-phenylalanine methyl ester 
(142): Prepared by the general procedure 4 with a yield of 131 mg (91%), Mp 
164–165 ºC; [α]23D  –46.1 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.44 (d, J 
= 2.0 Hz, 1H), 8.39 (dd, J = 2.0, 8.5 Hz, 1H), 8.07 (d, J = 8.5 Hz, 1H), 7.17–7.13 
(m, 3H), 7.07–7.06 (m, 2H), 5.86 (s, 1H), 4.40 (dd, J = 5.0, 8.5 Hz, 1H), 3.75 (s, 
3H), 3.20 (dd, J = 4.5, 14 Hz, 1H), 2.96 (dd, J = 9.0, 14.5 Hz, 1H); 13C NMR 
(125.6 MHz, CDCl3) δ 171.1, 149.3, 148.3, 135.1, 130.5, 129.9, 129.5, 129.0, 
127.6, 127.5, 114.4, 112.3, 58.1, 53.3, 39.1; ESI-HRMS calcd for 
C18H18N2O8SNa [M + Na]+, 412.0549; found, 412.0579.  
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N-[(2-Nitro-4-trifluoromethylphenyl)sulfonyl]–L-phenylalanine methyl 
ester (143): Prepared by the general procedure 4 with a yield of 36 mg (90%); 
[α]23D  –25.2 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 1.0 Hz, 1H), 
8.02 (d, J = 8.0 Hz, 1H), 7.86 (dd, J = 1.0, 8.0 Hz, 1H), 7.19–7.15 (m, 3H), 7.10–
7.08 (m, 2H), 5.99 (d, J = 8.5 Hz, 1H), 4.50 (dd, J = 3.0, 8.0 Hz, 1H), 3.64 (s, 3H), 
3.21 (dd, J = 5.0, 14 Hz, 1H), 3.04 (dd, J = 8.0, 14.0 Hz, 1H); 13C NMR (125.6 
MHz, CDCl3) δ 171.0, 147.6, 138.0, 135.0, 131.4, 129.9, 129.5, 129.0, 127.8, 
123.1, 58.4, 52.9, 39.3; ESI-HRMS calcd for C17H15N2O6SF3Na [M + Na]+, 
455.0494; found, 455.0501.  
Boc-L-Glu(STrt)-OtBu (147) 
To a stirred solution of Boc-L-Glu(OH)-OtBu (260 mg, 0.86 mmol), 
triphenylmethanethiol (236 mg, 0.86 mmol) and DMAP (21 mg, 0.17 mmol) in dry 
methylene chloride (5 mL) was added EDCI (192 mg, 1.03 mmol) at rt. The 
reaction mixture was stirred for 3 h and then subjected to chromatographic 
purification (30% ethyl acetate: hexane) which afforded the desired product (365 
mg, 76%). [α]24D  +15.4 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.31–7.22 
(m, 15H), 4.99 (d, J = 8.0 Hz, 1H), 4.14 (d, J = 7.5 Hz, 1H), 2.66–2.54 (m, 2H), 
4.25–4.21 (m, 2H), 2.10–2.05 (m, 1H), 1.88–1.81 (m, 1H), 1.45 (s, 18H); 13C 
NMR (125.6 MHz, CDCl3) δ 196.2, 171.4, 155.7, 144.0, 130.0, 128.0, 127.4, 
82.5, 80.1, 70.7, 53.5, 40.0, 28.6, 28.2; ESI-HRMS calcd for C33H39NO5SNa [M + 
Na]+, 584.2479; found, 584.2447. 
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Boc-L-Glu(SH)-OtBu (148) 
Boc-L-Glu(STrt)-OtBu (63 mg, 0.11 mmol) was dissolved in a mixture of 
5% TFA in methylene chloride (2 mL) with triethylsilane (100 µL) and stirred at rt 
for 5 min. Toluene (5 mL) was added to the reaction mixture and then the 
solvents were removed. The residue was diluted with ethyl acetate and washed 
with 1M HCl, water and brine, dried over sodium sulfate and concentrated under 
reduced pressure to give the crude thioacid. 
Boc-L-Asp(STrt)-OBn (150) 
To a stirred solution of Boc-L-Asp(OH)-OBn (100 mg, 0.31 mmol), 
triphenylmethanethiol (85 mg, 0.31 mmol) and DMAP (8 mg, 0.06 mmol) in dry 
methylene chloride (3 mL) was added EDCI (71 mg, 0.37 mmol) at rt. After 
stirring for 3 h, chromatographic purification (20% ethyl acetate: hexane) afforded 
the desired product (137 mg, 76%). [α]23D  –1.5 (c = 1, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 7.36–7.20 (m, 20H), 5.30 (d, J = 8.0 Hz, 1H), 5.10 (q, J = 12.5 Hz, 
2H), 4.51–4.48 (m, 1H), 3.22 (dd, J = 5.0, 16.5 Hz, 1H), 3.07 (dd, J = 4.5, 16.5 
Hz, 1H), 1.43 (s, 9H); 13C NMR (125.6 MHz, CDCl3) δ 195.2, 170.7, 155.5, 143.7, 
135.5, 130.0, 128.8, 128.6, 128.4, 128.1, 127.5, 80.3, 71.4, 67.7, 51.0, 44.9, 
28.5; ESI-HRMS calcd for C35H35NO5SNa [M + Na]+, 604.2172; found, 604.2134. 
Boc-L-Asp(SH)-OBn (151) 
Boc-L-Asp(STrt)-OBn (65 mg, 0.11 mmol) was dissolved in a mixture of 
5% TFA in methylene chloride (2 mL) with triethylsilane (100 µL) and stirred at rt 
for 5 min. Toluene (5 mL) was added to the reaction mixture and then solvents 
were removed. The residue was diluted with ethyl acetate followed by washing 
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with 1M HCl, water and brine, dried over sodium sulfate and concentrated under 
reduced pressure to give the crude thioacid. 
Fmoc-L-Glu(OtBu)-L-Val-L-Met-OMe (153) 
Boc-L-Val-L-Met-OMe (425 mg, 1.18 mmol) was dissolved in a mixture of 
40% TFA in methylene chloride (6 mL) with triethylsilane (200 µL) and stirred at rt 
for 15 min. Toluene (10 mL) was added to the reaction mixture and then the 
solvents were removed to give a crude ammonium salt, which was neutralized 
with triethylamine to give crude NH2-L-Val-L-Met-OMe which was applied 
immediately to the next step. 
To a stirred solution of Fmoc-L-Glu(OtBu)-OH (500 mg, 1.18 mmol), the above 
prepared NH2-L-Val-L-Met-OMe and HOBT (190 mg, 1.42 mmol) in dry 
methylene chloride (7 mL) was added EDCI (270 mg, 1.42 mmol) at 0 ºC after 
which the reaction mixture was stirred at rt for 6 h. Chromatographic purification 
(55% ethyl acetate: hexane) afforded the desired product (740 mg, 94%). [α]23D  
–7.2 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.5 Hz, 2H), 7.59 
(d, J = 5.5 Hz, 2H), 7.39 (t, J = 7.0 Hz, 2H), 7.28 (s, 2H), 7.14 (d, J = 6.5 Hz, 2H), 
6.13 (d, J = 6.0 Hz, 1H), 4.71 (d, J = 4.0 Hz, 1H),  4.37–4.33 (m, 4H), 4.21 (d, J = 
6.5 Hz, 1H), 3.72 (s, 3H), 2.49–2.40 (m, 4H), 2.17–1.99 (m, 8H), 1.46 (s, 9H), 
0.95 (dd, J = 10.0, 7.0 Hz, 6H); 13C NMR (125.6 MHz, CDCl3) δ 173.3, 172.4, 
172.0, 171.2, 156.7, 144.1, 144.0, 141.5, 128.0, 127.3, 125.4, 120.2, 81.4, 67.5, 
58.9, 54.9, 52.7, 51.8, 47.3, 32.1, 31.6, 31.0, 30.2, 28.3, 19.4, 18.2, 15.6; ESI-
HRMS calcd for C35H47N3O8SNa [M + Na]+, 692.2902; found, 692.2982. 
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Fmoc-L-Glu(STrt)-L-Val-L-Met-OMe (154) 
Fmoc-L-Glu(OtBu)-L-Val-L-Met-OMe (200 mg, 0.30 mmol) was dissolved in 
a mixture of 70% TFA in methylene chloride (5 mL) with triethylsilane (200 µL) 
and stirred at rt for 1 h. Toluene (10 mL) was added to the reaction mixture and 
then the solvents were removed to give the crude acid Fmoc-L-Glu(OH)-L-Val-L-
Met-OMe which was applied immediately to the next step. 
To a stirred solution of Fmoc-L-Glu(OH)-L-Val-L-Met-OMe, 
triphenylmethanethiol (83 mg, 0.30 mmol) and DMAP (4 mg, 0.03 mmol) in dry 
methylene chloride (3 mL) was added EDCI (69 mg, 0.36 mmol) at rt. After 
stirring for 4 h, the reaction mixture was subjected to chromatographic 
purification (55% ethyl acetate: hexane) to give the desired product (169 mg, 
65%). [α]24D  +1.9 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 7.0 
Hz, 2H), 7.58 (t, J = 7.0 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.31–7.22 (m, 17H), 
6.83 (d, J = 7.0 Hz, 2H), 6.55 (d, J = 7.5 Hz, 1H), 5.57 (d, J = 7.5 Hz, 1H), 4.68 
(dd, J = 7.5, 12.5 Hz, 1H),  4.43–4.36 (m, 2H), 4.25–4.21 (m, 2H), 4.07 (d, J = 6.5 
Hz, 1H), 3.72 (s, 3H), 2.77–2.74 (m, 1H), 2.66–2.63 (m, 1H), 2.43 (t, J = 7.5 Hz, 
2H), 2.16–1.91 (m, 4H), 0.91 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H); 13C 
NMR (125.6 MHz, CDCl3) δ 197.8, 172.3, 171.3, 170.8, 156.3, 144.0, 143.8, 
141.5, 130.1, 128.1, 128.0, 127.5, 127.3, 125.4, 125.3, 120.2, 71.1, 67.5, 59.0, 
54.1, 52.7, 51.7, 47.3, 39.9, 31.5, 30.8, 30.2, 28.6, 19.3, 18.0, 15.7; ESI-HRMS 
calcd for C50H53N3O7S2Na [M + Na]+, 894.3131; found, 894.3223. 
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Fmoc-L-Glu(SH)-L-Val-L-Met-OMe (155) 
Fmoc-L-Glu(STrt)-L-Val-L-Met-OMe (18 mg, 0.02 mmol) was dissolved in a 
mixture of 25% TFA in methylene chloride (1 mL) with triethylsilane (100 µL) and 
stirred at rt for 5 min. Toluene (5 mL) was added to the reaction mixture and then 
the solvents were removed to give the crude thioacid Fmoc-L-Glu(SH)-L-Val-L-
Met-OMe which was applied immediately to the next step. 
Z-Gly-STrt (158) 
To a stirred solution of Z-Gly-OH (150 mg, 0.71 mmol), 
triphenylmethanethiol (197 mg, 0.71 mmol) and DMAP (17 mg, 0.14 mmol) in dry 
methylene chloride (5 mL) was added EDCI (164 mg, 0.85 mmol) at rt. The 
reaction mixture was stirred for 2 h then subjected to chromatographic 
purification (20% ethyl acetate: hexane) which afforded the desired product (307 
mg, 92%); 1H NMR (500 MHz, CDCl3) δ 7.36–7.25 (m, 20H), 5.32–5.30 (m, 1H), 
5.14 (s, 1H), 4.08 (d, J = 5.5 Hz, 2H); 13C NMR (125.6 MHz, CDCl3) δ 194.7, 
156.3, 143.7, 136.5, 130.0, 128.8, 128.4, 128.3, 128.1, 127.5, 80.0, 67.4, 50.9; 
ESI-HRMS calcd for C29H25NO3SNa [M + Na]+, 490.1453; found, 490.1457. 
Boc-L-Val-STmob (164) 
To a stirred solution of Boc-L-Val-OH (500 mg, 2.30 mmol), 2,4,6-
trimethoxybenzylthiol (490 mg, 2.3 mmol) and DMAP (28 mg, 0.23 mmol) in dry 
methylene chloride (8 mL) was added DIC (422 µL, 2.76 mmol) at 0 ºC. The 
reaction mixture was stirred at 0 ºC for 2 h and then at rt over night. 
Chromatographic purification (20% ethyl acetate: hexane) afforded the desired 
product (874 mg, 92%). [α]23D  –15.8 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
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6.10 (s, 2H), 5.02 (d, J = 9.5 Hz, 1H), 4.30 (dd, J = 4.5, 9.5 Hz, 1H), 4.21 (s, 2H), 
3.80 (s, 3H), 3.79 (s, 6H), 2.30–2.67 (m, 1H), 1.44 (s, 9H), 0.98 (d. J = 7.0 Hz, 
3H), 0.86 (d. J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 201.6, 161.0, 
159.4, 155.8, 105.0, 90.7, 80.1, 65.4, 56.0, 55.6, 31.6, 28.6, 28.5, 22.3, 19.6, 
16.9; ESI-HRMS calcd for C20H31NO6SNa [M + Na]+, 436.1742; found, 436.1770. 
NH2-L-Val-STmob (165) 
Boc-L-Val-STmob (186 mg, 0.45 mmol) was dissolved in a mixture of 40% 
TFA in CH2Cl2 (4 mL) and stirred at rt for 5 min. The solvents were removed and 
the organic layer was extracted with ethyl acetate followed by washing with 20% 
aqueous sodium carbonate solution. The organic layer was dried over sodium 
sulfate and concentrated under reduced pressure to afford the free amine which 
was applied immediately to the next step. 
ENS-L-Trp-STmob (167) 
To a stirred solution of L-tryptophan (80 mg, 0.39 mmol) in dioxane/water 
(5mL/5mL) was added triethylamine (1 mL, 7.80 mmol) at 0 ºC. After 10 min, a 
solution of ENS-Cl (131 mg, 0.47 mmol) in dioxane (4 mL) was added slowly to 
the reaction mixture, which was then stirred for 30 min at 0 ºC and then at rt for 
1.5 h. The reaction mixture was concentrated and basified with 10% sodium 
bicarbonate solution (50 mL). The aqueous layer was extracted with methyl t-
butyl ether and the aqueous layer was acidified with 1M HCl and extracted with 
ethyl acetate (2x 100 mL). The combined organic layer was washed with water 
and brine, dried and concentrated. 
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To a stirred solution of ENS-L-Trp-OH (160 mg, 0.36 mmol), 2,4,6-
trimethoxybenzylthiol (77 mg, 0.36 mmol) and HOBT (58 mg, 0.43 mmol) in dry 
methylene chloride (4 mL) was added DIC (66 µL, 0.43 mmol) at 0 ºC. Stirring 
was continued at rt for 6 h before chromatographic purification (60% ethyl 
acetate: hexane) afforded the desired product (211 mg, 93%). [α]23D  –61.6 (c = 
1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.15 (d, J = 2.0 Hz, 1H), 7.92 (s, 1H), 
7.78 (dd, J = 2.0, 8.5 Hz, 1H), 7.66 (d, J = 8.5 Hz, 1H), 7.31 (d, J = 7.5 Hz, 1H), 
7.01–6.93 (m, 3H), 6.89 (d, J = 2.0 Hz, 1H), 6.69 (d, J = 7.0 Hz, 1H), 6.10 (s, 2H), 
4.50–4.48 (m, 1H), 4.23 (s, 2H), 3.94 (s, 3H), 3.82 (s, 3H), 3.81 (s, 6H), 3.46 (dd, 
J = 3.5, 15.0 Hz, 1H), 2.93 (dd, J = 11.0, 15.0 Hz, 1H); 13C NMR (125.6 MHz, 
CDCl3) δ 201.3, 165.6, 161.2, 159.5, 148.6, 144.2, 136.1, 129.8, 129.5, 126.6, 
125.5, 125.2, 124.2, 122.5, 119.9, 118.9, 111.2, 109.7, 104.6, 90.7, 64.2, 56.1, 
55.6, 54.0, 29.6, 22.9; ESI-HRMS calcd for C29H29N3O10S2Na [M + Na]+, 
666.1151; found, 666.1192. 
ENS-L-Trp-SH 
ENS-L-Trp-STmob (110 mg, 0.17 mmol) was dissolved in a mixture of 
70% TFA in methylene chloride (5 mL) with triethylsilane (300 µL) and stirred at rt 
for 1.5 h. Toluene (8 mL) was added to the reaction mixture and then the 
solvents were removed to give the crude thioacid ENS-L-Trp-SH which was 
applied immediately to the next step. 
ENS-L-Ala-OH (168) 
To a stirred solution of L-alanine (147 mg, 1.65 mmol) in dioxane/water 
(5mL/5mL) was added triethylamine (4.6 mL, 33.0 mmol) at 0 ºC. After 10 min, a 
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solution of ENS-Cl (600 mg, 2.15 mmol) in dioxane (4 mL) was added slowly to 
the reaction mixture which was then stirred for 30 min at 0 ºC and then at rt for 
1.5 h. The reaction mixture was concentrated and basified with 10% sodium 
bicarbonate solution (50 mL). The aqueous layer was extracted with methyl t-
butyl ether and then the aqueous layer was acidified with 1M HCl and extracted 
with ethyl acetate (2x 100 mL). The combined organic layer was washed with 
water and brine, dried and concentrated (543 mg, 99%). [α]24D  –24.1 (c = 1, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.69 (d, J = 2.5 Hz, 1H), 8.45 (dd, J = 2.5, 
8.5 Hz, 1H), 8.24 (d, J = 8.5 Hz, 1H), 6.80 (d, J = 8.0 Hz, 1H), 4.29–4.26 (m, 1H), 
4.08 (s, 3H), 1.51 (d, J = 7.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 177.0, 
166.1, 149.7, 145.7, 131.9, 130.7, 126.6, 126.2, 54.3, 52.3, 19.5; ESI-HRMS 
calcd for C11H12N2O8SNa [M + Na]+, 355.0179; found, 355.0212.  
ENS-L-Ala-L-Phe-STmob (169) 
To a stirred solution of ENS-L-Ala-OH (108 mg, 0.33 mmol), the above 
prepared NH2-L-Phe-STmob and HOBT (58 mg, 0.43 mmol) in dry methylene 
chloride (4 mL) was added EDCI (82 mg, 0.43 mmol) at 0 ºC. The reaction 
mixture was stirred at rt for 6 h before chromatographic purification (40% ethyl 
acetate: hexane) afforded the desired product (189 mg, 86%). [α]23D  –33.8 (c = 
1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.66 (d, J = 2.0 Hz, 1H), 8.29 (dd, J = 
2.0, 8.5 Hz, 1H), 8.06 (d, J = 8.5 Hz, 1H), 7.3–7.25 (m, 3H), 7.12–7.11 (m, 2H), 
6.61 (d, J = 8.0 Hz, 1H), 6.46 (d, J = 8.5 Hz, 1H), 6.10 (s, 2H), 4.75–4.73 (m, 1H), 
4.19 (dd, J = 12.5, 23.0 Hz, 2H), 4.07 (s, 3H), 3.81 (s, 3H), 3.80 (s, 6H), 3.16 (dd, 
J = 5.5, 14.0 Hz, 1H), 2.95 (dd, J = 7.5, 14.0 Hz, 1H), 1.26 (d. J = 7.5 Hz, 3H); 
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13C NMR (125.6 MHz, CDCl3) δ 199.5, 170.5, 166.2, 161.3, 159.5, 149.7, 145.3, 
135.9, 132.0, 131.0, 129.6, 128.8, 127.4, 126.6, 126.4, 104.3, 90.7, 60.0, 56.1, 
55.6, 54.3, 53.6, 38.9, 22.6, 19.4; ESI-HRMS calcd for C30H33N3O11S2Na [M + 
Na]+, 698.1443; found, 698.1454. 
ENS-L-Ala-L-Val-STmob (170) 
To a stirred solution of ENS-L-Ala-OH (100 mg, 0.30 mmol), the above 
prepared NH2-L-Val-STmob and HOBT (53 mg, 0.39 mmol) in dry methylene 
chloride (4 mL) was added EDCI (75 mg, 0.39 mmol) at 0 ºC. The reaction 
mixture was stirred at rt for 3 h, then was subjected to chromatographic 
purification (40% ethyl acetate: hexane) which afforded the desired product (123 
mg, 65%). [α]23D  –47.7 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.69 (d, J = 
2.5 Hz, 1H), 8.40 (dd, J = 2.0, 8.5 Hz, 1H), 8.25 (d, J = 8.5 Hz, 1H), 6.79 (s, 1H), 
6.51 (d, J = 8.5 Hz, 1H), 6.09 (s, 2H), 4.45 (dd, J = 5.0, 9.0 Hz, 1H), 4.18 (dd, J = 
12.5, 25.5 Hz, 2H), 4.07 (s, 3H), 3.80 (s, 3H), 3.78 (s, 6H),  2.18–2.17 (m, 1H), 
1.40 (d. J = 7.5 Hz, 3H), 0.80 (dd, J = 3.5, 7.0 Hz, 6H); 13C NMR (125.6 MHz, 
CDCl3) δ 199.6, 171.0, 166.0, 161.2, 159.4, 149.7, 145.4, 132.1, 131.1, 126.6, 
126.4, 104.5, 90.7, 63.9, 56.0, 55.6, 54.3, 53.7, 31.8, 22.4, 19.8, 19.5, 17.1; ESI-
HRMS calcd for C26H33N3O11S2Na [M + Na]+, 650.1496; found, 650.1454. 
ENS-L-Ala-L-Phe-SH 
ENS-L-Ala-L-Phe-STmob (220 mg, 0.33 mmol) was dissolved in a mixture 
of 70% TFA in methylene chloride (5 mL) with triethylsilane (300 µL) and stirred 
at rt for 1.5 h. Toluene (8 mL) was added to the reaction mixture and then the 
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solvents were removed to give the crude thioacid ENS-L-Ala-L-Phe-SH which 
was applied immediately to the next step. 
CNS-L-Phe-STmob (171) 
To a stirred solution of NH2-L-Phe-STmob (78 mg, 0.22 mmol) and 2-
cyano-4-nitrobenzenesulfonyl chloride (65 mg, 0.26 mmol) in methylene chloride 
(2 mL) was added DIPEA (45 µL, 0.26 mmol) at rt. The reaction mixture was 
stirred for 2h then was subjected to chromatographic purification (30% ethyl 
acetate: hexane) to give the desired product (89 mg, 72%). [α]24D  –37.8 (c = 1, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.32 (d, J = 2.0 Hz, 1H), 8.30 (d, J = 1.0 
Hz, 1H), 8.03 (dd, J = 0.5, 8.5 Hz, 1H), 7.13–7.11 (m, 3H), 7.08–7.06 (m, 2H), 
6.09 (s. 2H), 5.82 (s, 1H), 4.37 (s, 1H), 4.17 (s, 2H), 3.83 (s, 3H), 3.80 (s, 6H), 
3.26 (dd, J = 5.0, 14 Hz, 1H), 2.92 (dd, J = 9.0, 14.0 Hz, 1H); 13C NMR (125.6 
MHz, CDCl3) δ 198.6, 161.4, 159.3, 149.1, 148.1, 135.1, 130.6, 129.8, 129.6, 
129.0, 127.4, 127.3, 114.4, 112.3, 104.1, 90.7, 64.6, 56.1, 55.6, 39.7, 23.0; ESI-
HRMS calcd for C26H25N3O8S2Na [M + Na]+, 594.1009; found, 594.0981. 
DNS-L-Val-OtBu (172) 
To a stirred solution of L-valine methyl ester hydrochloride (880 mg, 4.2 
mmol) and pyridine (1.36 mL, 16.8 mmol) in dry methylene chloride (9 mL) was 
added 2,4-dinitrobenzenesulfonyl chloride (1.34 g, 5.05 mmol) slowly at 0 ºC. 
The reaction mixture was stirred at 0 ºC for 1h and over night at rt before it was 
diluted with ethyl acetate. The organic layer was washed with 1M HCl, water and 
brine, dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (20% ethyl acetate: hexane) afforded the desired 
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product (1.22 g, 72%). [α]23D  –179.8 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
8.74 (d, J = 2.0 Hz, 1H), 8.51 (dd, J = 2.0, 8.5 Hz, 1H), 8.28 (d, J = 8.5 Hz, 1H), 
6.08 (s, 1H), 3.96 (s. 1H), 2.23–2.19 (m, 1H), 1.25 (s, 9H), 1.05 (d, J = 7.0 Hz, 
3H), 0.92 (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 169.8, 150.0, 
148.2, 140.1, 132.3, 127.3, 121.2, 83.2, 63.1, 31.6, 27.9, 19.3, 17.3; ESI-HRMS 
calcd for C15H21N3O8SNa [M + Na]+, 426.0937; found, 426.0947. 
DNS-L-Phe-OtBu (173) 
To a stirred solution of L-phenylalanine methyl ester hydrochloride (200 
mg, 0.78 mmol) and pyridine (191 µL, 2.34 mmol) in dry methylene chloride (7 
mL) was added 2,4-dinitrobenzenesulfonyl chloride (247 mg, 0.93 mmol) slowly 
at 0 ºC. The reaction mixture was stirred at 0 ºC for 1h and 6 h at rt before it was 
diluted with ethyl acetate. The organic layer was washed with 1M HCl, water and 
brine, dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (25% ethyl acetate: hexane) afforded the desired 
product (238 mg, 68%). [α]30D  –53.6 (c = 0.8, CHCl3); 1H NMR (500 MHz, CDCl3) 
δ 8.65 (d, J = 2.0 Hz, 1H), 8.41 (dd, J = 2.0, 8.5 Hz, 1H), 8.12 (d, J = 8.5 Hz, 1H), 
7.24–7.14 (m, 5H), 6.01 (d, J = 9.0 Hz, 1H), 4.43–4.39 (m, 1H), 3.16 (dd, J = 6.0, 
14.0 Hz, 1H), 3.05 (dd, J = 6.5, 14.0 Hz, 1H), 1.32 (s, 3H); 13C NMR (125.6 MHz, 
CDCl3) δ 169.5, 149.8, 140.1, 135.2, 132.1, 129.6, 128.9, 127.7, 127.2, 121.0, 
83.6, 58.8, 39.4, 28.0; ESI-HRMS calcd for C19H21N3O8SNa [M + Na]+, 474.0947; 
found, 474.0955. 
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DNS-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (174) 
DNS-L-Val-OtBu (134 mg, 0.33 mmol) was dissolved in a mixture of 70% 
TFA in methylene chloride (5 mL) with triethylsilane (200 µL) and stirred at rt for 1 
h. Toluene (10 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude acid DNS-L-Val-OH which was applied immediately to 
the next step. 
Boc-L-Met-L-Val-L-Pro-L-Ala-OEt (150 mg, 0.28 mmol) was dissolved in a 
mixture of 40% TFA in methylene chloride (3 mL) with triethylsilane (100 µL) and 
stirred at rt for 15 min. Toluene (5 mL) was added to the reaction mixture and 
then solvents were removed to give a crude ammonium salt, which was 
neutralized with triethylamine to give the crude amine NH2-L-Met-L-Val-L-Pro-L-
Ala-OEt, which was applied immediately to the next step. 
To a stirred solution of the above prepared DNS-L-Val-OH and the above 
prepared NH2-L-Met-L-Val-L-Pro-L-Ala-OEt in dry methylene chloride (4 mL) was 
added HATU (160 mg, 0.42 mmol) followed by DIPEA (73 µL, 0.42 mmol) at 0 
ºC. The reaction mixture was stirred at rt for 6 h before it was diluted with ethyl 
acetate. The organic layer was washed with 1M HCl, water and brine, dried over 
sodium sulfate and concentrated under reduced pressure. Chromatographic 
purification (75–100% ethyl acetate: hexane) afforded the desired product (186 
mg, 87%). ESI-HRMS calcd for C31H47N7O12S2Na [M + Na]+, 796.2562; found, 
796.2622. 
LCMS: 5-20% B over 1 min then 20-55% B over 4 min with a flow rate of 0.7 
mL/min and 254 nm UV detection, retention time = 4.25 min. 
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DNS-L-Phe-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (175) 
DNS-L-Phe-OtBu (72 mg, 0.16 mmol) was dissolved in a mixture of 70% 
TFA in methylene chloride (3 mL) with triethylsilane (200 µL) and stirred at rt for 1 
h. Toluene (10 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude acid DNS-L-Phe-OH which was applied immediately to 
the next step. 
To a stirred solution of the above prepared DNS-L-Phe-OH and NH2-L-
Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt (150 mg, 0.16 mmol) in dry methylene 
chloride (4 mL) was added HATU (91 mg, 0.24 mmol) followed by DIPEA (70 µL, 
0.40 mmol) at 0 ºC. The reaction mixture was stirred at rt for 6 h before it was 
diluted with ethyl acetate and the organic layer was washed with 1M HCl, water 
and brine, dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (75–100% ethyl acetate: hexane) afforded the 
desired product (179 mg, 85%). ESI-HRMS calcd for C72H73N9O14SNa [M + Na]+, 
1342.4895; found, 1342.4955. 
LCMS: 5-98% B over 5 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 4.77 min. 
DNS-L-Val-L-Ala-L-Thr-L-Val-SFm (178) 
DNS-L-Val-OtBu (140 mg, 0.35 mmol) was dissolved in a mixture of 70% 
TFA in methylene chloride (4 mL) with triethylsilane (200 µL) and stirred at rt for 1 
h. Toluene (10 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude acid DNS-L-Val-OH which was applied immediately to 
the next step. 
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Boc-L-Ala-L-Thr-L-Val-SFm (202 mg, 0.35 mmol) was dissolved in a 
mixture of 40% TFA in methylene chloride (4 mL) with triethylsilane (100 µL) and 
stirred at rt for 15 min. Toluene (5 mL) was added to the reaction mixture and 
then the solvents were removed to give the crude ammonium salt, which was 
applied immediately to the next step. 
To a stirred solution of the above prepared DNs-L-Val-OH and crude 
ammonium salt in dry methylene chloride (4 mL) was added HATU (200 mg, 0.53 
mmol) followed by DIPEA (152 µL, 0.88 mmol) at 0 ºC. The reaction mixture was 
stirred at rt for 6 h before it was diluted with ethyl acetate and the organic layer 
was washed with 1M HCl, water and brine, dried over sodium sulfate and 
concentrated under reduced pressure. Chromatographic purification (75–100% 
ethyl acetate: hexane) afforded the desired product (251 mg, 89%). ESI-HRMS 
calcd for C37H44N6O11S2Na [M + Na]+, 835.2407; found, 835.2429. 
LCMS: 5-98 % B over 5 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 4.28 min. 
Methyl N-[(methyl 3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranoside)-2-
ylsuccinamyl]-L-phenylalaninate (181) from ENS-L-Phe-OMe 
To a stirred suspension of 3,4,6-tri-O-acetyl-2-amino-2-deoxy-β-D-
glucopyranoside (25 mg, 0.078 mmol) in dry DMF (100 µL) was added a solution 
of thiosuccinic anhydride (9 mg, 0.078 mmol) in dry DMF (250 µL) at rt over 30 
min. The reaction mixture was stirred for 1 h before cesium carbonate (25 mg, 
0.078 mmol) was added to the reaction mixture followed by ENS-L-Phe-OMe (25 
mg, 0.058 mmol), after which stirring was continued for further 3 h before the 
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reaction mixture was diluted with ethyl acetate. The organic layer was washed 
with water and brine, dried over sodium sulfate and concentrated under reduced 
pressure. Chromatographic purification afforded the desired product (16 mg, 
48%). 
Methyl N-[(methyl 3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranoside)-2-
ylsuccinamyl]-L-phenylalaninate (181) from CNS-L-Phe-OMe 
To a stirred suspension of 3,4,6-tri-O-acetyl-2-amino-2-deoxy-β-D-
glucopyranoside (25 mg, 0.078 mmol) in dry DMF (100 µL) was added a solution 
of thiosuccinic anhydride (9 mg, 0.078 mmol) in dry DMF (250 µL) at rt over 30 
min. The reaction mixture was stirred for further 1 h before cesium carbonate (25 
mg, 0.078 mmol) was added to the reaction mixture followed by CNS-L-Phe-OMe 
(23 mg, 0.058 mmol). The reaction mixture was stirred for further 3 h before it 
was diluted with ethyl acetate. The organic layer was washed with water and 
brine, dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification afforded the desired product (17 mg, 51%). 
Fmoc-L-Glu(L-Phe-OMe)-L-Val-L-Met-OMe (182) from ENS-L-Phe-OMe 
To a stirred solution of Fmoc-L-Glu(SH)-L-Val-L-Met-OMe (0.02 mmol) and 
ENS-L-Phe-OMe (8 mg, 0.0189 mmol] in dry DMF (200 µL) was added cesium 
bicarbonate (11 mg, 0.05 mmol) at rt. The reaction mixture was stirred for 1 h 
before it was diluted with ethyl acetate. The organic layer was washed with water 
and brine, dried over sodium sulfate and concentrated under reduced pressure. 
Radial Chromatographic purification (70% ethyl acetate: hexane) afforded the 
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desired product (12 mg, 79%). ESI-HRMS calcd for C41H50N4O9SNa [M + Na]+, 
797.3285; found, 797.3196. 
LCMS: 5-30% B over 1 min then 30-70% B over 4 min with a flow rate of 0.7 
mL/min and 254 nm UV detection, retention time = 4.03 min. 
Fmoc-L-Glu(L-Phe-OMe)-L-Val-L-Met-OMe (182) by CNS-L-Phe-OMe 
To a stirred solution of Fmoc-L-Glu(SH)-L-Val-L-Met-OMe (0.017 mmol) 
and CNS-L-Phe-OMe (6 mg, 0.015 mmol] in dry DMF (200 µL) was added 
cesium bicarbonate (9 mg, 0.05 mmol) at rt. After stirring for 1 h, the reaction 
mixture was diluted with ethyl acetate. The organic layer was washed with water 
and brine, dried over sodium sulfate and concentrated under reduced pressure. 
Radial Chromatographic purification (70% ethyl acetate: hexane) afforded the 
desired product (10 mg, 81%). 
Boc-L-Asp(L-Phe-OMe)-OBn (183) from CNS-L-Phe-OMe 
To a stirred solution of Boc-L-Asp(SH)OBn (0.12 mmol) and CNS-L-Phe-
OMe (30 mg, 0.077 mmol] in dry DMF (0.4 mL) was added cesium bicarbonate 
(75 mg, 0.39 mmol) at rt. The reaction mixture was stirred for 2 h before it was 
diluted with ethyl acetate. The organic layer was washed with water and brine, 
dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (40% ethyl acetate: hexane) afforded the desired 
product (28 mg, 75%). 
Boc-L-Asp(L-Phe-OMe)-OBn (183) from ENS-L-Phe-OMe 
To a stirred solution of Boc-L-Asp(SH)OBn (0.12 mmol) and ENS-L-Phe-
OMe (33 mg, 0.077 mmol] in dry DMF (0.4 mL) was added cesium bicarbonate 
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(75 mg, 0.39 mmol) at rt. The reaction mixture was stirred for 24 h before it was 
diluted with ethyl acetate. The organic layer was washed with water and brine, 
dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (40% ethyl acetate: hexane) afforded the desired 
product (11mg, 30%). 
CNS-L-Phe-L-Phe-OMe (186) 
CNS-L-Phe-STmob (175 mg, 0.31 mmol) was dissolved in a mixture of 
70% TFA in methylene chloride (4 mL) with triethylsilane (200 µL) and stirred at rt 
for 1.5 h. Toluene (10 mL) was added to the reaction mixture and then the 
solvents were removed to give the crude thioacid which was applied immediately 
to the next step. 
To a stirred solution of the above prepared crude thioacid CNS-L-Phe-SH 
and DNS-L-Phe-OMe (85 mg, 0.21 mmol) in dry DMF (1 mL) was added cesium 
carbonate at rt. After stirring for 45 min the reaction mixture was diluted with ethyl 
acetate. The organic layer was washed with water and brine, dried over sodium 
sulfate and concentrated under reduced pressure. Chromatographic purification 
(40% ethyl acetate: hexane) afforded the desired product (93 mg, 84%). [α]23D  –
37.4 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.31 (dd, J = 2.0, 8.5 Hz, 1H), 
8.27 (d, J = 2.0 Hz, 1H), 8.01 (d, J = 8.5 Hz, 1H), 7.30–7.20 (m, 3H), 7.13 (d, J = 
7.0 Hz, 2H), 7.06–7.01 (m, 5H), 6.83 (d, J = 7.5 Hz, 1H), 6.59 (d, J = 7.0 Hz, 1H), 
4.86 (q, J = 7.0 Hz, 1H), 4.13 (q, J = 7.0 Hz, 1H), 3.74 (s, 3H), 3.21 (dd, J = 5.5, 
14.0 Hz, 1H), 3.12–3.08 (m, 2H), 2.81 (dd, J = 10.5, 14.5 Hz, 1H); 13C NMR 
(125.6 MHz, CDCl3) δ 171.7, 169.8, 149.1, 147.6, 135.8, 130.7, 130.3, 129.6, 
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128.9, 127.5, 127.2, 114.4, 111.8, 59.5, 53.9, 52.8, 38.6, 38.0; ESI-HRMS calcd 
for C26H24N4O7SNa [M + Na]+, 559.1254; found, 559.1263. 
ENS-L-Ala-L-Phe-L-Phe-OMe (187) 
To a stirred solution of ENS-L-Ala-L-Phe-SH (0.33 mmol) and DNS-L-Phe-
OMe (89 mg, 0.22 mmol in dry DMF (1 mL) was added cesium carbonate (106 
mg, 0.33 mmol) at 0 ºC. The reaction mixture was stirred at rt for 45 min before it 
was diluted with ethyl acetate. The organic layer was washed with water and 
brine, dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (40% ethyl acetate: hexane) afforded the desired 
product (113 mg, 81%). [α]23D  –10.1 (c = 1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
8.67 (s, 1H), 8.38 (d, J = 6.4 Hz, 1H), 8.19 (d, J = 8.0 Hz, 1H), 7.30–7.20 (m, 6H), 
7.15–7.13 (m, 2H), 7.05–7.03 (m, 2H), 6.70 (d, J = 8.4 Hz, 1H), 6.55 (d, J = 6.0 
Hz, 1H), 6.43 (d, J = 7.2 Hz, 1H), 4.76–4.71 (m, 1H), 4.54 (dd, J = 8.0, 14.8 Hz, 
1H), 4.07 (s, 3H), 3.80–3.77 (m, 1H), 3.68 (s, 3H), 3.07 (dt, J = 6.4, 14.4 Hz, 2H), 
2.94 (dd, J = 7.6, 14.0 Hz, 1H), 2.81 (dd, J = 8.0, 13.6 Hz, 1H), 1.15 (d, J = 7.2 
Hz, 3H); 13C NMR (100.9 MHz, CDCl3) δ 171.6, 170.8, 170.1, 166.2, 150.0, 
144.0, 136.4, 136.1, 132.2, 131.9, 129.4, 129.0, 128.8, 127.4, 127.3, 126.7, 
126.5, 76.9, 54.5, 54.4, 53.8, 53.7, 52.5, 38.1, 38.0, 19.1; ESI-HRMS calcd for 
C30H32N4O10SNa [M + Na]+, 663.1691; found, 663.1737. 
ENS-L-Ala-L-Phe-L-Phe-OMe (187) (Reaction in aqueous buffer)[a] 
To a stirred solution of ENS-L-Ala-L-Phe-SH (0.18 mmol) in ligation buffer 
(0.5 mL, [4:1 v/v N-methyl-2-pyrrolidinone (NMP): 6 M guanidine hydrochloride, 1 
M HEPES, pH = 8][a]) was added DNS-L-Phe-OMe (49 mg, 0.12 mmol) at 0 ºC. 
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The reaction mixture was stirred at rt for 45 min before it was diluted with ethyl 
acetate.  The organic layer was washed with water and brine, dried over sodium 
sulfate and concentrated under reduced pressure. Chromatographic purification 
(40% ethyl acetate: hexane) afforded the desired product (57 mg, 74%). 
[a]
 An aqueous buffer containing 6 M Gn.HCl and 1 M HEPES was prepared and 
adjusted to pH 8 using 25% cesium carbonate solution in water. The resulting 
solution (1 mL) was diluted with NMP (4 mL) to produce the final buffer for use in 
the peptide coupling reaction. 
ENS-L-Ala-L-Phe-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (188) 
To a stirred solution of ENS-L-Ala-L-Phe-SH (0.099 mmol) and DNS-L-Val-
L-Met-L-Val-L-Pro-L-Ala-OEt (45 mg, 0.058 mmol in dry DMF (0.5 mL) was added 
cesium carbonate (32 mg, 0.099 mmol) at 0 ºC under a nitrogen atmosphere. 
The reaction mixture was stirred at 0 ºC for 1 h and then at rt for 2.5 h before it 
was diluted with ethyl acetate. The organic layer was washed with water and 
brine, dried over sodium sulfate and concentrated under reduced pressure. 
Reversed phase HPLC purification (40–70% A with a flow rate of 10 mL/min over 
50 min and 254 nm UV detection, retention time = 22 min) provided the 
heptapeptide with a yield of 47 mg (81%). ESI-HRMS calcd for C45H64N8O14S2Na 
[M + Na]+, 1027.3838; found, 1027.3881.  
LCMS: 5-30% B over 1 min then 30-60% B over 4 min with a flow rate of 0.7 
mL/min and 254 nm UV detection, retention time = 3.18 min. 
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ENS-L-Ala-L-Val-SH 
ENS-L-Ala-L-Val-STmob (62 mg, 0.097 mmol) was dissolved in a mixture 
of 70% TFA in methylene chloride (3 mL) with triethylsilane (400 µL) and stirred 
at rt for 1.5 h. Toluene (8 mL) was added to the reaction mixture and then the 
solvents were removed to give the crude thioacid ENS-L-Ala-L-Val-SH which was 
applied immediately to the next step. 
ENS-L-Ala-L-Val-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (189) 
To a stirred solution of ENS-L-Ala-L-Val-SH (0.099 mmol) and DNS-L-Val-
L-Met-L-Val-L-Pro-L-Ala-OEt (45 mg, 0.058 mmol in dry DMF (0.5 mL) was added 
cesium bicarbonate (34 mg, 0.174 mmol) at 0 ºC under a nitrogen atmosphere. 
The reaction mixture was stirred at 0 ºC for 1 h and then stirred at rt for 30 min 
before it was diluted with ethyl acetate. The organic layer was washed with water 
and brine, dried over sodium sulfate and concentrated under reduced pressure. 
Reversed phase HPLC purification (35–60% A in B with a flow rate of 10 mL/min 
over 40 min and 254 nm UV detection, retention time = 23 min) provided the 
heptapeptide with a yield of 43 mg (78%). ESI-HRMS calcd for C41H64N8O14S2 [M 
+ H]+, 979.4000; found, 979.3881.  
LCMS: 5-30% B over 1 min then 30-55% B over 4 min with a flow rate of 0.7 
mL/min and 254 nm UV detection, retention time = 2.78 min. 
Ac-L-Trp-L-Phe-OMe (190) 
To a stirred solution of ENS-L-Trp-SH (0.17 mmol) and DNS-L-Phe-OMe 
(58 mg, 0.14 mmol] in dry DMF (1.5 mL) was added cesium carbonate (68 mg, 
0.21 mmol) at rt. After stirring for 2.5 h, thioacetic acid (13 µL, 0.17 mmol) was 
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added to the reaction mixture followed by cesium carbonate (68 mg, 0.21 mmol). 
Stirring was continued for a further 2.5 h before the reaction mixture was diluted 
with ethyl acetate. The organic layer was washed with water and brine, dried 
over sodium sulfate and concentrated under reduced pressure. Chromatographic 
purification (5% methanol: methylene chloride) afforded the desired product (35 
mg, 60%). [α]23D  +11.6 (c = 1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.10 (s, 1H), 
7.71 (d, J = 8.0 Hz, 1H), 7.36 (d, J = 8.0 Hz, 1H), 7.22–7.13 (m, 6H), 7.06 (d, J = 
2.0 Hz, 1H), 6.88 (d, J = 7.0 Hz, 2H), 6.27 (d, J = 7.0 Hz, 1H), 6.11 (d, J = 7.5 Hz, 
1H), 4.73–4.69 (m, 1H), 3.65 (s, 3H), 3.31 (dd, J = 5.0, 14.0 Hz, 1H), 3.11 (dd, J 
= 8.0, 14.0 Hz, 1H), 3.01 (dd, J = 5.5, 14.5 Hz, 1H), 2.93 (dd, J = 6.5, 14.0 Hz, 
1H), 1.98 (s, 3H); 13C NMR (100.9 MHz, CDCl3) δ 171.5, 171.1, 170.2, 136.4, 
135.8, 129.4, 128.8, 127.7, 127.3, 123.6, 122.6, 120.1, 119.1, 111.5, 110.8, 54.0, 
53.6, 52.5, 38.0, 29.9, 28.5, 23.5; ESI-HRMS calcd for C23H25N3O4Na [M + Na]+, 
430.1729; found, 430.1743. 
Boc-L-Glu(L-Phe-L-Phe-OMe)-OtBu (191) 
To a stirred solution of Boc-L-Glu(SH)OtBu (0.11 mmol) and CNS-L-Phe-L-
Phe-OMe (40 mg, 0.075 mmol] in dry DMF (0.5 mL) was added cesium 
carbonate (36 mg, 0.11 mmol) at rt. After stirring for 4 h, the reaction mixture was 
diluted with ethyl acetate. The organic layer was washed with water and brine, 
dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (60% ethyl acetate: hexane) afforded the desired 
product (37 mg, 81%). [α]23D  +6.3 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.27–7.20 (m, 8H), 7.03 (d, J = 6.5 Hz, 2H), 6.79 (d, J = 7.0 Hz, 1H), 6.48 (d, J = 
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7.0 Hz, 1H), 5.23 (d, J = 7.5 Hz, 1H), 4.71 (q, J = 6.5 Hz, 1H), 4.66 (q, J = 6.5 Hz, 
1H), 3.89 (s, 1H), 3.69 (s, 3H), 3.13–3.08 (m, 2H), 3.04–2.97 (m, 2H), 2.22–2.17 
(m, 2H), 2.08–2.02 (m, 1H), 1.75–1.72 (m, 1H), 1.48–1.46 (m, 18H); 13C NMR 
(125.6 MHz, CDCl3) δ 172.5, 171.6, 171.5, 170.9, 156.1, 136.9, 136.0, 129.6, 
129.4, 128.8, 127.3, 127.1, 82.6, 80.3, 54.6, 53.6, 53.3, 52.6, 38.1, 37.7, 32.7, 
29.9, 28.6, 28.2; ESI-HRMS calcd for C33H45N3O8Na [M + Na]+, 634.3148; found, 
634.3104.  
Boc-L-Asp(L-Phe-L-Phe-OMe)-OBn (192) 
To a stirred solution of Boc-L-Asp(SH)OBn (0.11 mmol) and CNS-L-Phe-L-
Phe-OMe (40 mg, 0.075 mmol] in dry DMF (1 mL) was added cesium 
bicarbonate (88 mg, 0.45 mmol) at rt. The reaction mixture was stirred for 4 h 
before it was diluted with ethyl acetate. The organic layer was washed with water 
and brine, dried over sodium sulfate and concentrated under reduced pressure. 
Chromatographic purification (70% ethyl acetate: hexane) afforded the desired 
product (37 mg, 78%). [α]23D  +64.4 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.34–7.20 (m, 11H), 7.15 (d, J = 7.0 Hz, 2H), 7.01 (d, J = 7.0 Hz, 2H), 6.39 (d, J 
= 7.0 Hz, 1H), 6.26 (d, J = 7.0 Hz, 1H), 5.77 (d, J = 8.5 Hz, 1H), 5.15 (s, 2H), 
4.74 (dd, J = 6.5, 13.5 Hz, 1H), 4.6–4.53 (m, 2H), 3.67 (s, 3H), 3.08 (dd, J = 5.5, 
14 Hz, 1H), 3.00–2.95 (m, 2H), 2.86–2.83 (m, 1H), 2.68 (dd, J = 4.5, 16 Hz, 1H), 
1.43 (s, 9H); 13C NMR (125.6 MHz, CDCl3) δ 171.6, 171.5, 170.4, 170.0, 155.9, 
136.5, 135.9, 135.7, 129.6, 129.4, 128.9, 128.8, 128.5, 128.4, 127.4, 127.3, 80.3, 
67.5, 54.6, 53.7, 52.6, 50.8, 38.4, 38.1, 28.5; ESI-HRMS calcd for C35H41N3O8Na 
[M + Na]+, 654.2834; found, 654.2791. 
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Boc-L-Glu(L-Ala-L-Phe-L-Phe-OMe)-OtBu (193) 
To a stirred solution of Boc-L-Glu(SH)-OtBu (0.094 mmol) and ENS-L-Ala-
L-Phe-L-Phe-OMe (40 mg, 0.063 mmol) in dry DMF (300 µL) was added cesium 
carbonate (31 mg, 0.094 mmol) at rt. The reaction mixture was stirred for 5 h 
before the it was diluted with ethyl acetate. The organic layer was washed with 
water and brine, dried over sodium sulfate and concentrated under reduced 
pressure. Chromatographic purification (10% Methanol: methylene chloride) 
afforded the desired product (35 mg, 83%). ESI-HRMS calcd for C36H50N4O9Na 
[M + Na]+, 705.3538; found, 705.3475. 
LCMS: 5-30% B over 1 min then 30-70% B over 4 min with a flow rate of 0.7 
mL/min and 195 nm UV detection, retention time = 3.38 min. 
Boc-L-Glu(L-Ala-L-Phe-L-Phe-OMe)-OtBu 193 (Reaction in aqueous buffer)[a] 
To a stirred solution of Boc-L-Glu(SH)-OtBu (0.094 mmol) in ligation buffer 
(0.3 mL, [4:1 v/v N-methyl-2-pyrrolidinone (NMP): 6 M guanidine hydrochloride, 1 
M HEPES, pH = 8][a]) was added ENS-L-Ala-L-Phe-L-Phe-OMe (40 mg, 0.063 
mmol) at rt. After stirring for 6 h the reaction mixture was diluted with ethyl 
acetate and the organic layer was washed with water and brine, dried over 
sodium sulfate and concentrated under reduced pressure. Chromatographic 
purification (10% methanol: methylene chloride) afforded the desired product (34 
mg, 80%). 
Boc-L-Glu(L-Ala-L-Phe-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt)-OtBu (194) 
To a stirred solution of Boc-L-Glu(SH)-OtBu (0.018 mmol) and ENS-L-Ala-
L-Phe-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (9 mg, 0.009 mmol) in dry DMF (100 µL) 
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was added cesium carbonate (6 mg, 0.018 mmol) at rt under a nitrogen 
atmosphere. After stirring for 6 h the reaction mixture was diluted with ethyl 
acetate and the organic layer was washed with water and brine, dried over 
sodium sulfate and concentrated under reduced pressure. Reversed phase 
HPLC purification (40–80% A with a flow rate of 10 mL/min over 50 min and 215 
nm UV detection, retention time = 21 min) provided the octapeptide with a yield 
of 6.6 mg (71%). ESI-HRMS calcd for C51H82N8O13SNa [M + Na]+, 1069.5726; 
found, 1069.5620.  
LCMS: 5-30% B over 1 min then 30-60% B over 4 min with a flow rate of 0.7 
mL/min and 195 nm UV detection, retention time = 3.60 min. 
Boc-L-Glu(L-Ala-L-Val-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt)-OtBu (195) 
To a stirred solution of Boc-L-Glu(SH)-OtBu (0.062 mmol) and ENS-L-Ala-
L-Val-L-Val-L-Met-L-Val-L-Pro-L-Ala-OEt (30 mg, 0.031 mmol) in dry DMF (150 
µL) was added cesium bicarbonate (24 mg, 0.124 mmol) at rt under a nitrogen 
atmosphere. The reaction mixture was stirred for 8 h before it was diluted with 
ethyl acetate and the organic layer was washed with water and brine, dried over 
sodium sulfate and concentrated under reduced pressure. Reversed phase 
HPLC purification (40–60% A with a flow rate of 10 mL/min over 40 min and 215 
nm UV detection, retention time = 22 min) provided the octapeptide with a yield 
of 20 mg (65%). ESI-HRMS calcd for C47H82N8O13S [M + H]+, 1021.5589; found, 
1021.5620.  
LCMS: 5-30% B over 1 min then 30-60% B over 4 min with a flow rate of 0.7 
mL/min and 195 nm UV detection, retention time = 3.05 min. 
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Reaction of Z-Gly-L-Phe-SH (110) + DNS-L-Val-OtBu (172) to give Z-Gly-L-
Phe-L-Val-OtBu (111)  
To a stirred solution of Z-Gly-L-Phe-SH (0.36 mmol) in DMF (1.0 mL) was added 
cesium carbonate (117 mg, 0.36 mmol) at 0 ºC. After 5 min, a solution of DNS-L-
Val-OtBu (97 mg, 0.24 mmol) in DMF (0.3 mL) was added to the reaction mixture 
at 0 ºC which was then stirred for 30 min at 0 ºC before the reaction mixture was 
quenched with 1 M HCl (4 mL). The organic layer was extracted with ethyl 
acetate followed by washing with water and brine, dried and concentrated. 
Chromatographic purification (50% ethyl acetate: Hexane) gave the desired 
product (87 mg, 71%). The product was analyzed for the presence of Z-Gly-D-
Phe-L-Val-OtBu by HPLC with the aid of an authentic sample. 
LCMS: 5-36.5% B over 1 min then 36.5-55% B over 4 min with a flow rate of 0.7 
mL/min and 215 nm UV detection, retention time = 3.62 min. 
Z-Gly-D-Phe-L-Val-OtBu: retention time = 3.77 min. 
FNS-L-Val-L-Val-STmob (197) 
To a stirred solution of L-valine t-butyl ester hydrochloride (200 mg, 0.95 
mmol) and the 2-nitro-4-trifluoromethylbenzenesulfonyl chloride (332 mg, 1.14 
mmol) in methylene chloride (7 mL) was added DIPEA (396 µL, 2.28 mmol) at rt. 
The reaction mixture was stirred for 4h before it was subjected to 
chromatographic purification to give the desired sulfonamide FNS-L-Val-OtBu 
(380 mg, 93%). 
FNS-L-Val-OtBu (380 mg, 0.89 mmol) was dissolved in a mixture of 70% 
TFA in methylene chloride (5 mL) with triethylsilane (200 µL) and stirred at rt for 1 
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h. Toluene (10 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude acid FNS-L-Val-OH which was applied immediately to 
the next step. 
To a stirred solution of the above prepared FNS-L-Val-OH, NH2-Val-
STmob (294 mg, 0.94 mmol) and HOBT (153 mg, 1.13 mmol) in dry methylene 
chloride (6 mL) was added EDCI (217 mg, 1.13 mmol) at 0 ºC. The reaction 
mixture was stirred at rt for 6 h, after which chromatographic purification (40% 
ethyl acetate: hexane) afforded the desired product (537 mg, 86%). [α]23D  –74.2 
(c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.23 (d, J = 8.5 Hz, 1H), 8.16 (d, J = 
1 Hz, 1H), 7.92 (dd, J = 1.0, 8.0 Hz, 1H), 6.39 (d, J = 9.0 Hz, 1H), 6.33 (d, J = 9.0 
Hz, 1H), 6.09 (s, 2H), 4.46–4.43 (m, 1H), 4.18 (dd, J = 12.5, 23.0 Hz, 2H), 3.97 
(dd, J = 5.0, 9.0 Hz, 1H), 3.80 (s, 3H), 3.77 (s, 6H), 2.24–2.20 (m, 1H),  2.10–
2.05 (m, 1H), 1.03 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.69 (d, J = 7.0 
Hz, 3H), 0.65 (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 199.5, 169.8, 
161.3, 159.4, 148.1, 137.7, 135.9, 135.6, 131.8, 129.9, 123.3, 123.2, 121.1, 
104.4, 90.7, 63.9, 63.3, 56.0, 55.6, 31.9, 31.8, 22.4, 19.6, 19.3, 17.2, 17.0; ESI-
HRMS calcd for C27H34N3O9F3S2Na [M + Na]+, 688.1586; found, 688.1697. 
FNS-L-Ala-L-Phe-OtBu (199) 
To a stirred solution of FNS-L-Ala-OH (380 mg, 1.11 mmol), L-
phenylalanine methyl ester hydrochloride (286 mg, 1.11 mmol) and HOBT (194 
mg, 1.44 mmol) in dry methylene chloride (7 mL) was added EDCI (277 mg, 1.44 
mmol) at 0 ºC followed by DIPEA (289 µL, 1.67 mmol) and the reaction mixture 
was stirred at rt for 5 h and then subjected to chromatographic purification (40% 
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ethyl acetate: hexane) which afforded the desired product (521 mg, 86%). [α]22D  
–2.8 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.17 (d, J = 8.0 Hz, 1H), 8.13 
(s, 1H), 7.87 (d, J = 8.0 Hz, 1H), 7.30–7.10 (m, 5H), 6.54 (d, J = 7.5 Hz, 1H), 6.20 
(d, J = 8.0 Hz, 1H), 4.56 (dd, J = 6.5, 14.0 Hz, 1H), 4.13–4.10 (m, 1H), 3.00 (dd, 
J = 6.0, 14.0 Hz, 2H), 2.93 (dd. J = 6.5, 14.0 Hz, 1H), 1.39–1.37 (m, 12H); 13C 
NMR (125.6 MHz, CDCl3) δ 170.3, 170.2, 148.1, 137.6, 136.1, 136.0, 135.7, 
132.0, 130.0, 129.9, 129.6, 128.7, 127.4, 123.3, 123.2, 123.2, 121.1, 83.0, 54.0, 
53.7, 38.2, 28.1, 19.9; ESI-HRMS calcd for C23H26N3O7F3SNa [M + Na]+, 
568.1341; found, 568.1355. 
FNS-L-Ala-L-Phe-L-Val-STmob (200) 
FNS-L-Ala-L-Phe-OtBu (300 mg, 0.55 mmol) was dissolved in a mixture of 
70% TFA in methylene chloride (7 mL) with triethylsilane (200 µL) and stirred at rt 
for 1 h. Toluene (15 mL) was added to the reaction mixture and then the solvents 
were removed to give the crude acid FNS-L-Ala-L-Phe-OH which was applied 
immediately to the next step. 
To a stirred solution of the above prepared FNS-L-Ala-L-Phe-OH and NH2-
L-Val-STmob (172 mg, 0.55 mmol) in dry methylene chloride (5 mL) was added 
HATU (316 mg, 0.83 mmol) at 0 ºC followed by DIPEA (239 µL, 1.38 mmol) and 
the reaction mixture was stirred at rt for 5 h before chromatographic purification 
(40% ethyl acetate: hexane) afforded the desired product (515 mg, 89%). [α]23D  
–13.4 (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 8.0 Hz, 1H), 8.08 
(d, J = 1.0 Hz, 1H), 7.82 (dd, J = 8.0, 1.0 Hz, 1H), 7.25–7.12 (m, 6H), 6.71 (d, J = 
9.0 Hz, 1H), 6.37 (d, J = 7.5 Hz, 1H), 6.10 (s, 2H), 4.70 (dd, J = 7.5, 14.5 Hz, 
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1H), 4.57 (dd, J = 5.0, 9.0 Hz, 1H), 4.24 (dd, J = 12.0, 18.0 Hz, 2H), 4.13 (t, J = 
7.5 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 6H), 3.10 (dd, J = 6.5, 14.0 Hz, 1H), 2.83 (dd, J 
= 7.5, 14.0 Hz, 1H), 2.20–2.16 (m, 1H), 1.31 (d. J = 7.0 Hz, 3H), 0.90 (d, J = 7.0 
Hz, 3H), 0.80 (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 199.6, 171.0, 
170.9, 161.2, 159.5, 148.1, 137.4, 136.3, 135.9, 135.6, 132.2, 129.9, 129.6, 
128.9, 127.3, 123.3, 123.0, 121.1, 104.5, 90.7, 67.3, 64.2, 58.4, 56.0, 55.6, 54.8, 
53.5, 38.4, 31.7, 22.5, 22.1, 19.4, 17.5; ESI-HRMS calcd for C34H39N4O10F3S2Na 
[M + Na]+, 807.1957; found, 807.1927. 
FNS-L-Val-L-Val-L-Phe-OMe (201) 
FNS-L-Val-L-Val-STmob (350 mg, 0.53 mmol) was dissolved in a mixture 
of 70% TFA in methylene chloride (5 mL) with triethylsilane (300 µL) and stirred 
at rt for 1.5 h. Toluene (8 mL) was added to the reaction mixture and then the 
solvents were removed to give the crude thioacid FNS-L-Val-L-Val-SH which was 
applied immediately to the next step. 
To a stirred solution of FNS-L-Val-L-Val-SH (0.15 mmol) and DNS-L-Phe-
OMe (41 mg, 0.10 mmol in dry DMF (0.5 mL) was added cesium bicarbonate (98 
mg, 0.05 mmol) at 0 ºC. The reaction mixture was stirred at 0 ºC for 30 min and 
then at rt for 2h before it was diluted with ethyl acetate. The organic layer was 
washed with water and brine, dried over sodium sulfate and concentrated under 
reduced pressure. Chromatographic purification (40% ethyl acetate: hexane) 
afforded the desired product (49 mg, 78%). [α]23D  –12.7 (c = 1, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 8.24 (d, J = 8.5 Hz, 1H), 8.15 (s, 1H), 7.92 (d, J = 8.0 Hz, 
1H), 7.26–7.22 (m, 3H), 7.07 (d, J = 6.5 Hz, 2H), 6.64 (d, J = 9.0 Hz, 1H), 6.40 
188 
 
 
 
(d, J = 8.5 Hz, 2H), 4.83 (dd, J = 6.5, 14.0 Hz, 1H), 4.16 (dd, J = 6.0, 8.5 Hz, 1H), 
3.87 (dd, J = 5.5, 8.5 Hz, 1H), 3.73 (s, 3H), 3.11 (dd, J = 5.5, 14.0 Hz, 1H), 3.03 
(dd, J = 6.5, 14.0 Hz, 1H), 2.55–2.11 (m, 1H), 1.86–1.22 (m, 1H), 0.94 (d, J = 6.5 
Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H), 0.70 (d, J = 7.0 Hz, 3H), 0.63 (d, J = 6.5 Hz, 
3H); 13C NMR (125.6 MHz, CDCl3) δ 171.8, 170.3, 169.9, 148.1, 137.4, 135.7, 
132.0, 129.9, 129.3, 128.9, 127.5, 123.2, 63.4, 58.5, 53.5, 52.7, 38.0, 31.9, 31.4, 
19.5, 19.0, 17.8, 17.5; ESI-HRMS calcd for C27H33N4O8SF3Na [M + Na]+, 
653.1869; found, 653.1863. 
Z-Gly-L-Val-L-Val-L-Phe-OMe (204) 
Z-Gly-STrt (50 mg, 0.11 mmol) was dissolved in a mixture of 10% TFA in 
methylene chloride (3 mL) with triethylsilane (100 µL) and stirred at rt for 10 min. 
Toluene (8 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude thioacid Z-Gly-SH which was applied immediately to 
the next step. 
To a stirred solution of Z-Gly-SH (0.11 mmol) in dry DMF (200 µL) was 
added cesium bicarbonate (70 mg, 0.36 mmol) followed by a solution of FNS-L-
Val-L-Val-L-Phe-OMe (45 mg, 0.071 mmol) in dry DMF (100 µL) rt. The reaction 
mixture was stirred for 12 h before it was diluted with ethyl acetate and the 
organic layer was washed with water and brine, dried over sodium sulfate and 
concentrated under reduced pressure. Chromatographic purification (5% 
methanol: methylene chloride) afforded the desired product. (28 mg, 69%).ESI-
HRMS calcd for C30H40N4O7Na [M + Na]+, 591.2795; found, 591.2833.  
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Alloc-Gly-Gly-L-Val-L-Val-L-Phe-OMe (205) 
Alloc-Gly-Gly-STmob (30 mg, 0.073 mmol) was dissolved in a mixture of 
70% TFA in methylene chloride (4 mL) with triethylsilane (200 µL) and stirred at rt 
for 1.5 h. Toluene (8 mL) was added to the reaction mixture and then the 
solvents were removed to give the crude thioacid Alloc-Gly-Gly-SH which was 
applied immediately to the next step. 
To a stirred solution of the above prepared Alloc-Gly-Gly-SH in dry DMF 
(200 µL) was added cesium bicarbonate (47 mg, 0.24 mmol) followed by a 
solution of FNS-L-Val-L-Val-L-Phe-OMe (31 mg, 0.048 mmol) in dry DMF (100 
µL) at rt. The reaction mixture was stirred for 18 h before it was diluted with ethyl 
acetate and the organic layer was washed with water and brine, dried over 
sodium sulfate and concentrated under reduced pressure. Reversed phase 
HPLC purification (45–100% A in B with a flow rate of 8 mL/min over 40 min and 
215 nm UV detection, retention time = 18 min) provided the pentapeptide with a 
yield of 19 mg (67%). ESI-HRMS calcd for C28H41N5O8Na [M + Na]+, 598.2853; 
found, 598.2897. 
FNS-L-Ala-L-Phe-L-Val-L-Val-L-Ala-L-Thr-L-Val-SFm (210) 
FNS-L-Ala-L-Phe-L-Val-STmob (100mg, 0.13 mmol) was dissolved in a 
mixture of 70% TFA in methylene chloride (4 mL) with triethylsilane (300 µL) and 
stirred at rt for 2 h. Toluene (10 mL) was added to the reaction mixture and then 
the solvents were removed to give the crude thioacid FNS-L-Ala-L-Phe-L-Val-SH 
which was applied immediately to the next step. 
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To a stirred solution of the above prepared FNS-L-Ala-L-Phe-L-Val-SH 
(0.13 mmol) and DNS-L-Val-L-Ala-L-Thr-L-Val-SFm (52 mg, 0.064 mmol in dry 
DMF (300 µL) was added cesium bicarbonate (63 mg, 0.32 mmol) at 0 ºC. After 
stirring at 0 ºC for 30 min and then at rt for 2h the reaction mixture was diluted 
with ethyl acetate and the organic layer was washed with 1M HCl solution, water 
and brine, dried over sodium sulfate and concentrated under reduced pressure. 
HPLC purification (40–100% A with a flow rate of 6-9 mL/min over 40 min and 
254 nm UV detection, retention time = 24 min) provided the heptapeptide with a 
yield of 49 mg (67%). ESI-HRMS calcd for C55H67N8O12S2F3Na [M + Na]+, 
1175.4170; found, 1175.4211. 
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system 
with 254 nm UV detection, using a Waters Cosmosil SC18-AR-300 analytical 
column (4.6 × 250 mm). 40-100% A over 25 min with a flow rate of 1.0 mL/min. 
Retention time = 10.264 min. 
Alloc-Gly-Gly-L-Ala-L-Phe-L-Val-L-Val-L-Ala-L-Thr-L-Val-SFm (211) 
To a stirred solution of Alloc-Gly-Gly-SH (0.078 mmol) and FNS-L-Ala-L-
Phe-L-Val-L-Val-L-Ala-L-Thr-L-Val-SFm (30 mg, 0.026 mmol) in dry DMF (300 µL) 
was added cesium bicarbonate (31 mg, 0.156 mmol) at rt. The reaction mixture 
was stirred for 10 h before it was diluted with ethyl acetate. The organic layer 
was washed with water and brine, dried over sodium sulfate and concentrated 
under reduced pressure. Reversed phase HPLC purification (40–100% A with a 
flow rate of 6-9 mL/min over 40 min and 254 nm UV detection, retention time = 
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23 min) provided the nonapeptide with a yield of 17 mg (61%). ESI-HRMS calcd 
for C56H75N9O12SNa [M + Na]+, 1120.5161; found, 1120.5154. 
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system 
with 254 nm UV detection, using a Waters Cosmosil SC18-AR-300 analytical 
column (4.6 × 250 mm). 40-100% A over 25 min with a flow rate of 1.0 mL/min. 
Retention time = 10.261 min. 
Fmoc-L-Phe-L-Ala-STmob (212) 
To a stirred solution of Fmoc-L-Phe-OH (387 mg, 1.0 mmol), NH2-L-Ala-
STmob (285 mg, 1.0 mmol) and HOBT (162 mg, 1.20 mmol) in dry methylene 
chloride (8 mL) was added EDCI (230 mg, 1.20 mmol) at 0 ºC. The reaction 
mixture was stirred at rt for 4 h, after which chromatographic purification (40% 
ethyl acetate: hexane) afforded the desired product (602 mg, 92%). [α]23D  –10.1 
(c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 7.5 Hz, 2H), 7.53 (d, J = 
7.5 Hz, 2H), 7.41 (t, J = 7.5 Hz, 2H), 7.31 (t, J = 7.5 Hz, 2H), 7.27–7.19 (m, 5H), 
6.51 (d, J = 5.5 Hz, 1H), 6.10 (s, 2H), 5.43 (d, J = 6.0 Hz, 1H), 4.71–4.68 (m, 1H), 
4.22–4.13 (m, 3H), 3.80 (s, 9H), 3.10 (d. J = 3.5 Hz, 2H), 1.36 (d, J = 6.5, 3H); 
13C NMR (125.6 MHz, CDCl3) δ 200.7, 170.6, 161.2, 159.5, 156.2, 144.0, 141.5, 
136.4, 129.7, 129.0, 128.0, 127.4, 125.4, 125.3, 120.2, 104.4, 90.7, 67.3, 56.3, 
56.0, 55.6, 55.1, 47.3, 38.7, 22.6, 19.5; ESI-HRMS calcd for C37H38N2O7SNa [M 
+ Na]+, 677.2297; found, 677.2295. 
DNS-L-Val-L-Ala-STmob 
DNS-L-Val-OtBu (380 mg, 0.94 mmol) was dissolved in a mixture of 70% 
TFA in methylene chloride (9 mL) with triethylsilane (200 µL) and stirred at rt for 1 
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h. Toluene (15 mL) was added to the reaction mixture and then the solvents were 
removed to give the crude acid DNS-L-Val-OH which was applied immediately to 
the next step. 
To a stirred solution of DNS-L-Val-OH (0.94 mmol), NH2-L-Ala-STmob 
(269 mg, 0.94 mmol) and HOBT (153 mg, 1.13 mmol) in dry methylene chloride 
(7 mL) was added EDCI (217 mg, 1.13 mmol) at 0 ºC. The reaction mixture was 
stirred at rt for 5 h before chromatographic purification (40% ethyl acetate: 
hexane) afforded the desired product (515 mg, 89%). [α]23D  –66.0 (c = 1, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 8.68 (d, J = 2.5 Hz, 1H), 8.47 (dd, J = 2.5, 8.5 Hz, 
1H), 8.28 (d, J = 8.5 Hz, 1H), 6.61 (d, J = 8.0 Hz, 1H), 6.35 (d, J = 9.0 Hz, 1H), 
6.08 (s, 2H), 4.49–4.46 (m, 1H), 4.15 (d, J = 1.5 Hz, 2H), 3.95 (dd, J = 5.0, 9.0 
Hz, 1H), 3.80 (s, 3H), 3.78 (s, 6H),  2.21–2.19 (m, 1H), 1.23 (d. J = 7.0 Hz, 3H), 
1.01 (d, J = 6.5 Hz, 3H), 0.94 (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 
200.5, 169.3, 161.3, 159.4, 150.0, 148.2, 139.6, 132.4, 127.3, 121.2, 104.0, 90.7, 
63.6, 56.0, 55.6, 55.2, 31.8, 22.6, 19.6, 19.5, 17.4; ESI-HRMS calcd for 
C24H30N4O11S2Na [M + Na]+, 637.1250; found, 637.1215. 
Fmoc-L-Phe-L-Ala-SH 
Fmoc-L-Phe-L-Ala-STmob (210 mg, 0.32 mmol) was dissolved in a mixture 
of 70% TFA in methylene chloride (5 mL) with triethylsilane (300 µL) and stirred 
at rt for 1.5 h. Toluene (8 mL) was added to the reaction mixture and then the 
solvents were removed to give the crude thioacid Fmoc-L-Phe-L-Ala-SH which 
was applied immediately to the next step. 
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Fmoc-L-Phe-L-Ala-L-Val-L-Ala-STmob (213) 
To a stirred solution of Fmoc-L-Phe-L-Ala-SH (0.32 mmol) in dry DMF (0.5 
mL) was added cesium bicarbonate (159 mg, 0.81 mmol) at 0 ºC followed by a 
solution of DNS-L-Val-L-Ala-STmob (166 mg, 0.27 mmol in dry DMF (1 mL). The 
reaction mixture was stirred at 0 ºC for 1 h and then at rt for 3 h before the 
reaction mixture was diluted with ethyl acetate. The organic layer was washed 
with water and brine, dried over sodium sulfate and concentrated under reduced 
pressure. Chromatographic purification (85% ethyl acetate: hexane) afforded the 
desired product (183 mg, 82%). ESI-HRMS calcd for C45H52N4O9SNa [M + Na]+, 
847.3353; found, 847.3425. 
LCMS: 5-98% B over 5 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 4.00 min. 
Fmoc-L-Phe-L-Ala-L-Val-L-Ala-SH (214) 
Fmoc-L-Phe-L-Ala-L-Val-L-Ala-STmob (10 mg, 0.012 mmol) was dissolved 
in a mixture of 70% TFA in methylene chloride (3 mL) with triethylsilane (100 µL) 
and stirred at rt for 1.5 h. Toluene (8 mL) was added to the reaction mixture and 
then the solvents were removed to give the crude thioacid Fmoc-L-Phe-L-Ala-L-
Val-L-Ala-SH which was applied immediately to the next step. 
Fmoc-L-Phe-L-Ala-L-Val-L-Ala-L-Val-L-Ala-L-Thr-L-Val-SFm (215) 
 To a stirred solution of Fmoc-L-Phe-L-Ala-L-Val-L-Ala-SH (0.012 mmol) in 
dry DMF (50 µL) was added cesium bicarbonate (8 mg, 0.04 mmol) at 0 ºC 
followed by a solution of DNS-L-Val-L-Ala-L-Thr-L-Val-SFm (6.5 mg, 0.008 mmol 
in dry DMF (100 µL). The reaction mixture was stirred at 0 ºC for 30 min and then 
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at rt for 2 h before it was diluted with ethyl acetate.  The organic layer was 
washed with water and brine, dried over sodium sulfate and concentrated under 
reduced pressure. Reversed phase HPLC purification (40–100% A with a flow 
rate of 8 mL/min over 45 min and 215 nm UV detection, retention time = 31 min) 
provided the octatapeptide with a yield of 7 mg (71%). ESI-HRMS calcd for 
C66H80N8O11SNa [M + Na]+, 1215.5565; found, 1215.5696.  
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system with 254 
nm UV detection, using a Varian Microsorb 300-5C18 analytical column (4.6 × 
250 mm). 40-100% A over 25 min with a flow rate of 0.7 mL/min. Retention time 
= 11.66 min. 
Fmoc-L-Phe-L-Ala-L-Val-L-Ala-L-Phe-L-Asn(Trt)-L-Asn(Trt)-L-Ile-L-Ala-OEt 
(216) 
To a stirred solution of Fmoc-L-Phe-L-Ala-L-Val-L-Ala-SH (0.012 mmol) in 
dry DMF (100 µL) was added cesium bicarbonate (8 mg, 0.04 mmol) at 0 ºC 
followed by a solution of DNS-L-Val-L-Ala-L-Thr-L-Val-SFm (11 mg, 0.008 mmol) 
in dry DMF (50 µL). The reaction mixture was stirred at 0 ºC for 30 min and then 
at rt for 2 h before it was diluted with ethyl acetate.  The organic layer was 
washed with water and brine, dried over sodium sulfate and concentrated under 
reduced pressure. Reversed phase HPLC purification (45–100% A with a flow 
rate of 7 mL/min over 40 min and 215 nm UV detection, retention time = 32 min) 
provided the octatapeptide with a yield of 10 mg (68%). ESI-HRMS calcd for 
C101H109N11O14Na [M + H]+, 1722.8053; found, 1722.8152.  
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LCMS: 5-98% B over 5 min with a flow rate of 0.5 mL/min and 254 nm UV 
detection, retention time = 4.40 min. 
General Procedure 5 for the Preparation of Schiff Bases 
 
To a stirred solution of free amine (0.92 mmol) and 2-fluoro-5-
nitrobenzaldehyde (0.61 mmol) in dry methylene chloride (6 mL) was added 
sodium sulfate (2 g) at rt. After 14 h, the reaction mixure was filtered and washed 
with more methylene chloride. The filterate was concentrated and subjected to 
chromatographic purification to afford the desired products. 
N-(2-fluoro-5-nitrobenzylidene)-2-phenylethylamine (217) 
Prepared by the general procedure 5 with a yield of 544 mg (100%). 1H 
NMR (300 MHz, CDCl3) δ 8.89 (dd, J = 2.4, 5.7 Hz, 1H), 8.42 (s, 1H), 8.30–8.24 
(m, 1H), 7.33–7.19 (m, 6H), 3.95 (t, J = 7.5 Hz, 2H), 3.06 (t, J = 7.5 Hz, 2H); 13C 
NMR (75 MHz, CDCl3) δ 152.6 (d, J = 4.5 Hz), 139.6, 129.2, 128.7, 127.3, 127.2, 
126.5, 124.2 (d, J = 5.0 Hz), 117.3 (d, J = 23 Hz), 63.5, 37.4. ESI-HRMS calcd 
for C15H13N2O2FNa [M + Na]+, 272.0961; found, 272.0967.  
Methyl 2-((2-fluoro-5-nitrobenzylidene)amino)-3-(1H-indol-3-yl)propanoate 
(218) 
Prepared by the general procedure 5 with a yield of 625 mg (99%), Mp 
109-110 oC; 1H NMR (500 MHz, CDCl3) δ 8.90 (dd, J = 2.5, 5.5 Hz, 1H), 8.26–
8.23 (m, 1H), 8.14 (s, 1H), 8.04 (s, 1H), 7.64 (d, J = 7.5 Hz, 1H), 7.32 (d, J = 8.5 
Hz, 1H), 7.18–7.09 (m, 3H), 6.99 (d, J = 2 Hz, 1H), 4.36 (dd, J = 4.5, 8.5 Hz, 1H), 
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3.79 (s, 3H), 3.58 (dd, J = 4.5, 14.5 Hz, 1H), 3.33 (dd, J = 9.0, 14.5 Hz, 1H); 13C 
NMR (125.6 MHz, CDCl3) δ 172.1, 166.2, 164.1, 154.8 (d, J = 14.5 Hz), 144.8, 
136.4, 127.7, 127.6, 127.5, 124.8, 124.7, 124.6, 123.5, 122.4, 119.8, 119.1, 
117.2 (d, J = 96.5 Hz), 111.4 (d, J = 33 Hz), 74.2, 52.7, 29.6. ESI-HRMS calcd 
for C19H16N3O4FNa [M + Na]+, 369.1125; found, 369.1135. 
Boc-L-Ala-STmob (222) 
To a stirred solution of Boc-L-Ala-OH (500 mg, 2.64 mmol), 2,4,6-
trimethoxybenzylthiol (563 mg, 2.64 mmol) and HOBT (428 mg, 3.17 mmol) in 
dry methylene chloride (8 mL) was added EDCI (608 mg, 3.17 mmol) at 0 ºC. 
Stirring was continued at rt over night before chromatographic purification (30% 
ethyl acetate: hexane) afforded the desired product (886 mg, 87%). [α]23D  –55.8 
(c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.09 (s, 2H), 5.08 (d, J = 7.5 Hz, 
1H), 4.40 (t, J = 7.0 Hz, 1H), 4.18 (d, J = 1 Hz, 2H), 3.79 (s, 3H), 3.78 (s, 6H), 
1.43 (s, 9H), 1.37 (d. J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 202.5, 
161.1, 159.5, 155.2, 104.8, 90.7, 80.1, 56.4, 56.0, 55.6, 28.6, 22.4, 19.5; ESI-
HRMS calcd for C18H27NO6SNa [M + Na]+, 408.1457; found, 408.1484. 
NH2-L-Ala-STmob (223) 
Boc-L-Ala-STmob (186 mg, 0.45 mmol) was dissolved in a mixture of 40% 
TFA in methylene chloride (4 mL) and stirred at rt for 5 min. The solvents were 
removed and the the organic layer was extracted with ethyl acetate followed by 
washing with 20% aqueous sodium carbonate solution. The organic layer was 
dried over sodium sulfate, concentrated under reduced pressure and purified by 
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column chromatography to afford the free amine which was applied immediately 
to the next step. 
General Procedure 6 for the Coupling of Thioacids with the Schiff Bases 
To a stirred solution of thioacid (0.41 mmol) in dry DMF (1.5 mL) was 
added cesium bicarbonate (1.35 mmol) followed by the addition of Schiff base 
(0.27 mmol) at rt. After stirring of 4-12 h at rt, the reaction mixture was diluted 
with ethyl acetate. The organic layer was washed with water and brine, dried, 
concentrated. Chromatographic purification afforded the desired peptides. 
General Procedure 7 for the Synthesis of Fmoc Protected Peptide tert Butyl 
Esters 
 
To a stirred solution of Fmoc protected amino acid (1 mmol), glycine tert 
butyl ester hydrochloride (1 mmol) and HOBT (1.2 mmol) in dry methylene 
chloride (10 mL) was added EDCI (1.2 mmol) followed by the addition of DIPEA 
(3 mmol) at 0 oC. After stirring of 30 min at 0 oC, the reaction mixture was 
warmed up to rt and stirred for 2 h. The solvents were removed and the product 
was purified by column chromatography over silica gel. 
Fmoc-D-Phe-Gly-OtBu (249) 
Prepared by the general procedure 7 with a yield of 1.15 g (89%), [α]22D 
+16.1 (in CHCl3); IR (CHCl3) 1740, 1705, 1660 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.76 (d, J = 8.0 Hz, 2H), 7.53 (dd, J = 8.0, 10.5 Hz, 2H), 7.41 (t, J = 7.5 Hz, 
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2H), 8.33–7.22 (m, 7H), 6.32 (s, 1H), 5.37 (d, J = 5.5 Hz, 1H), 4.50–4.33 (m, 3H), 
4.19 (t, J = 7.0 Hz, 1H), 3.96–3.82 (m, 2H), 3.12 (s, 2H), 1.46 (s, 9H); 13C NMR 
(125.6 MHz, CDCl3) δ 172.0, 168.7, 156.2, 144.0, 141.5, 136.6, 129.5, 129.0, 
128.0, 127.4, 127.3, 125.3, 120.2, 82.7, 67.3, 56.3, 47.3, 42.3, 38.7, 28.3. ESI-
HRMS calcd for C30H32N2O5Na [M + Na]+, 523.2209; found, 523.2217.  
Fmoc-Gly-Gly-OtBu (250) 
Prepared by the general procedure 7 with a yield of 4.23 g (84%), IR 
(CHCl3) 1739, 1704, 1660 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 7.5 Hz, 
2H), 7.60 (d, J = 7.5 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.31 (dt, J = 7.0, 0.5 Hz, 
2H), 6.65 (s, 1H), 5.73 (t, J = 5.5 Hz, 1H), 4.43 (d, J = 7.0 Hz, 2H), 4.22 (t, J = 7.0 
Hz, 1H), 3.95 (t, J = 6.0 Hz, 4H), 1.47 (s, 9H); 13C NMR (125.6 MHz, CDCl3) δ 
169.4, 169.1, 156.9, 144.0, 141.5, 128.0, 127.3, 125.3, 120.2, 82.8, 67.5, 47.3, 
44.6, 42.2, 28.3. ESI-HRMS calcd for C23H26N2O5Na [M + Na]+, 433.1739; found, 
433.1732.  
General Procedure 8 for the Synthesis of Thioamide Linkers 
 
A solution of Fmoc protected peptide tert butyl esters (4 mmol) and 
Lawesson’s reagent (2.4 mmol) in dry toluene (40 mL) was heated to reflux 
under nitrogen for 2 h. After cooling down to rt, toluene was removed and the 
crude was subjected to column chromatography.  
 The resulting thioamides tert butyl esters were dissolved in a mixture of 
TFA/CH2Cl2/Et3SiH (15.0/5.0/2.0 mL). After 2 h of stirring at rt, the solvents were 
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removed and the product was washed with 40% ethyl acetate/hexanes to afford 
the desired products. 
Fmoc-L-Phe-Gly-OH Thioamide Linker (251) 
Prepared by the general procedure 8 with a yield of 1.20 g (78%), [α]24D -
12.1 (c = 0.75, CH3OH); IR (CHCl3) 3305, 1720, 1705, 1247 cm-1; 1H NMR (500 
MHz, CD3OD) δ 7.77 (d, J = 7.5 Hz, 2H), 7.56 (t, J = 9.0Hz, 2H), 7.37 (t, J = 7.5 
Hz, 2H), 7.31–7.19 (m, 7H), 4.76 (dd, J = 5.0, 9.5 Hz, 1H), 4.35–4.10 (m, 5H), 
3.36–3.31 (m, 1H), 2.94 (dd, J = 10.0, 13.0 Hz, 1H); 13C NMR (125.6 MHz, 
CD3OD) δ 205.3, 170.2, 156.8, 144.0, 141.3, 137.7, 129.2, 128.2, 127.6, 127.0, 
126.5, 125.2, 125.1, 119.7, 71.2, 66.9, 62.8, 48.7, 47.5, 47.3, 47.1, 46.3, 41.4. 
ESI-HRMS calcd for C26H24N2O4SNa [M + Na]+, 483.1354; found, 483.1346.  
Fmoc-D-Phe-Gly-OH Thioamide Linker (252) 
Prepared by the general procedure 8 with a yield of 1.15 g (76%), [α]24D 
+10.5 (c = 0.5, CH3OH); IR (CHCl3) 3305, 1720, 1705, 1247 cm-1; 1H NMR (500 
MHz, CD3OD) δ 7.77 (d, J = 7.5 Hz, 2H), 7.56 (t, J = 9.0Hz, 2H), 7.37 (t, J = 7.5 
Hz, 2H), 7.31–7.19 (m, 7H), 4.76 (dd, J = 5.0, 9.5 Hz, 1H), 4.35–4.10 (m, 5H), 
3.36–3.31 (m, 1H), 2.94 (dd, J = 10.0, 13.0 Hz, 1H); 13C NMR (125.6 MHz, 
CD3OD) δ 205.3, 170.2, 156.8, 144.0, 141.3, 137.7, 129.2, 128.2, 127.6, 127.0, 
126.5, 125.2, 125.1, 119.7, 71.2, 66.9, 62.8, 48.7, 47.5, 47.3, 47.1, 46.3, 41.4. 
ESI-HRMS calcd for C26H24N2O4SNa [M + Na]+, 483.1354; found, 483.1359. 
Fmoc-Gly-Gly-OH Thioamide Linker (253) 
Prepared by the general procedure 8 with a yield of 2.60 g (72%), IR 
(CHCl3) 3295, 1725, 1714, 1247 cm-1; 1H NMR (500 MHz, CD3OD) δ 7.75 (d, J = 
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7.5 Hz, 2H), 7.65 (d, J = 7.5 Hz, 2H), 7.36 (t, J = 7.5 Hz, 2H), 7.26 (t, J = 7.0 Hz, 
2H), 4.38–4.34 (m, 4H), 4.20–4.19 (m, 3H); 13C NMR (125.6 MHz, CD3OD) δ 
201.4, 170.5, 157.9, 144.1, 141.4, 127.7, 127.1, 125.1, 119.8, 67.1, 51.3, 48.8, 
48.4, 47.4, 47.2, 46.3. ESI-HRMS calcd for C19H18N2O4SNa [M + Na]+, 393.0885; 
found, 393.0891.  
Synthesis of the both L- and D-Diastereomers of L-Val-L-Ala-Phe-SBn  
Derivatization of aminomethyl polystyrene resin with Fmoc-Phe-Gly-
OH thioamides linkers (254 and 255): In a 10 mL glass reaction vessel, 
aminomethyl polystyrene resin (244 mg, 0.1 mmol) was swelled in DMF (4 mL) 
for 30 min, after which the solvent was removed by filtration. To a stirred solution 
of thioamides linker 254 or 255 (184 mg, 0.4 mmol), HOBT (54 mg, 0.4 mmol) 
and HBTU (152 mg, 0.4 mmol) in dry DMF (3 mL) was added DIPEA (70 µL, 0.4 
mmol) at room temperature. The reaction mixture was stirred for 4 min before the 
activated HOBt ester of 254 or 255 was added to the reaction vessel with an 
additional DMF (1 mL) which was then shaken for 2 h before the resin was 
washed thoroughly using DMF (3 × 2 mL) and DCM (3 × 2 mL). 
Iterative peptide assembly: The Fmoc group was removed with 20% 
piperidine in DMF. After Fmoc removal, the resin was washed with DMF (2x5 
mL), methylene chloride (2x5 mL), isopropanol (2x5 mL) and hexane (2x5 mL). 
All couplings were carried out by adding a preactivated solution of protected 
amino acid (0.4 mmol), HOBT (0.4 mmol), DIPEA (0.4 mmol), and HBTU (0.4 
mmol) in dry DMF (4.0 mL) to the resin. After 2 h, the resin was washed with 
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DMF (2x5 mL), methylene chloride (2x5 mL) and DMF (2x5 mL). The peptide 
chain was terminated with the Boc protected amino acid (Boc-L-Val-OH). 
Alkylation of resin bound peptide thioamides: After completion of the 
on-resin procedure, the resin-bound peptide was treated with a solution of DBU 
(150 µL, 1 mmol) and benzyl bromide (107 µL, 0.9 mmol) in DMF (4 mL). After 2 
h, the resin was washed with DMF (2x5 mL), methylene chloride (2x5 mL) and 
DMF (2x5 mL) and dried to provide the resin bound thioimidate. 
Cleavage from the resin: The resin bound thioimidate was suspended in 
a 10 mL mixture of TFA/water (1:1) and stirred magnetically for 2 h at rt. The 
resin was filtered and washed twice with 10 mL of acetonitrile. The combined 
filtrates were concentrated and the concentrate was neutralized with a saturated 
solution of sodium bicarbonate (40 mL) followed by the extraction with chloroform 
150 mL (3x50 mL). Then the organic layer was washed with brine and dried. 
Evaporation of the solvent in a rotovapor afforded the crude peptide thioester, 
which was subjected to chromatographic purification over silica gel. 
L-Val-L-Ala-L-Phe-SBn (254) 
Following the above described procedure with a yield of 32 mg (72%). 1H NMR of 
the 241 shows epimerization (ratio, L/D = 78.1/21.9). ESI-HRMS calcd for 
C24H32N3O3S [M + H]+, 442.2164; found, 442.2168. 
L-Val-L-Ala-D-Phe-SBn (255) 
Following the above described procedure with a yield of 33 mg (74%). 1H NMR of 
the 241 shows epimerization (ratio, L/D = 22.5/77.5). ESI-HRMS calcd for 
C24H32N3O3S [M + H]+, 442.2164; found, 442.2158. 
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Fmoc-SPPS of Peptidyl Thioesters on the 2-Chlorotrityl Resin 
Derivatization of 2-chlorotrityl resin with 257: In a 10 mL glass reaction 
vessel, 2-Chlorotrityl chloride resin (117 mg, 0.1 mmol) was suspended in 
methylene chloride (5 mL) shaken for 5 min and filtered. A solution of 257 (149 
mg, 0.4 mmol) and DIPEA (174 µL, 1.0 mmol) in methylene chloride (4 mL) was 
added to the resin, shaken for 2 h at rt, and filtered. The resin was washed with 
DMF (2x 5 mL) and capped with 5.0 mL of a mixture of methylene 
chloride/MeOH/DIPEA (80:15:5). 
Iterative peptide assembly: The Fmoc group was removed with 20% 
piperidine in DMF. After Fmoc removal, the resin was washed with DMF (2x5 
mL), methylene chloride (2x5 mL), isopropanol (2x5 mL) and hexane (2x5 mL). 
All couplings were carried out by adding a preactivated solution of protected 
amino acid (0.4 mmol), HOBT (0.4 mmol), DIPEA (0.4 mmol), and HBTU (0.4 
mmol) in dry DMF (4.0 mL) to the resin. After 2 h, the resin was washed with 
DMF (2x5 mL), methylene chloride (2x5 mL) and DMF (2x5 mL). The peptide 
chain was terminated with the Boc protected amino acid. 
Alkylation of resin bound peptide thioamides: After completion of the 
on-resin procedure, the resin-bound peptide was treated with a solution of DBU 
(150 µL, 1 mmol) and benzyl bromide (107 µL, 0.9 mmol) in DMF (4 mL). After 2 
h, the resin was washed with DMF (2x5 mL), methylene chloride (2x5 mL) and 
DMF (2x5 mL) and dried to provide the resin bound thioimidate. 
Cleavage from the resin: The resin bound thioimidate was suspended in 
a 12 mL mixture of TFA/water/Anisole (6/5/1 mL) and stirred magnetically for 2 h 
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at rt. 20 mL of additional TFA/DCM/Et3SIH (15/4/1 mL) was added to the reaction 
mixture and stirred for 4 h. The resin was filtered and washed twice with 10 mL of 
acetonitrile. The combined filtrates were concentrated and the concentrate was 
subsequently dissolved in acetonitrile/water (v/v 1:1, 5 mL) and subjected to RP-
HPLC purification (10 - 100% A in B with a flow rate of 12 mL/min over 40 min 
and 215 nm UV detection) to afford the peptide thioester. 
L-Thr-L-Ala-L-Ser-L-Phe-L-Ser-L-Leu-Gly-SBn (262) 
Reversed phase HPLC purification (10–100% A with a flow rate of 12 
mL/min over 40 min and 215 nm UV detection, retention time = 22 min) provided 
the heptapeptide thioester with a yield of 51 mg (57%). ESI-HRMS calcd for 
C37H54N7O10S [M + H]+, 788.3653; found, 788.3661.  
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system 
with 254 nm UV detection, using a Waters Cosmosil SC18-AR-300 analytical 
column (4.6 × 250 mm). 10–90% A over 30 min with a flow rate of 1.0 mL/min. 
Retention time = 15.52 min. 
L-Thr-L-Phe-L-Tyr-L-Ser-L-Ala-L-Tyr-Gly-SBn (263) 
Reversed phase HPLC purification (10–100% A with a flow rate of 12 
mL/min over 40 min and 215 nm UV detection, retention time = 26 min) provided 
the heptapeptide thioester with a yield of 57 mg (56%). ESI-HRMS calcd for 
C46H56N7O11S [M + H]+, 914.3759; found, 914.3768.  
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system 
with 254 nm UV detection, using a Waters Cosmosil SC18-AR-300 analytical 
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column (4.6 × 250 mm). 10–90% A over 30 min with a flow rate of 1.0 mL/min. 
Retention time = 17.90 min. 
L-Asn-L-Trp-L-Arg-L-Tyr-L-Ile-L-Ser-L-Thr-L-Phe-Gly-SBn (264) 
Reversed phase HPLC purification (10–100% A with a flow rate of 12 
mL/min over 40 min and 215 nm UV detection, retention time = 31 min) provided 
the nonapeptide thioester with a yield of 76 mg (48%). ESI-HRMS calcd for 
C61H81N14O13S [M + H]+, 1249.5828; found, 1249.5849.  
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system 
with 254 nm UV detection, using a Waters Cosmosil SC18-AR-300 analytical 
column (4.6 × 250 mm). 10–90% A over 30 min with a flow rate of 1.0 mL/min. 
Retention time = 23.18 min. 
L-Glu-L-Met-L-Arg-Gly-SBn (266) 
Derivatization of aminomethyl polystyrene resin with Fmoc-Gly-Gly-
OH thioamides linker (253): In a 10 mL glass reaction vessel, aminomethyl 
polystyrene resin (244 mg, 0.1 mmol) was swelled in DMF (4 mL) for 30 min, 
after which the solvent was removed by filtration. To a stirred solution of 
thioamides linker 253 (154 mg, 0.4 mmol) and HBTU (152 mg, 0.4 mmol) in dry 
DMF (3 mL) was added DIPEA (70 µL, 0.4 mmol) at room temperature. The 
reaction mixture was stirred for 4 min before the activated HOBt ester of 253 was 
added to the reaction vessel with an additional DMF (1 mL) which was then 
shaken for 2 h before the resin was washed thoroughly using DMF (3 × 2 mL) 
and DCM (3 × 2 mL). 
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Iterative peptide assembly: The Fmoc group was removed with 20% 
piperidine in DMF. After Fmoc removal, the resin was washed with DMF (2x5 
mL), methylene chloride (2x5 mL), isopropanol (2x5 mL) and hexane (2x5 mL). 
All couplings were carried out by adding a preactivated solution of protected 
amino acid (0.4 mmol), HOBT (0.4 mmol), DIPEA (0.4 mmol), and HBTU (0.4 
mmol) in dry DMF (4.0 mL) to the resin. After 2 h, the resin was washed with 
DMF (2x5 mL), methylene chloride (2x5 mL) and DMF (2x5 mL). The peptide 
chain was terminated with the Boc protected amino acid (Boc-L-Glu(OtBu)-OH). 
Alkylation of resin bound peptide thioamides: After completion of the 
on-resin procedure, the resin-bound peptide was treated with a solution of DBU 
(150 µL, 1 mmol) and benzyl bromide (107 µL, 0.9 mmol) in DMF (4 mL). After 2 
h, the resin was washed with DMF (2x5 mL), methylene chloride (2x5 mL) and 
DMF (2x5 mL) and dried to provide the resin bound thioimidate. 
Cleavage from the resin: The resin bound thioimidate was suspended in 
a 12 mL mixture of TFA/water/Anisole (6/5/1 mL) and stirred magnetically for 2 h 
at rt. 20 mL of additional TFA/DCM/Et3SIH (15/4/1 mL) was added to the reaction 
mixture and stirred for 4 h. The reaction mixture was now treated with NH4I/Me2S 
(25 mg/100 µL) to reduce the sulfoxide moiety. The resin was filtered and 
washed twice with 10 mL of acetonitrile. The combined filtrates were 
concentrated and the concentrate was subsequently dissolved in 
acetonitrile/water (v/v 1:1, 5 mL) and subjected to RP-HPLC purification (10 - 
100% A in B with a flow rate of 12 mL/min over 40 min and 215 nm UV detection, 
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retention time 22 min) to afford the tetrapeptide thioester with a yield of 51 mg 
(62%). ESI-HRMS calcd for C25H40N7O6S2 [M + H]+, 598.2481; found, 598.2492.  
HPLC Analysis was performed on a Varian Prep Star 218 HPLC system 
with 254 nm UV detection, using a Waters Cosmosil SC18-AR-300 analytical 
column (4.6 × 250 mm). 10–90% A over 30 min with a flow rate of 1.0 mL/min. 
Retention time = 15.44 min. 
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ABSTRACT 
CHEMICAL SYNTHESIS OF PEPTIDES AND PEPTIDE THIOESTERS 
by 
INDRAJEET SHARMA 
May 2011 
Advisor:  Dr. David Crich 
Major: Chemistry 
Degree: Doctor of Philosophy 
This dissertation describes investigations toward the development of a 
new chemistry for the block synthesis of peptides and peptidyl thioesters. A direct 
approach for the Fmoc-SPPS of peptidyl thioesters is also delineated in this 
thesis. 
In the first part of chapter one, the difficulty and importance of chemical 
synthesis of peptides is explained, and a brief survey of available methods is 
given. The second part of chapter one presents the challenges inherent in the 
synthesis of peptidyl thioesters by Fmoc-SPPS. 
The second chapter outlines the investigations conducted towards the 
development of a new chemistry for epimerization-free block synthesis of 
peptides from thioacids and amines by a process involving the in situ formation of 
highly active thioesters by nucleophilic aromatic substitution of C-terminal 
thioacids on electron-deficient halogenoarenes. The superiority of this new 
chemistry over available methods is illustrated through direct comparisons in the 
block synthesis of an octapeptide. 
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In chapter three, studies carried out to probe the reactivity of N-terminal 
sulfonamides towards peptidyl thioacids are presented.  Studies directed at 
determining the optimal sulfonamide for use in convergent multiple peptide 
fragment ligation are presented as is the application of these sulfonamides in 
both left to right and right to left block synthesis of peptides.. Model studies on 
the development of an intramolecular variant of the thioacid/sulfonamide coupling 
are also presented in this chapter. 
Continuing the theme, Chapter 4 presents studies undertaken with the 
goal of developing a direct method for the efficient synthesis of peptidyl 
thioesters by the widely used Fmoc-SPPS chemistry. A method to construct the 
thioester functionality from thioamides is described based on alkylation to give an 
intermediate thioimide and its subsequent hydrolysis. The application of this 
methodology to the synthesis of functionality diverse oligo-peptide thioesters is 
also presented. 
In chapter five, the overall conclusions of the dissertation are presented, 
while in chapter six, the experimental procedures and characterization data for 
the synthesized compounds are documented. 
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